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Abstract
Before any novel biochemical device is fabricated, one needs to know that the technology 
and methodology being used are the most efficient. In the case of immobilised proteins, 
one needs to know that the method used will not harm the protein and that the 
conjugation technique used facilitates the highest binding efficiencies for the protein in 
question.
Three methods from literature (non-specific binding, non-covalent binding and covalent 
binding) were used to conjugate bovine serum albumin (BSA) to single-walled carbon 
nanotubes (SWNTs). Efforts to use simple methods for protein concentration 
determination were hampered by the strong absorbance and interference from the 
nanotubes themselves. FITC tagged BSA was then used to investigate the conjugation 
methods. This technique was also subject to interference from the nanotubes when they 
were present. However, the subtraction of the amount of BSA removed from the 
nanotubes during washing was found to be accurate enough to compare the different 
conjugation techniques used. This showed that non-specific binding was the best method 
for conjugation, with approximately 79% of the original BSA remaining on the nanotubes 
after eight washes. The non-covalent and covalent method showed efficiencies of 54 and 
60% respectively.
A novel method for protein binding was investigated. This involved using a short DNA 
oligonucleotide as a tether for binding. The protein concentration was investigated as 
before using fluorescent BSA. This showed that approximately 88% of the BSA originally 
added remained on the nanotubes after washing. This value is higher than the other 
methods investigated and therefore this was the best technique.
In addition to BSA conjugation, the enzyme urease was attached using non-specific 
binding and non-covalent conjugation. An attempt was made to determine the amount 
of urease bound through an assessment of its catalytic activity. This investigation was 
unable to accurately determine the amount of urease present, but did show there to be a 
difference in the amount of urease bound to SWNTs using either non-specific binding and 
non-covalent binding.
The investigation of the best method for protein immobilisation in this thesis has shown 
that the novel DNA mediated conjugation is the most efficient, closely followed by the
simplest method, non-specific binding. Both of these methods can allow the protein to 
remain structurally intact, an important factor to consider in the creation of novel 
devices.
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Chapter 1. Introduction
Chapter 1. Introduction
Nanotechnology is quite literally technology on the 'dwarf scale. The prefix 'nano' comes 
from the Greek for dwarf; in science, it means lx lO '9. In terms of size, one nanometre 
(nm) is one billionth of a metre. Nanotechnology is concerned with the study and control 
of matter on the atomic and molecular scale, and generally incorporates any technologies 
which fall between 0.2nm (atomic scale) and 100nm.lt has a huge number of applications, 
spanning every discipline of scientific research.
Nanotechnology as we perceive it today is a relatively new term, whereas in reality it has 
been around for millennia. The Romans, although not truly understanding the underlying 
science, milled gold into nanoparticles to pigment the glaze on their vases. The fourth 
century A.D Lycurgus cup (Figure 1.1) contained gold and silver particles within the soda 
lime glass, causing the colour of the glass to change from green to red when illuminated. 
The many different pigments in medieval stained glass windows are also due to the 
presence of nanoparticles. A more modern commercial use of nanotechnology is the 
incorporation of titanium nanoparticles into sunscreens.
Figure 1.1: The Lycurgus Cup, from the 4th century AD. Colloidal silver and gold in the glass alter 
the colour of the cup when illuminated internally (right).
The potential impact that nanotechnology could have on society is vast. It holds the 
potential to allow the creation of new materials for all types of applications in every walk 
of life. Conversely, nanotechnology also poses many questions and potential risks. The
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impact of using such small manmade structures, both good and bad, on the environment 
and on ourselves is under much debate.
1.1 Bionanotechnology
According to a Royal Society report, bionanotechnology is:
"Concerned with molecular-scale properties and applications of biological nanostructures 
and as such sits at the interface between the chemical, biological and the physical
sciences."t1*
Bionanotechnology is not concerned with the production or modification of biological 
material. It incorporates biological material into nanotechnology, as many biological 
materials fall within the nanotechnology scale. DNA for example, is approximately 2nm in 
diameter. A human hair is around 80pm in diameter, 40000 times bigger.
Biomolecules, including DNA and proteins, represent natural nanoscale engineering. They 
have structure at the sub-nanometre level and have evolved over billions of years to 
perform dynamic tasks in the living cell. They are thus of great interest to the scientific 
community and can be used both in their natural capacity or engineered and adapted to 
suit the need.
Proteins can be classed as nanoparticles. They hold practically any shape and are found 
up to 50nm in size. Amino acids, the protein building blocks, are each approximately
0.6nm in size. A DNA molecule is essentially a double nanowire twisted around each 
other. It has a diameter of 2nm and every 3.4nm (10 nucleotide units) the nanowire 
structure is repeated, albeit with a different chemical make-up. If one were to put all the 
DNA contained within a human cell end to end, it would stretch to around 2 metres, well 
out of the nano range. The smallest individual human DNA molecule, chromosome 21, is 
approximately 1.5pm in length. Even viruses, essentially a collection of proteins and 
nucleic material (either DNA or RNA) could be classified as nanoparticles, as they are 
generally between 1 and 200nm in diameter.
With any novel material, a lot of research must be undertaken to fully understand the 
potential that the new material can possess. For carbon nanotubes (CNTs), the potential 
is immense and stretches across almost all scientific disciplines. The properties of carbon 
nanotubes and their applications shall be examined in sections 1.3 and 1.5.
2
Chapter 1. Introduction
One however cannot get carried away with all the weird and wonderful new properties 
and applications that could be brought about using CNTs. The fundamental basics need 
to be studied to fully realise the potential of this material. For this reason, the research 
presented in this thesis will investigate methods of binding an exemplar protein (bovine 
serum albumin, BSA) to carbon nanotubes. Three previously established methods for 
protein conjugation to single walled carbon nanotubes (SWNTs) will be compared with a 
view to establishing which is the best for conjugation efficiency. In order to assess this, a 
method for determining the protein load on carbon nanotubes in bulk solution is 
established. As will be explained, none of the conventional methods for protein 
concentration determination can be used in the presence of CNTs, and so a method 
involving fluorescent tagged proteins will be utilized. This method will then be used to 
compare the binding efficiency of each method employed.
In addition, a novel method for protein conjugation involving DNA will be investigated 
and compared to the established methods. Two of the conjugation methods will then be 
used to attach the enzyme urease to the carbon nanotubes, and the enzyme will be 
assayed for activity.
The attachment of proteins to nanotubes in this thesis has been carried out with a view to 
their use in biosensor type devices. Although not used in a sensor capacity, bovine serum 
albumin as a model protein allows one to determine how efficient the construction of the 
sensing component of the biosensor could be. Of all the biosensors, apart from glucose, 
urea level is one of the most frequent requests from doctors, along with the electrolyte 
levels*2*. Urea levels are determined using the enzymatic action of urease, the second 
protein used in this study.
1.2 Biosensors and Biosensing
Many definitions for a biosensor exist; however, the general consensus is that a biosensor 
is an analytical device that, using a biological component as a sensing element closely 
associated with a physico-chemical transducer, identifies the target*3'4*. The aim of the 
biosensor is to produce either discrete or continuous digital electronic signals that are 
proportional to the concentration of a single or group of analytes.
Biosensors can be both qualitative and quantitative. Qualitative biosensors employ 
species such as antibodies, which are specific to their target, to say whether the target is
3
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present in the sample being tested. Qualitative biosensors have many applications; for 
example in medicine, when a rapid result is required to ascertain if a certain 
microorganism is present in a blood sample taken from a patient. Quantitative sensors 
do not just detect the target, they also quantify it. This is needed in situations such as a 
glucose sensor that diabetics would use. It is not enough to know whether glucose is in 
the blood of a diabetic or not, they need to know the quantity to adjust the 
administration of insulin as needed.
Biosensors are used in a wide variety of environments. By far the biggest user of 
biosensors is the clinical laboratory, incorporating biochemistry, microbiology and 
haematology. Also within the umbrella of healthcare is point-of-care testing. These 
sensors are often smaller systems or handheld devices that are used on hospital wards, at 
a GP surgery or even at home. However, it is not just the healthcare industry that uses 
biosensors. Environmental agencies use biosensors to monitor air and water samples to 
assess pollution levels. The military develop biosensors to detect the presence of 
biowarfare agents such as nerve gases, or biological agents such as anthrax. Biosensors 
are used in the food industry to monitor processes such as fermentation, food spoilage 
and contamination, and to assess food ripeness.
The first biosensor, known as the "enzyme electrode" appeared in 1962 when Clark and 
Lyons coupled glucose oxidase to an amperometric electrode to detect P02(5>. 1974 saw 
the first successful launch of a commercial biosensor for glucose, made by Yellow Springs 
Instruments. In 1977 Rechnitz et al.(6) coined the phrase "bio-selective sensor," which in 
time was shortened to "biosensor."
A biosensor needs to have several properties to operate effectively. It needs to be 
specific to its target and sensitive enough to detect in some cases picomolar 
concentrations of the target analyte. It needs to be accurate, and quick to produce a 
result. The ideal biosensor should also be easy to use and be compact in size.
Biosensors generally consist of two components: a bioreceptor and a transducer. The 
interaction with the biological element and the target produce a measurable change 
within the sensor, which the transducer converts into a quantifiable signal. They can 
detect a wide variety of targets, including metabolites, toxins, pathogens (viral and 
bacterial), hormones, therapeutic drug levels, antibodies, antigens (viral and tumoural) 
and individual genes.
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Biological materials that are used in the bioreceptor section of sensors are tailored to suit 
the need of the sensor; they are what make the sensor selective. They should be capable 
of recognising the presence, activity or concentration of a specific analyte in solution. The 
biomaterial can be proteins (cell receptors, enzymes and antibodies), genetic material 
(DNA or RNA) or whole cells (microbial, plant or animal). Sensing can be either a binding 
event (as with DNA/RNA, cell receptors, antibodies or whole cells) or a biocatalytic event 
(enzymes). Sensing can be either direct or indirect. Direct sensing is where the target 
molecule itself is sensed and quantified. Indirect sensing is where a product of the target 
is sensed and quantified. The amount of that product therefore must be in direct 
proportion to the amount of the original target.
The effect of the bioreceptor upon the analyte is to promote a physical or chemical 
response within the sample, which must be detected by the transducer, and converted 
into a measurable signal. Those changes could be a change in proton concentration, a 
change in ionic concentration, release or uptake of gases, a change in temperature, a 
change in optical absorbance, a conductivity change or a mass change (as with antigen- 
antibody binding systems)*7’.
The type of transducer used is dependent upon what the signal is that needs to be 
detected. Potentiometric or amperometric transducers exploit the electrochemistry of a 
sample. Conductivity changes in a sample are detected with an electrical transducer. All 
electrical based systems incorporate electrodes in one form or another. Optical 
transducers detect changes in the optical properties of the system. Thermal systems can 
detect small changes in heat liberated or consumed during a chemical reaction or binding 
event. Piezoelectric systems detect changes in the resonant frequency of a crystal upon 
target binding (e.g. quartz crystal microbalance).
Potentiometric devices measure the electrical potential difference between an indicator 
and reference electrode. These devices therefore measure ions such as H+, NH4+ which 
can be produced as the result of an enzymic reaction. Amperometric sensors measure 
the current resulting from the electrochemical oxidation or reduction of an electroactive 
species. A working electrode (platinum, gold or carbon) is held at a constant potential 
and, together with a reference electrode, the electrons that are exchanged between the 
biological system and the working electrode are measured as current. The detected 
current is directly proportional to the bulk concentration of the electroactive species.
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Conductometric devices monitor the ability of ions in solution to carry current between 
two electrodes under an alternating current. A change in ionic strength of a sample 
brought about through enzyme mediation can be detected with a conductometric 
transducer.
Photometric, or optical transducers measure changes in the optical properties of the 
sample. They link changes in the light intensity to changes in the mass or concentration 
of a product in the sample. The sample must therefore contain chromogenic or 
fluorescent molecules, or include molecules in the sample which upon the action of an 
enzyme are made chromogenic or fluorescent. The main advantage to an optical signal is 
that the reaction of the sample can be followed in a non-destructive manner(8). The 
majority of biosensors used in the clinical biochemistry laboratory today are based on 
optical systems. In general, they are more sensitive than electrical methods, and cheaper 
than methods such as the quartz crystal microbalance (QCM)
Efficient sensing of biological species requires directly interrogating individual 
biomolecules with sizes ranging from 1 to lOOnm. It is therefore sensible to assume that 
the tools needed for this should be on the same scale as those biomolecules. One such 
tool is the carbon nanotube (CNT). Since their discovery, the application of CNTs in 
biosensing has been explored.
1.3 Carbon and Nanotubes
Carbon, with an atomic number of 6 and atomic mass of 12, is the sixth most abundant 
element in the universe. For such a simple atom, it is the basis for all organic molecules. 
Its six electrons ( Is2, 2s2p2) are distributed evenly over the lowest energy levels of the 
atom. Carbon has a high affinity for bonding not only with other elements but also with 
itself, and thus is generally very short-lived as an individual atom. As a result, at least 18 
million carbon-containing compounds are registered with the Chemical Abstract Registry 
(CAS). Carbon has various allotropes, substances that consist of the same element but in 
differing structural formations and therefore have differing properties. Perhaps the two 
most commonly known allotropes are diamond, one of the hardest known minerals, and 
graphite, one of the softest.
The differing properties of the two are all due to the manner in which the carbon atoms 
bond with each other. In diamond, each atom is covalently bonded to four others in a
6
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tetrahedron arrangement (sp3). Diamonds are good conductors of heat but poor 
electrical conductors (or excellent insulators, depending upon the viewpoint), in 
graphite, each carbon is bonded to three others along the same planar axis, forming a 
hexagonal lattice (sp2 bonding), akin to honeycomb. When layered, these sheets, known 
as graphene, form graphite. As a bulk material, graphite is a very good electrical 
conductor, with conduction proceeding along the plane of the layers.
Along with amorphous carbon (carbon without any particular crystalline structure), 
diamond and graphite are said to be the only naturally found allotropes of carbon. 
Chemical synthesis however, has unveiled further allotropes, with perhaps more to come. 
Figure 1.2 shows a graphical representation of eight of the known carbon allotropes.
The allotrope of interest to this thesis is carbon nanotubes, unique nanostructures with 
remarkable electronic and mechanical properties. Nanotubes are simply tubes or 
cylinders on the nanoscale. Their discovery is generally attributed to Sumio lijima, who 
while investigating the soot produced by an electrical discharge between two carbon 
electrodes, discovered structures consisting of concentric tubes of carbon(9). In 1992, 
Ebbesen and Ajayan(10) published details of the synthesis of carbon nanotubes. 
Structurally, carbon nanotubes consist of a rolled hexagonal carbon lattice, rather like 
that found in graphene sheets, creating seamless cylinders capped at each end with half a 
fullerene molecule. The properties of nanotubes have long been investigated, and can 
change from nanotube to nanotube. CNTs can exist in a variety of forms. They can be 
composed of a single wall (single walled carbon nanotubes, SWNTs), or of multiple walls 
(multi-walled carbon nanotubes, MWNTs), concentric rings of nanotubes. Three different 
chiralities (the angle at which the effective graphene sheet is rolled) of nanotube have 
been identified, armchair, zigzag and chiral. The chirality has a great impact on the 
properties of a nanotube. Nanotubes with only the armchair chirality are metallic, 
whereas zigzag and chiral nanotubes are both metallic and semi-conducting depending on 
the chiral angle. Figure 1.3 shows an image of single and multi-walled carbon nanotubes, 
and the three different modes of chirality.
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Figure 1.2: Eight allotropes of carbon: a) Diamond, b) Graphite, c) Lonsdaleite, d) C60 
(Buckminsterfullerene), e) C540, f) C70, g) Amorphous carbon, and h) Single-walled carbon 
nanotube.
Figure 1.3: A: Single walled carbon nanotube (SWNT), B: Multi-walled carbon nanotube 
(MWNT), C: Armchair SWNT, D: Zigzag SWNT, E: Chiral SWNT.
The nanotubes lijima first saw were multi-walled; single-walled tubes were characterised 
in the same laboratory in 1993(11).
One can think of carbon nanotubes (CNTs) as molecular wires or nanowires. SWNTs can 
have a diameter ranging between 0.5 and 3nm, MWNTs can have diameters of 5-100nm. 
CNTs can be any length from less than a micron to a few centimetres. CNTs are one­
dimensional (have a very high aspect ratio) and thus have a high surface area. They are
8
Chapter 1. Introduction
unique in that they have all of their atoms on the surface. The extraordinary mechanical 
and electronic properties of carbon nanotubes have led them to be of great interest in 
scientific research of many disciplines over the past 15 years. The stiffness of carbon 
nanotubes, measured in terms of its Young's modulus (ratio of stress over strain), can be 
as high as 1.8 TPa for SWNTs, which makes them almost 10 times stiffer than steel, with 
the tensile strength or breaking strain reaching values of up to 63GPa, around 50x higher 
than steel(12). When carbon nanotubes bend, they buckle like straws, rather than break. 
This strength is due to the covalent sp2 bonding within the nanotube. In addition, they 
are light, with a density of around 2 g/cm3(13), half that of aluminium.
The electrical properties of carbon nanotubes are rather unique. As nanotubes are in 
effect rolled up graphene sheets, similarities between the two are observed. Graphene 
has a unique band structure, and on this basis, the properties of CNTs have been 
predicted. All nanotubes can conduct electrons, but the mechanism of conduction 
depends upon the type of nanotube. The conductance of a tube is quantized, and a 
SWNT may act as a ballistic conductor*14’. All multi-walled nanotubes are metallic, i.e. 
their band gap is either zero or negative. At low temperatures, SWNTs behave as 
coherent quantum wires where the conduction occurs through discrete electron states 
over large distances. Some of these effects are also observed in MWNTs in spite of their 
larger diameter. Multiple shells and inter-wall interactions redistribute the current over 
individual tubes non-uniformly. Approximately one third of single walled nanotubes are 
metallic, whereas the other two thirds are semi-conducting. The conduction properties 
greatly depend upon both the chirality and the diameter of the nanotube*15’; as the 
diameter of the tube increases, the band-gap decreases. Nanotubes also have, a constant 
resistivity, and a tolerance to a very high current density.
Various methods have been investigated to make carbon nanotubes. When lijima first 
observed nanotubes*16’, he was examining the soot produced on a negative graphite 
electrode during arc discharge for fullerenes. This method entails the condensation of 
carbon atoms and radicals on a negative electrode that have previously been evaporated 
from solid carbon sources at a positive electrode. MWNTs are generally formed using this 
method, although the addition of a small amount of a catalyst of either cobalt, iron or 
nickel can cause the formation of SWNTs. The nanotubes, produced in powder form, are 
highly bundled with a wide diameter and length distribution. This method generally has a
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low yield (around 30%), in addition to high amounts of impurities such as amorphous 
carbon and fullerenes.
A second method of manufacture is that of laser ablation, or laser evaporation. 
Developed in 1996 by Richard Smalley and co-workers at Rice University*171, this novel 
method uses a pulsed laser to vaporize a graphite target. The target is heated to 1200°C 
in the presence of cobalt or nickel, and an inert gas. Metals are used as nucleation sites 
for nanotube formation. The gas sweeps the carbon and metal atoms through to cooler 
parts of the reaction chamber, where the carbon condenses to form nanotubes. This 
method has a yield of approximately 70%, and produces mainly single walled nanotubes. 
It is however, the most expensive of the methods.
First used in 1993 for nanotube production*181, the third and perhaps most commonly 
used method is that of chemical vapour deposition (CVD). Small chain hydrocarbon gases 
such as methane or acetylene are decomposed at high temperatures. The carbon atoms 
produced condense onto a cooler substrate that contains catalyst nanoparticles, the 
composition of which is most often either nickel, cobalt, or iron. It has been shown that 
the diameter of the nanotubes is related to the size of the nanoparticle acting as the 
catalyst*191. Controlling the catalyst size is therefore a method for controlling the 
nanotubes produced. Perhaps the most recognised modification of the CVD method is 
that developed by Bronikowski et al.*20) in 2001 at Rice University; the High Pressure 
Carbon Monoxide process, or HiPCO for short. The technique allows large quantities 
(lOg/day) of high purity single walled nanotubes to be produced. A further variation on 
the CVD method is the introduction of plasma into the process. A strong electric field 
during the growth process together with the plasma presence causes the nanotubes to 
grow in the direction of the electric field. Plasma-enhanced CVD (PECVD) allows for the 
growth of vertically aligned nanotubes on a substrate, resembling a forest. Aligned 
nanotubes have been used to create many prototype biosensors*21'251.
In all, carbon nanotubes vary widely in their properties, and fabricating only one 
particular type of nanotube at a time is currently virtually impossible. Within any given 
sample however, one can find nanotubes with a high strength, high elasticity, high 
conductivity, and high thermal and chemical stability, all within a low-density material. 
Coupled with the ability to manipulate and functionalise the nanotubes with other
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materials, carbon nanotubes are an extremely versatile material to work with, and thus 
lend themselves to a huge variety of applications.
In addition to their use in biosensors as stated previously, carbon nanotubes have many 
potential applications, which exploit both their mechanical and electrical properties. 
Composites incorporating CNTs may yield incredible strengths potentially sufficient to 
allow the building of such things as space elevators and artificial muscles. Manufacturing 
companies are already incorporating nanotubes into tennis rackets and bicycle parts. 
Carbon nanotubes have even been found in a sample of the legendary Damascus steel 
from a sword made in the 17th century*26*. Exploitation of their electrical and optical 
properties has led them to being used for field emission127*, in solar cells*28* and in 
scanning probe microscopy*29,30*. They have been shown to work as field effect 
transistors*31*, incorporating them as the conducting channel as opposed to the traditional 
silicon. In addition, they have been shown to be absorbers of molecular gasses, such as 
oxygen*32* and ammonia*33*, making them suitable not just for biomedical sensors, but also 
for environmental ones. Figure 1.4 demonstrates that a large amount of nanotubes can 
be isolated and trapped using dielectrophoresis. All of these properties and applications 
lead CNTs to be at the forefront of current research.
Figure 1.4: Scanning electron micrograph of dimethylformamide purified SWNTs trapped 
between gold electrodes using dielectrophoresis. Such an arrangement would allow the 
trapping of functionalised nanotubes in specified positions within a device.
1.4 Proteins and DNA
Proteins and deoxyribonucleic acid (DNA) are both examples of biomolecules. Along with 
others such as ribonucleic acid (RNA) and carbohydrates, they represent natural nano­
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scale engineering. The main focus of this thesis is the functionalization of single walled 
carbon nanotubes with two different proteins; bovine serum albumin and urease. Several 
different conjugation techniques will be employed. These include both methods used 
previously and a novel method incorporating not only a protein, but also deoxyribonucleic 
acid (DNA). When considering the method to use to conjugate nanotube and 
biomolecule, one must first understand the basics of biomolecular structure.
Proteins are large organic biomolecules. They have a complex 3D structure that can be 
broken down into three and on occasions four stages. The primary structure consists of a 
chain of amino acids joined in a chain with peptide bonds (a polypeptide chain). The 
secondary structure of the protein refers to the shape that the polypeptide assumes. This 
shape can include a-helices, a spiral conformation of the amino acid chain, and (3-sheets, 
where one part of the chain lines up alongside another. These structures are held with 
weak forces such as hydrogen bonding and ionic interactions, and stronger disulphide 
bridges. The tertiary structure of a protein refers to its spatial configuration. Those 
amino acids within the protein which are not involved in an a-helix or (3-sheet are able to 
twist relatively freely, and thus different sections within a protein can lie in different 
configurations with respect to each other. This tertiary structure generally has the lowest 
energy state, and is thus the easiest shape into which the protein can fold. The tertiary 
structure is again maintained with hydrogen bonding, ionic interactions and disulphide 
bridges. Proteins can also have a quaternary structure as well. This is where several 
chains (subunits) come together to form a whole protein. For example, haemoglobin 
consists of four subunits - two alpha and two beta. Without this quaternary structure, 
haemoglobin would not be able to carry the vital oxygen around our bodies. Figure 1.5 
demonstrates the protein structural arrangements, and an image of haemoglobin 
showing the subunits.
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Figure 1.5: Protein primary, secondary, tertiary and quaternary structure (left) and haemoglobin 
(right). The red and blue chains represent the alpha and beta strands, with the haem group (an 
iron atom at the centre of a porphyrin) included in each chain.
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Deoxyribonucleic acid (DNA), along with ribonucleic acid (RNA) belongs to a group of 
macromolecules known as nucleic acids. In this thesis, DNA will be used as a linker 
molecule to facilitate a novel form of attachment of a protein to single walled carbon 
nanotubes (SWNTs).
DNA, as most people know, is the basic building block of life. Without it, life as we know 
it today would not exist. DNA contains all of the information that a cell needs to carry out 
its functions. A DNA chain consists of many nucleotide units. Each of these units is 
composed of three main components, a phosphate group, the sugar 2-deoxyribose and a 
base. Alternating phosphate groups and the sugar make up the backbone of a DNA 
molecule. Attached to each one of the sugars is any one of the four molecules, known as 
bases (Figure 1.6a). The four bases, adenine (A), cytosine (C), guanine (G) and thymine (T) 
can be present in any combination, and are the parts responsible for information storage 
within a cell. In groups of three, they are translated into amino acids, the primary 
component of proteins.
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Figure 1.6: Diagram of DNA structure, (a) The alternating deoxyribose and phosphate backbone 
anchor the bases of adenine, thymine, guanine and cytosine, with the 5 prime (5') end 
terminating in a free phosphate group and the 3 prime (3') end in a hydroxyl group, (b) The 
periodic structure of the DNA double helix. Each nucleotide is 0.34nm wide, with each turn 
consisting of 10 nucleotides totalling 3.4nm in length. The minor groove is 1.2nm wide and the 
major groove is 2.2nm wide. The total width of double stranded DNA is 2nm.
Of all the properties that DNA holds, it is not their information capacity or cellular 
function that is of interest in this thesis. DNA as a structural material has potential 
applications in many novel scientific areas, such as quantum computing and self-assembly 
of devices. DNA is being used for the solubilisation of nanotubes in aqueous media, and 
has been joined with nanotubes for nucleic acid sensing, gene delivery and therapy and 
controlled patterning onto conducting or semiconducting materials.’34 38’
DNA in its most common form is found as two complementary strands that wrap around 
each other to form a double helix. The two strands are held together with hydrogen 
bonding between complementary bases (adenine pairs with thymine and cytosine with 
guanine). Each nucleotide (phosphate, sugar and base) is 0.34nm wide, with 10 together 
forming a complete turn in the helix, as shown in Figure 1.6b. Each strand twists with a 
regular periodical structure, giving rise to the helical structure that most people will 
recognise as DNA. In theory, the total length of a DNA molecule is endless. The longest 
known chain of human DNA is chromosome 1, with approximately 220 million base
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The properties of DNA have shown it to be a good natural surfactant for the suspension of 
carbon nanotubes(40). Coupled with the fact that it is relatively easy to manipulate and 
synthesise chemically, DNA is more than suited to being a linker in protein conjugation to 
carbon nanotubes
1.5 Biomolecular functionalization of carbon nanotubes
The modification of carbon nanotubes with biomolecules (proteins, nucleic acids and 
carbohydrates) is essentially the bottom-up fabrication principle of bionanotechnology. 
That is, to start with the basic building blocks and grow from there. Nature has been 
doing this since life first emerged on earth, and today the tools and knowledge for 
humans to replicate and potentially improve upon nature are being created, understood 
and used. One such novel 'tool' is that of carbon nanotubes, which have been shown by 
many parties to have large implications for bionanotechnology and biomedicine*41'42’. 
Potential applications for nanotubes functionalised with biomolecules include biosensors 
(both medical and environmental)*43'45’, targeted drug*46'49’ and gene delivery*50'52’ agents, 
agents for cellular imaging*53'55’, and novel anti-cancer agents*38'56,57’. The methods of 
attachment of biomolecules are the same, no matter if the nanotubes are single-walled or 
multi-walled, therefore functionalization of nanotubes in general shall be discussed.
Before carbon nanotubes can be used, two major barriers have to be overcome; 
nanotubes are not soluble in water, and they are chemically inert. Functionalization of 
nanotubes allows one to overcome both of these problems. The ability to solubilise and 
separate nanotubes from the bundles they form when manufactured can aid in their 
purification and allow easy manipulation, as well as opening new paths in the field of 
nanotechnology.
Two routes for nanotube functionalization exist, no matter what the adjunct to the 
nanotube may be: - covalent and non-covalent. Each method has its pros and cons, and 
these must be considered when determining the functionalization method of choice in 
the creation of novel devices. In addition, the chemistry of the adjunct must be 
considered. Friddle et a!.*58’ used AFM tips functionalised with short chain silanes 
terminated with either amine, cyano or methyl groups to investigate the interactions of 
individual functional groups with nanotubes. They found that amino groups had the
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strongest affinity for nanotubes, followed by the methyl group with the cyano group 
having the weakest adhesion. Amino groups are found in abundance on biomolecules. 
Covalent functionalization of nanotubes with any material, be it biological or chemical can 
offer the best stability, accessibility and selectivity. The ability to control the location of 
the bound species offers selectivity, and as the linkages are permanent, leaching is 
prevented and thus a higher stability can be achieved. However, with this stability comes 
disruption of the nanotube bonding, and therefore the electronic structure*59*. Enough 
disruption seriously impedes conduction through carbon nanotubes, and can cancel out 
the advantages they have over conventional wires. Non-covalent bonding does not 
disrupt the nanotube structure, but the bonding is not generally as strong. Each method 
has an impact on the structure of the biomolecule as well. Proteins in particular have 
complex tertiary and quaternary structures that cannot be compromised if the protein is 
to continue to operate at its highest efficiency. Thus, any conjugation method chosen has 
to take into account the potential application for the nanotube-biomolecule complex, as 
there would be no point in constructing for example, a glucose sensor where the enzyme 
being used, glucose oxidase, has been rendered inoperative by the conjugation 
technique.
As protein and DNA cannot covalently bond themselves directly to nanotubes, chemical 
methods have to be used. These methods involve the functionalization of the nanotube 
first with groups amenable to the biomolecule of interest. These are generally either 
carboxyl, amino or thiol groups on the protein and phosphate groups in DNA. For 
example, free carboxyl groups on the nanotubes can easily be joined with free amino 
groups present within a protein. Carboxyl and other functional groups can be introduced 
into the nanotube structure using methods such as acid oxidation or addition 
chemistry*60,61*. Oxidation of the nanotubes has a further benefit, in that it removes a lot 
of the contaminant material that may be included with a sample of as-produced 
nanotubes (e.g. amorphous carbon and catalyst particles). Carboxylated nanotubes are 
available commercially.
In addition to removing unwanted contaminants, the oxidation of nanotubes has a 
further desired effect in that it makes the nanotubes suspendable in water. Single walled 
carbon nanotubes in particular are inherently hydrophobic, and as biomolecules exist in 
water in order to bond the two one of them must be given the ability to remain in the
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environment of the other. This cannot be done with biomolecules, as changing their 
environment entails altering the properties of the biomolecule potentially rendering it 
inactive. Although not entirely desirable, altering the properties of a nanotube does not 
completely destroy its functionality. The addition of biomolecules also conveys water 
solubility on the nanotubes.
Any covalent method involves disrupting the sp2 bonding of the nanotube -  the main 
feature that gives the nanotube its unique properties. When a molecule is bound to a 
nanotube, the original carbon-carbon sp2 bonding alters to sp3 bonding to make way for 
the chemical addition. This means that all electrons of the carbon atom have been 
incorporated into a chemical bond, as found in diamond, an insulator. With no free 
electrons, local conductivity is decreased.
Non-covalent functionalization (physisorption) and a hybrid approach (non-covalent 
bonding to the nanotube and covalent linkage to the biomolecule) do not employ 
methods which impair the sp2 bonding of a nanotube, as with covalent functionalization. 
Instead, the formation of van der Waals bonds and n (pi) stacking are used by the 
biomolecules and their linkers to anchor themselves to the nanotubes<62). Whilst the 
binding energy for these bonds is lower than the traditional covalent linkage, due to the 
delocalised electrons present within the nanotube, they can be stronger than traditional 
non-covalent bonding. The non-disruption of the nanotube lattice implies that the 
nanotube properties will not be impaired upon binding. However, this is not entirely 
true, as when two molecules come into close proximity with one another, they each exert 
an influence over the other.
Physisorption (physical adsorption) means that no chemicals are used which would 
disrupt the structure of the biomolecule in question -  the nanotubes and biomolecules 
are simply mixed together (perhaps with the aid of sonication). Balavoine et al.(63) used 
this method with the proteins streptavidin and HupR, and showed the ordered 
crystallization of the proteins around MWNTs (Figures 1.7a-b). DNA interacts with 
nanotubes in a non-covalent manner. Like proteins, it has also been found to wrap 
nanotubes in a regular manner, and thus a single strand can coil around a nanotube as it 
would a complementary DNA strand.
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Figure 1.7: Demonstration of non-covalent protein interactions with carbon nanotubes. (A) 
representation of helical wrapping of proteins around a carbon nanotubes (physisorption) and 
(B) a three dimensional model of the assembly of streptavidin on a carbon nanotube, as 
calculated using electron microscopy and Fourier transform analysis'63'. (C) Prevention of non­
specific binding of streptavidin to nanotubes using tween and (D) the conjugation of biotin 
molecules to tween allows streptavidin to bind to the nanotube using a hybrid approach'641
A hybrid approach, such as that first demonstrated by Chen et al.(65), uses linkers to join 
the nanotubes and adjuncts. In this example, the bifunctional molecule 1-pyrenebutanoic 
acid succinimidyl ester (PBSE) was used to anchor proteins to the nanotube. PBSE 
contains a pyrene group, which has been shown to interact with graphene and nanotubes 
through pi stacking166’, and a succinimidyl ester group which reacts readily with the free 
amino groups within proteins. A further example of this approach, using Tween, has been 
shown to prevent unwanted adsorption of proteins to the sidewalls of the nanotube, and 
thus only allows proteins to bind where the researchers want them to, i.e. at the end of 
the Tween molecules’67’ (Figures 1.7c-d).
Proteins and nucleic acids are not the only molecules of biological interest to have been 
conjugated with carbon nanotubes’68'69’. Bianco et al.’70’ and Pantarotto et al.’71’ have 
used nanotubes functionalised with portions of the foot and mouth virus to test for 
antigenicity and immunogenicity of antibodies. Individual amino acids have been 
attached to nanotubes by Georgakilas et al.’72’, which would allow further
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functionalization. Lin et al.(73) have mixed SWNTs with phospholipids, and tracked their 
progress through breast cancer cells, Hartman et al.(74) have used shortened SWNTs 
containing m AtCl to test for potential radiotherapeutic benefits in cancer treatment. 
Several groups have attached known chemotherapy agents such as methotrexate*75* and 
cisplatin<76,77) to nanotubes, in order to bring about direct delivery of the drugs to the 
target cells.
A more detailed description of the functionalization of and interactions between carbon 
nanotubes, DNA and proteins is given below.
1.5.1 Carbon Nanotubes and DNA
The first reported interactions between DNA and carbon nanotubes was by Tsang et al. in 
1997(78). They used transmission electron microscopy to image platinated and iodinated 
DNA fragments that had been immobilised onto multi-walled carbon nanotubes. Since 
then, research into the attachment of DNA to carbon nanotubes has grown to incorporate 
wide reaching applications and devices.
DNA of differing lengths and sequences have been joined to carbon nanotubes using a 
variety of methods, and in general, that method depends upon the application. Both 
covalent and non-covalent chemistry have been used in the attachment of DNA to 
nanotubes.
Baker et al.<79) attached DNA oligonucleotides (oligos) to SWNTs by producing maleimide 
terminated sites on the nanotubes, which then cross reacted with thiol-terminated oligos. 
This method slightly removes the DNA from the surface of the nanotube, allowing it to be 
involved in hybridization reactions with complementary DNA strands. Such hybridization 
events have two implications. The complementary DNA strand could be attached to a 
surface and used as an anchor point to create an aligned array of carbon nanotubes. 
Conversely, the hybridization event itself is of interest in detecting genetic sequences 
useful in disease detection and diagnosis. Dwyer et al.(80) were the first to covalently 
conjugate amino terminated DNA oligonucleotides to carboxylated single walled carbon 
nanotubes using carbodiimide chemistry (zero length cross-linking between carboxyl and 
amine groups).
The majority of current research has however focussed on non-covalent methods, as DNA 
has been found to bind strongly to nanotubes with no chemical interventions. Adsorption
19
Chapter 1. Introduction
to a nanotube surface occurs within picoseconds'81*, and general consensus is that the 
DNA molecule wraps around the nanotube as if it were a complementary DNA strand 
(Figure 1.8). DNA has also been found in theoretical studies to spontaneously insert itself 
into a nanotube'82*, and an experimental study has shown DNA to pass through 
MWNTs'83*.
Figure 1.8: Model of DNA bound to a single walled carbon nanotube. The phosphate sugar 
backbone is shown in yellow, and the bases are in red'40*.
Several groups have studied how DNA and carbon nanotubes interact. Enyashin and co­
workers'84* used theoretical studies to try to understand some of the interactions 
between homopolymeric (i.e. all one type of base molecule) single stranded DNA 
molecules and single walled carbon nanotubes. Their calculations tried to determine the 
amount of energy needed by the DNA to wrap round nanotubes and keep them in a 
stable aqueous environment. By breaking the process down into three distinct stages; I -  
decomposition of the SWNT bundles (endothermic), II -  deformation of the ssDN A so that 
it would wrap around a nanotube (endothermic) and III -  the adsorption of the DNA onto 
the nanotube (exothermic), they were able to determine which of the bases is more 
favourable for allowing SWNTs to remain suspended. They found that the change in 
energy upon the formation of DNA-SWNT complexes with a single strand of DNA does not 
overcome that of the nanotube bundles -  i.e. simply mixing nanotubes with one strand of 
the DNA is not enough to allow dispersal of the nanotubes in the solvent. Several strands 
per nanotube bundle however, can prompt the formation of DNA-SWNT complexes. The 
size of the bundle prior to DNA introduction also has an influence on how well the DNA 
can interact with the nanotubes. Smaller initial bundles require less energy for the 
complexes to form. This would be achieved if the nanotubes were sonicated as the DNA 
is added. The group also showed that the type of base has a role in the formation of the 
complexes. The purine bases (adenine and guanine) are less favourable in terms of
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providing solubility. They are, however, more sensitive to the radius of a nanotube, and 
therefore could have some applications for size selection and sorting. Upon analysis of 
the electronic structure of the complexes, they found evidence of charge transfer 
between nucleotide and nanotube.
Rajendra and Rodger’85’ used linear dichroism to show that the likeliest conformation of 
DNA on nanotubes is with the backbone wrapping around the nanotube at an angle of 
around 45°, with the bases lying flat on the surface. Hughes et al.’86) showed using 
experimental methods that DNA binds to nanotubes through pi stacking. In addition, 
they were able to show the preferred orientation of each of the bases along the long axis 
of a nanotube. Within a nanotube itself, it is the free pi electrons that allow the 
nanotubes their great conductivity and mobility. As DNA bases interact with each other 
and with the nanotube through these electrons, there should be no reason that any 
electrical response from a binding event (either though a protein or through the DNA 
itself) would be significantly hindered in reaching the nanotube and therefore being 
transduced into a measureable signal.
Exploiting the mechanical properties of DNA and the chemistry of its interactions with the 
nanotubes, one can potentially sort differing lengths and chiralities of carbon 
nanotubes’87'89’. As nanotubes are incredibly strong, flexible and highly conductive, but 
extremely small, for some applications it would be advantageous to spin them into strips 
and fibres. Barisci et al.’90’ have shown that as opposed to using conventional surfactants 
to suspend carbon nanotubes (such as sodium dodecyl sulphate, SDS) ready for spinning, 
DNA was able to suspend a larger concentration of nanotubes (up to 1% by weight). The 
resulting fibres were considerably stronger than those using SDS, but had a lower 
conductivity. This was however somewhat recovered by annealing the nanotubes prior to 
addition to the DNA.
The sequences and lengths of nucleic material that researchers have been mixing with 
nanotubes have varied immensely. In addition, both single and double strands of DNA 
have been used. Gigliotti’91’ and co-workers were able to show that long strands of 
genomic single stranded DNA (>100 bases) were efficient in dispersing nanotubes, 
providing that the complementary strands of DNA had been completely removed from 
the test sample. This allows the single strand to wrap around the nanotube with a 
periodic pitch. The pitch was found to remain constant down the length of a single
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nanotube, but would change depending upon the nanotube being wrapped. Yang et 
al.(92) found that the longer the length of DNA, the looser the wrapping of the DNA around 
the nanotube. No matter what the length or sequence, DNA is a good material to disrupt 
nanotube bundles and to aid in solubilisation.
Despite DNA only being used in a tethering capacity in this thesis, there are several 
applications of DNA-nanotube complexes in the literature. The majority of researchers 
have focussed on the detection of binding events between complimentary strands of 
DNA*93"95’. Nanotubes would aid in the determination of whether the match was whole,
i.e. a perfect match, or whether there was a mismatch, i.e. there had been a mutation in 
the target DNA. This has vast implications for genetic screening, as it is mutations that 
cause genetic diseases, and can convey susceptibility to other diseases such as cancer. 
This principle can also be used for the patterning of nanotubes on a surface*80’96*. Staii et 
al.(97) have constructed DNA decorated nanotubes for field effect transistors to be used in 
chemical sensing. Several researchers have used DNA as an option for sorting carbon 
nanotubes*98'101*. Different sequences and lengths have been found to bind with different 
strengths to nanotubes of differing chiralities and diameters. This potentially allows the 
sorting of metallic and semi-conducting nanotubes, and allows the further study of 
individual nanotubes, whose properties can differ from the bulk material. A further 
application for DNA functionalised nanotubes is the delivery of genetic material into 
cells*52'102'104*. This would allow genetic abnormalities to be corrected and can offer 
further treatment for diseases such as cancer through gene silencing1105*. Wu et al.<106) 
have found that nanotubes can protect DNA strands when entering cells, an important 
discovery as genetic material that is not recognised as natural by the host cell can be 
destroyed.
DNA is not the only nucleic acid to have been joined with nanotubes. Ribose nucleic acid 
(RNA) has also been used. Jeynes et al.(107) devised a method for nanotubes purification 
employing RNA first to select the nanotubes out of the bulk material and suspend them in 
solution whilst other material was removed through centrifugation. The RNA was then 
removed using the enzyme Ribonuclease A.
All of the properties and functionalities of DNA conjugated nanotubes have led to their 
use in this thesis as a novel binding agent in the conjugation of proteins to nanotubes.
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1.5.2 Carbon Nanotubes and Proteins
The functionalization of carbon nanotubes with proteins has been investigated since 
Tsang et al.(108) first reported the filling of carbon nanotubes with three different proteins 
in 1995. They found that if small enough, proteins can insert themselves in the interior of 
carbon nanotubes. Since this point, many groups have aimed to join proteins and 
nanotubes in a variety of manners for many purposes.
As mentioned previously, the two main functionalization routes, covalent and non- 
covalent, have been applied to conjugate proteins and carbon nanotubes. Covalent 
functionalization takes advantage of free functional groups within a protein. These 
groups, either the 'R' group of an amino acid or the protein termini, are the targets as 
they are accessible. The side group of amino acids are what convey the properties of an 
amino acid. For example, aspartic acid, glutamic acid, lysine, arginine, cysteine, histidine, 
and tyrosine all contain ionisable side chains. In their unprotonated state, each of these 
side chains are nucleophiles and can engage in addition reactions*109*. Lysine, aspartate, 
glutamate, arginine and histidine tend to be the amino acids exposed on the surface of a 
protein, and therefore can be derivatized with ease. All contain amine groups, with the 
most important reactions that can occur with these residues being alkylation and 
acylation. In alkylation, an active alkyl group is transferred to the amine nucleophile with 
the loss of one hydrogen. In acylation, an active carbonyl group undergoes addition to 
the amine. A further important amino acid in protein conjugation is cysteine, which is the 
only amino acid to contain a thiol (sulfhydryl, SH) group. Conjugation with this group is 
very selective, but can also be tricky. The thiol groups are key points in stabilizing protein 
structure and conformation, and also relatively hydrophobic and therefore often buried 
within the core of a protein.
Any chemistry that breaks peptide bonds or disulphide bridges within a protein disrupts 
protein structure, which is potentially catastrophic to the protein. Any method used must 
therefore be gentle enough to target only the readily available functional groups, and not 
disrupt the three dimensional structure of the protein to a great extent. This can also 
apply to non-covalent bonding, as factors such as hydrogen bonding and van der Waals 
forces help maintain protein structure and therefore preserve its function in its natural 
environment.
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Due to the easy access to free amine containing amino acids on the surface of a protein, 
these sites are generally the first choice for the covalent functionalization and 
conjugation of proteins. Perhaps the commonest method involving the amine groups is 
to use carbodiimide chemistry to couple the protein with free carboxyl groups on a 
nanotube*110"113*. Carbodiimides mediate the formation of amide linkages between 
carboxylates and amines or phosphoramidate linkages between phosphates and amines. 
Such zero-length cross-linkers mediate the conjugation of two molecules by forming a 
bond containing no additional atoms; a molecule is covalently attached to an atom of a 
second molecule with no intervening linker or spacer. Nanotubes can be carboxylated 
through acid oxidation, and then mixed with a carbodiimide coupling agent such as 1- 
ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDAC) to form highly reactive, o- 
acylisourea intermediates. The use of carbodiimides and EDAC in particular in protein 
conjugation chemistry is well documented, and schemes generally follow one of two 
routes. A protein with free amine groups can be directly attached to the activated 
nanotubes*47'112'114*, but this has to be done almost immediately after EDAC addition. The 
active intermediates can be a little slow in forming amide linkages, and can easily 
hydrolyse in an aqueous environment. This problem can be overcome with the addition 
of either N-hydroxysuccinimide (NHS) or N-hydroxysulfosuccinimide (sulfo-NHS), to form 
active esters at the site of carbodiimide activation on the nanotubes*113'115'118*. These 
highly reactive esters provide stability of the active intermediates whilst maintaining the 
ability to react with available amine groups. There is however, some argument over 
whether results presented using this method for protein attachment to nanotubes are in 
fact showing evidence for non-specific protein adsorption and not covalent bonding*119*. 
An alternative method for conjugation is the acylation of the nanotubes, followed by 
amidation with the target of choice. This scheme was used by Wang et al.*120* who were 
able to confirm using Fourier Transform Infrared (FTIR) spectroscopy the covalent linkage 
between nanotube and protein.
The non-specific binding (or physisorption) of proteins to carbon nanotubes has been well 
documented*63,121'126*. Investigations into the mechanism of binding of proteins have 
revealed that it is the hydrophobic amino acids which are responsible for adsorption*127*. 
Karajanagi et al. found that by orientating its hydrophobic pocket towards a nanotube, 
the enzyme soybean peroxidase (Figure 1.9) was able to maintain more activity than a
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similar protein with no such hydrophobic area<128). In addition, analysis of the anti- 
fullerene antibody which binds to nanotubes as well as fullerenes has shown the binding 
site to contain clusters of hydrophobic amino acids(129).
Figure 1.9: (A) structure of soybean peroxidase, dearly showing the hydrophobic pocket. 
Hydrophobic and hydrophilic amino acids are shown in blue and yellow respectively (B) 
Orientation of hydrophobic pocket towards the SWNT, leaving the active site accessible*12*'.
The importance of the aromatic amino acids (phenylalanine, tyrosine and tryptophan) in 
particular which contribute to the hydrophobic regions in proteins, has been 
demonstrated by Zorbas et al.’130', Wang et al.*1311, and Arnold et al.(132'. These aromatic 
side chains are likely to interact with the nanotube surface in much the same way as DNA 
bases or pyrene moieties through n stacking and van der Waals forces*1331. Dieckmann et 
al.(134) have taken the protein-nanotube interactions a stage further, by designing 
polypeptide helices which not only coat the nanotubes and solubilise them, but also allow 
the creation of macromolecular structures through peptide-peptide interactions between 
polypeptide chains. Despite this research into protein-nanotube binding, it is still not 
entirely understood. This is mainly because the behaviour of proteins at solid surfaces 
greatly depends upon both the protein and the surface.
However, evidence has been presented demonstrating that in close proximity to the 
nanotube surface, proteins can become denatured due to the physical forces alone. By 
using FTIR spectroscopy analysis of the proteins on the SWNTs Karajanagi et al. found that 
some degree of denaturation of the protein was seen upon adsorption*1281. This finding 
has been repeated by others using differing methods of analysis*116,1351. Zhang et al.*1361 
deliberately functionalised MWNTs with various moieties to bind to specific sites in the 
enzyme a-chymotrypsin. Using this approach, they were able to recognise and bind to
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the catalytic site and inhibit activity. This method provides a novel mechanism for 
enzyme inhibition. The denaturation and inhibition of proteins, especially enzymes, leads 
to loss of function and catalytic rate. The higher the function loss, the less feasible it is to 
make a device with the nanotube-enzyme system being used. Encouragingly, not all 
enzymes that have been attached to nanotubes have shown a significant drop in 
activity*137'138* or large changes in structure*139*.
The denaturation of proteins in close proximity to carbon nanotubes may be prevented 
by using functionalization methods that could hold the protein further away from the 
nanotube surface, and therefore negate some of the forces at work. Some non-covalent 
methods of attachment may be able to do just that. These methods involve linkers that 
bind non-covalently to the nanotubes but bind covalently to the protein in question. 
Chen et al.*140* used the pyrene based linker 1-pyrenebutanoic acid succinimidyl ester 
(PBSE) to conjugate two different proteins and biotin tagged with polyethylene oxide 
(PEO) and an amine group. The amine group is important as it is the point of attachment 
of the adjunct to the PBSE, and ultimately the nanotube. The ester group in PBSE is the 
same as that found with NHS, used in stabilising the coupling agent EDAC in covalent 
functionalization; it is highly reactive to nucleophilic substitution by primary and 
secondary amine groups, resulting in an amide bond. It has previously been shown that 
pyrene groups interact with the basal plane of graphite through n stacking*141*. Other 
proteins that have been added to nanotubes in this manner include glucose oxidase*44*, 
the prostate specific antigen (PSA) antibody*142* and streptavidin*143*. Figure 1.10 shows 
an interpretation of the conjugation of a protein to a SWNT using PBSE. A similar 
molecule, pyrenecarboxylic acid (PCA) has been used by Simmons et al.*144* to introduce 
carboxyl groups onto nanotubes non-covalently. PBSE only contains a short hydrocarbon 
chain to elevate the protein from the nanotube surface. The same group have used 
Tween 20 in a similar manner*145*. Tween is known to prevent non-specific protein 
binding, but it can also be functionalised to allow protein binding at the hydrophilic 
termini that would protrude from the nanotube surface. Star et al.29 coated CNTs in 
polyethylene imine (PEI) and polyethylene glycol (PEG) and added biotin-N- 
hydroxysuccinimide ester. The ester group reacts with the primary amines of PEI and 
thus bonds biotin to the nanotubes. Streptavidin (SA) is then free to bind to the biotin, 
without also directly adsorbing to the nanotubes. Such schemes would prevent the non-
26
Chapter 1. Introduction
specific binding of proteins on the nanotube surface*146*. This therefore means that 
functionalization can be selective and site-specific.
Figure 1.10: Schematic for the immobilization of a protein to carbon nanotubes using 1- 
pyrenebutyric acid N-hydroxysuccinimide ester (PBSE) (adapted from Chen et al.(147>)
A further option for non-covalent functionalization is to trap proteins close to the 
nanotube surface using polymers*1481 or surfactants. Panhuis et al.*149) used Triton-XlOO 
to make the surface of SWNTs hydrophilic so that an enzyme could be attached through 
physisorption. Rege et al.*150) found that without the presence of SWNTs in composites of 
poly(methyl-methacrylate) and an enzyme, enzyme activity would be lower, possibly due 
to leaching of the enzyme from the film. Cai et al.*151) have coated a glassy carbon 
electrode with nanotubes and glucose oxidase (GOx) bound with Nafion. Nafion belongs 
to a class of synthetic polymers known as ionomers. Its chemical structure serves to give 
the polymer a negative charge, and is used as a semi-permeable membrane which allows 
only cations passage through its pores. It is also being used in this example to bind the 
GOx and nanotubes to the carbon electrode. The device of Cai et al. was used as a 
glucose biosensor which would be capable of discriminating glucose from common 
interferents that could be present in clinical samples.
1.5.3 Carbon Nanotube Sensors
Many types of sensor have been created with carbon nanotubes*152"156*, for many 
different purposes. Nanotubes have been shown to be sensitive to both 
mechanical*157,158’ and chemical stimuli, with chemical sensors being of interest to this 
thesis. As mentioned in section 1.1, sensors and biosensors in particular have many
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different forms. A sensor can either detect its analyte directly, or a product of the analyte 
brought about through factors such as enzymatic decomposition.
Nanotubes have the ability to sense chemicals in both gaseous and liquid forms. Sensors 
for gases such as hydrogen*159*, oxygen*160*, nitric oxide*161*, and ammonia*159,162"165’ have 
been created. As explained by Robinson et al.*166*, adsorption at defect sites within 
SWNTs produces the large electronic response that dominates SWNT capacitance and 
conductance sensitivity. As a result, controlled oxidation of nanotubes can enhance 
sensitivity to gasses, and could potentially increase sensitivity in liquid environments as 
well.
Both optical and electronic carbon nanotubes biosensors have been created, with the 
majority of research being focussed on the electronic sensors. Barone et al.’167’ used the 
near infrared fluorescence properties of nanotubes to create a glucose sensor. The 
sensor they created was such that it could be inserted under the skin for continual blood 
glucose monitoring. Unsurprisingly, glucose sensors feature heavily in the literature on 
nanotube biosensors, as the miniaturization of sensors for glucose monitoring for 
diabetics is perhaps the most highly desired potential commercial use for nanotube 
sensors. Many different techniques have been employed to create such sensors, but all, 
apart from that created by Barone et al., are based on electronic detection. With their 
electron rich structure, carbon nanotubes make good electron donors and acceptors, with 
the change in electron concentration being measured as current. Indeed, individual 
SWNTs have been used as nanoelectrodes by Heller et al.*168* who showed that both 
metallic and semiconducting nanotubes yielded similar steady state voltammetric curves. 
One method*24,169'173’ for glucose sensing is to add carbon nanotubes and glucose oxidase 
to pre-existing electrodes (either gold, carbon or platinum). The glucose oxidase breaks 
down glucose to form D-glucono-1,5-lactone and hydrogen peroxide, which is the analyte 
detected. Methods of attachment of the enzyme include physisorption’169*, entrapment 
in polymers*174,175’ and covalent attachment’24,171,176*, with sensing being carried out whilst 
the modified electrodes are held at a constant voltage and the current is monitored 
(amperometric sensor). A second scheme is one which uses the nanotubes directly as the 
signal transducer*23,44,177'181*. Nanotubes were either used as 'forests'*177,182 185*, 
individually’44*, as a composite electrode*186,187*, in a biocatalytic film*188* or packed in a 
needle*189*. In those devices that include polymers, the purpose of the polymer can be
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two-fold. It can hold the enzyme in contact with the nanotubes, negating the need for any 
conjugate chemistry to be performed’23,187'190'191’. In addition, the polymer can protect 
the nanotubes and their contact with the substrate from non-specific binding of the 
enzyme, ensuring that the enzyme is attached to the nanotube in the desired manner1177’. 
The polymer could also heighten sensitivity as the effect of environmental gasses could 
be excluded from the device. Functionalization methods include carbodiimide coupling 
and physisorption, as with the modified electrodes, with detection being of an 
amperometric nature. In the case of Besteman et al.’44’ however, PBSE was used to 
attach glucose oxidase (GOx) to individual nanotubes, at the ends of which gold 
electrodes were placed using lithography. Not only did Besteman show that individual 
nanotubes were capable biosensors by effecting stepwise changes in conductance, the 
devices were also pH sensors as proteins carry pH-dependent charged groups that can 
electrostatically gate semiconducting SWNTs. Nanotube pH sensors have been 
demonstrated by other groups, using both optical1192’ and electronic methods1193 198’. The 
detection of changes in pH is important as there are many enzymatic reactions that do 
not involve electron transfer, and would thus be more difficult to detect in an electronic 
biosensor.
Some further examples of biosensors incorporating nanotubes and enzymes include 
those for organophosphate pesticides’199’, amino acids’200’, dopamine’201'202’, nerve 
agents’203,204’, cholesterol’205’, putrescine’206’, lactate’197'207’, ethanol’207’, urea’208’, 
acetylcholine’209’, phenols’210’ and hydrogen peroxide’211,212’.
In addition to the detection of chemical species, nanotubes have been shown to be 
sensitive to binding events in both proteins and nucleic acids. Boussaad et al.’213’ used a 
field effect transistor based sensor to look at the binding of cytochrome C on carbon 
nanotubes. Using a liquid gate (cytochrome C in phosphate buffer), they found that 
conductance decreased over time for all the semiconducting SWNTs tested, but the 
decrease varied from one nanotube to the next. This would potentially be due to 
variations in nanotube structure. Chen et al.’214’ reinforced this finding, but also found 
that the mechanism of sensing was hard to elucidate. The expectation would be that 
positively charged proteins would change the conductance in an opposite manner to a 
negatively charged one, but this prediction was found to be false. Further investigation 
revealed that protein adsorption at the metal-nanotube contacts within devices
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contributed more to the electronic effects than those proteins binding along the exposed 
length of the nanotube*215’.
Not only have researchers shown the detection of binding of biomolecules to the 
nanotubes themselves, the binding of molecules to the biomolecules with which 
nanotubes have been functionalised can be detected. Ramoni et al.(216> used an odorant 
binding protein to create optical sensors for the detection of hazardous compounds in the 
environment, such as explosives. Munge et al.(217) have been able to detect as little as 80 
DNA copies (5.4aM) and 2000 streptavidin molecules (67aM). Using enzyme multilayers, 
they were able to amplify the signal generated when a binding event occurred and 
therefore make a more sensitive device. This approach was also applied by Wang et 
al.(218) to detect both DNA hybridization and antigen recognition electronically. Other 
examples of antibodies being used include the optical detection of bacteria1219*, the 
electronic detection of prostate specific antigen (PSA)(220,221) and breast cancer cells1222*, 
and the detection of viral proteins*223*. Conversely, nanotubes can also be used to look 
for antibodies specific to an antigen of interest*224* and to determine whether a peptide 
sequence is immunogenetically active*70* (i.e. whether they are recognised by an 
antibody). They can also be used to detect protein-protein interactions*225’, of great 
importance in the field of proteomics.
This thesis will examine the attachment of proteins to single walled carbon nanotubes 
using the three functionalization types mentioned above. Although no sensor devices are 
made, proteins have been conjugated with their use in sensor in mind. The methods of 
functionalization will be compared and assessed as to which would be best for sensor 
devices.
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Chapter 2. Experimental Techniques
2.1 Introduction
This chapter discusses the theory behind the experimental methods used within this 
thesis. Many different techniques have been employed, due to the multidisciplinary 
nature of the work. The main aspect of this thesis features protein concentration 
determination and the optical methods employed therein. Absorption spectroscopy and 
fluorescence will be discussed, along with enzyme kinetics and concentration assays, and 
atomic force microscopy. General protocols for each of the techniques will be given, with 
exact protocols described fully in the relevant results chapters.
2.2 Protein Concentration Determination
The determination of protein concentration on a novel immobilization platform for 
sensors is of great importance. There need to be confidence that the method being 
utilized for immobilization will afford the greatest possible amount of binding, in addition 
to the least amount of denaturation. The most accurate method for concentration 
determination of a protein is hydrolysis followed by total amino acid analysis. This 
however is time consuming, costly and completely destroys the sample. Many different 
simpler methods exist to determine protein concentration, all of which rely on some form 
of optical spectroscopy. All of the most commonly used methods rely upon the 
measurement of absorbance at a particular wavelength of light. The most commonly 
used methods, absorbance of a sample at a wavelength of 280nm and colorimetric assays 
such as the Lowry and Bradford assays, will be discussed. In chapter three, absorbance 
spectroscopy and a modified Lowry assay will be used to assess protein concentration. 
However, as will be demonstrated, conventional methods for protein concentration 
determination are neither accurate nor adequate when dealing with the presence of 
carbon nanotubes. Thus, the principles of fluorescence and how it can be used to 
determine protein concentration will also be explained.
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2.2.1 Absorbance Spectroscopy
The measurement of the absorbance of ultraviolet light, particularly at a wavelength of 
280nm, is the simplest and quickest way of determining protein concentration. 
Electromagnetic radiation, as shown diagrammatically by the spectrum in Figure 2.1, is 
radiation in the form of electromagnetic (EM) waves, and is classified according to the 
frequency and length of the wave. Frequency (v), measured in hertz, is defined as the 
number of wave cycles to pass a fixed point in one second, with one hertz (Hz) being 
equal to one oscillation per second. The wavelength (X) is the length of one complete 
wave cycle, peak to peak or trough to trough. Wavelengths of the EM spectrum range 
from 10'10cm for gamma rays to 108cm for extremely low frequency radio waves. 
Frequency is inversely proportional to wavelength, as shown by the equation u = c/A, 
where c is the speed of light (3 x 1010 cm/sec). All the waves in the electromagnetic 
spectrum have the same speed (c) in free space.
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Figure 2.1: The electromagnetic spectrum, showing wavelength and frequency.
The particle model for EM radiation, a notion that light is both a wave and a discrete 
particle introduced in the early 20th century, states that light consists of packets of energy 
known as photons. They have effectively zero mass, and thus are able to travel at the 
speed of light. All waves contain a certain amount of energy, which is demonstrated with 
the equation E = hv, where E is the energy associated with the wave, v is the frequency 
and h is Planck's constant (4.14 x 10 15 eV). The amount of energy conveyed by a wave is 
dependent on the frequency and wavelength of the wave -  the higher the frequency and
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the shorter the wavelength, the more energy the wave has. The idea of light as a particle 
is necessary to explain just how it is possible for light to be absorbed by a substance at 
any wavelength. As a discrete particle, or photon, light can be quantized, and thus has a 
quantifiable energy.
Using different wavelengths, the physical properties of atoms and molecules can be 
probed. The absorption of light in the UV and visible wavelength ranges (lOOnm for far 
UV light to 800nm for red visible light with energies between 100 and 2eV) is associated 
with the excitement of electrons, in both atoms and molecules. Other wavelengths in the 
EM spectrum also have uses in molecular spectroscopy. Absorbance of radiation within 
the infra-red range is most closely associated with molecular vibration, and microwaves 
are associated with molecular rotation.
Of interest in this thesis is UV-Vis absorbance spectroscopy, and in particular absorbance 
at specific wavelengths. When atoms and molecules absorb photons, their associated 
electrons become excited. If the energy provided by the photons is sufficient, the 
electron will be promoted to a higher energy orbital. In order for electrons to become 
excited, they must absorb the correct amount of energy to move to a higher energy state. 
Electrons jump from the highest occupied molecular orbital (HOMO) to the lowest 
unoccupied molecular orbital (LUMO). The difference in energy between the two is 
termed the excitation energy. In organic matter in particular, these transitions generally 
involve the non-bonded or n electrons. The o electrons are occupied in covalent bonding, 
and thus require more energy to transition to a higher state than is conferred by light of 
the wavelengths in question. Figure 2.2 shows a representation of electron energy levels 
and transitions between orbitals.
Figure 2.2: Diagram showing transitions of the n, n and a electrons upon excitation with energy 
in the form of electrons. The higher the amount of energy, the larger the transition.
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Conveniently, the energy needed for these transitions falls into the UV and visible light 
ranges, and thus can be easily measured. For example, the colour of a material is 
determined by the absorption of light with energies within the visible spectrum (~400- 
800nm), as these are the wavelengths which can be detected by the human eye. UV light, 
however, cannot be detected with the human eye. A spectrophotometer measures 
absorbance by examining the difference between the amount of light emitted from a 
source, and the amount received by the detector. This can be used either to create a 
spectrum over a wavelength range for the sample being examined, or individual 
wavelengths can be measured and samples compared. Absorbance readings are 
generated by the calculation of the difference between the light emitted by the source 
and measured by a detector after passing through the sample, and are measured with a 
spectrophotometer.
When measuring samples at discrete wavelengths, it is possible to use the data to 
determine the concentration of the molecule in the solution being measured. The 
Lambert-Beer law states that absorbance is proportional to concentration, and that molar 
absorptivity is constant for a given substance in a given solute at a given wavelength as 
shown by Equation 2.1. The absorbance at a particular wavelength (Ax) is equal to the 
molar absorptivity (e), the molar concentration (c) and the light path length (L) in 
centimetres, multiplied.
Ax =  e e l  (2.1)
For the majority of spectrophotometers L is 1cm, the width of the sample cuvette. To 
determine the concentration of a sample, the equation is rearranged so that with a single 
absorbance measurement the concentration can be calculated providing that the 
extinction coefficient for the compound in question is known. The extinction coefficient 
is simply a measure of how much light is absorbed by a particular molecule at a certain 
wavelength. It can be measured either in terms of molarity (usually M^cm1 as the units 
must cancel with the light path and concentration because absorbance values are 
unitless), weight (mg/ml) or percent concentration (1% solution is lg/lOOml). Whatever 
the desired concentration unit is, e must be in the same units.
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2 .2 .2  Protein Ultraviolet Absorbance
The measurement of the absorbance of UV light by proteins is the simplest and fastest 
method for the determination of protein concentration. UV spectroscopy can be 
performed on the sample without the addition of any extra reagents, it is fast in 
comparison with other methods as there are no reactions to perform, and the relation 
between absorbance and protein concentration is linear (226). This method is able to 
examine protein concentrations from 20 to 3000pg.
Within a protein molecule, there are two factors that are responsible for absorption of 
photons with energies found in the UV range -  the peptide bond and the side chains of 
some of the amino acids. Due to the different molecular structures of each, they require 
different energies and therefore wavelengths for excitation. Peptide bonds become 
excited at wavelengths below 210nm with a maxima at about 190nm, whereas at a 
wavelength of 280nm aromatic amino acids are responsible for UV light absorption. 
Proteins therefore absorb UV light in proportion to their aromatic amino acid content and 
total concentration.
Wavelength (tun)
Figure 2.3: (A) the molecular structure of tryptophan, clearly showing the ring structure 
responsible for UV absorbance at 280nm, (B) the molar absorptivities of tryptophan (red), 
tyrosine (blue) and phenylalanine (green).
Aromatic compounds contain ring structures with delocalised electrons in n orbitals. The 
delocalisation mean that the amount of energy needed to excite these compounds is less 
than for a conventionally bonded structure (for example a peptide bond). With less 
energy needed, the wavelength of light needed for excitation is higher (280nm as 
opposed to 200nm for proteins). In this case, it is the side groups of tryptophan, tyrosine 
and phenylalanine in particular that are responsible for absorption at 280nm (Figure 2.3).
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Indeed, it has been shown that proteins with a low tryptophan content have a lower 
absorbance at 280nm(226). In addition, protein structure can influence readings, and so 
factors such as buffer pH and ionic strength that can alter structure will affect the 
absorbance spectrum of a protein. At this wavelength, the presence of nucleic acids can 
also interfere with the measurement, as they also absorb light at 280nm. However, it can 
be corrected mathematically if interference is suspected.
The measurement of protein concentration at wavelengths of between 190 and 210nm 
can be very sensitive, due to the high abundance of peptide bonds within a protein. 
However, this method has several problems. The energy at this wavelength is potentially 
enough to disrupt bonding within a protein, thus denaturing it. This goes against the idea 
that measuring the UV absorbance of a sample is non-destructive. Many chemicals 
absorb light at these wavelengths, especially those that contain double bonds. This 
includes the nitrogen and oxygen found in the atmosphere and many buffers in which the 
proteins can be contained. The majority of conventional spectrophotometers do not 
have a high output at low wavelengths. Both of these problems can however be limited 
by measuring absorbance at 205nm, where values are around 50% of those at the 
maxima. Potential destruction of the sample however, cannot be overcome. On a 
positive note, there is little interference from nucleic acids at this wavelength. 
Measurement
Using the Lambert-Beer law, an absorbance measurement of the sample in question can 
easily be converted to a concentration as long as the extinction coefficient for the protein 
is known. As UV absorbance is such a simple and widely used method, the values of e at 
both 205 and 280nm have been published for a large number of proteins. If unknown, an 
approximate value for e can be determined using Equation 2.2, a weighted summation of 
the contribution of the relevant amino acids to absorbance at 280nm(227):
e  =  (nW x 5500) + (nY x 1490) + (nC x 125) (2.2)
where n refers to the number of tryptophan (W), tyrosine (Y) and cysteine (C) residues 
found in the protein in question, and the values are the molar absorptivities for the 
individual amino acids at 280nm.
The majority of extinction coefficients are published for solutions as a percent 
concentration, and therefore must be converted to give either molar or weight
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concentrations. As a 1% solution is lg/lOOml, a factor of 10 is all that is needed to 
convert this value to mg/ml, as shown by rearranging Equation 2.1 (the Lambert-Beer 
law) into Equation 2.3.
concentration (m g /m l)  =  (Aa/e1%")10 (2.3)
With the extinction coefficient known, a simple measurement of the sample at the 
wavelength used to measure the coefficient is all that is needed to determine the 
concentration of the sample in question. Generally, 1ml sample volume is used in either 
quartz or UV transparent plastic cuvettes. The spectrophotometer should first be blanked 
against air, then the buffer used in sample, and finally the absorbance of the sample is 
read. With the absorbance known, the concentration can be calculated. For example, an 
absorbance reading of 1.2 for a sample of bovine serum albumin (BSA) gives a 
concentration of 2mg/ml, using 8i% of 6.6(227).
2.2.3 Enhanced Alkaline Copper Protein Assay (Lowry)
The detection of absorption of UV light by proteins is a method for quickly and simply 
determining protein concentration based on the properties of the protein itself. 
However, the method relies upon the extinction coefficient or the amino acid content 
being known, as well as the protein being pure. Alternative concentration assays include 
those in which chemicals react with the protein itself to yield a measurable coloured 
product (colorimetric assay). This does however mean that the proteins within these 
samples cannot be recovered for further investigation. Two such examples of this are the 
Lowry Assay, discussed here, and the Bradford Assay, which will be discussed in the next 
section.
The Lowry assay was established in 1951 by Lowry et al.<228), and has since become one of 
the most used methods for protein concentration assays, with many commercial 
companies producing assay kits based on the method. The Lowry assay is composed of 
two stages. In the first, the protein is mixed with copper ions (Cu2+) in the presence of an 
alkali. Each copper ion forms a tetradentate complex with four peptide bonds within the 
protein, and is reduced to the monovalent cation (Cu+). The Biuret chromophore(229) (so 
called due to the similarity between the complex and that formed by copper and the 
molecule Biuret) has a characteristic pink-purple colour, which in itself can be used as a 
concentration assay measured at a wavelength of 540nm. However, this method alone is
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not particularly sensitive, with a detection range of approximately 5-100mg/ml protein. 
Coupling the Biuret test with the Folin-Ciocalteu (FC) or Folin phenol reagent increases 
the sensitivity of the assay by almost 1 0 0 -fold<230), with a linear detection range of around 
l-100pg/ml protein<229). The Folin-Ciocalteu reagent (phosphomolybdate and 
phosphotungstate) reacts with and is reduced primarily by the copper-peptide bond 
complex, but also the R groups of tyrosine and tryptophan. The colour shown by the final 
products is most likely to be due to the reduced molybdenum and tungsten blue. The FC 
reagent is reduced with the loss of either one, two or three oxygen atoms and a mix of 
the three can exist within an assay sample. For this reason, the range over which the 
assay is linear is small (l-100pg). Concentrations above these values are still within the 
detection limits for the assay, but are non-linear in nature.
The Lowry assay is not without its drawbacks. The FC reagent must be immediately mixed 
into the assay sample after its addition, as it is reactive only for a short period of time. 
Various chemicals can interfere with the assay(226'229’231), including agents which lower the 
solution pH (e.g. strong acids or buffers), chelating agents (such as EDTA which chelate 
the copper) and substances which reduce the copper (e.g. mercaptoethanol and 
dithiothreitol), many of which are used in the preparation of protein extracts from whole 
cell lysates.
Measurement
In this thesis, a modified form of the Lowry assay is used in the microplate form of the DC 
(detergent compatible) protein concentration assay from Bio-Rad (Hercules, California). 
Colour development with this version of the assay is more stable, and the colour develops 
faster than with the conventional Lowry assay.
Prior to starting the assay, 20pl of reagent S (Sodium dodecyl sulphate) is added to each 
ml of reagent A (Copper sulphate, sodium tartrate and sodium hydroxide -  the alkaline 
copper solution) that is needed for the assay. The SDS is not essential to the assay, but 
allows for a more even colour development throughout the protein sample. 5pl of the 
sample is placed into a microplate well, along with 25pl of the prepared reagent A and 
200pl of reagent B (Lithium sulphate, tungstic acid sodium salt, molybdic acid sodium salt, 
hydrochloric acid and phosphoric acid; the Folin-Ciocalteu reagent). A blank should also 
be prepared using the buffer in which the protein is contained. The reagents in the plate 
are mixed and the colour is allowed to develop for 15 minutes, changing from yellow to
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blue. The absorbance maxima occurs at a wavelength of 750nm, although any 
wavelength between 500 and 750nm can be used<229).
In order to determine the concentration of a protein sample, a calibration curve using a 
protein standard with known concentrations must be constructed. Due to wide variations 
on the Lowry assay, the extinction coefficients for proteins investigated with these 
methods are not published. It is therefore not possible to use the Lambert-Beer law for 
the calculation of concentration as with the UV assay. As with the UV assay, the amount 
of tryptophan and tyrosine within a protein can alter the absorbance of the assay. Unless 
the protein being assayed is the same as that being used as the standard with known 
concentration, the results from the assay can only be relative to the standard, i.e. the 
concentration is not definitive.
The DC protocol recommends creating 3-5 standard protein solutions with concentrations 
between 0.2 and 1.5mg/ml. These concentrations, when diluted with the assay reagents, 
translate to concentrations between 4 and 33pg/ml, well within the linear range for the 
assay. The standard graphical format is to place the absorption values on the Y-axis, and 
the protein concentration on the X-axis. A fit of the points plotted on the graph provides 
the formula for the calculation of the protein concentration in the unknown test sample. 
For the concentrations used here, a linear fit should be applicable.
If after measurement the absorbance of the test sample is higher than that of the 
standards, the sample should be diluted in order to bring it in range.
2.2.4 Coomassie Blue Assay (Bradford)
First described in 1976(232>, the Bradford assay is based on the binding of the dye 
Coomassie brilliant blue G-250 dye (CBBG, Figure 2.4) to certain amino acids within a 
protein. Arginine, tryptophan, tyrosine, histidine, lysine and phenylalanine are all 
responsible for dye binding, with arginine being the preferred residue (up to 8 x more 
responsible for binding12291). Under acidic conditions, the absorbance spectrum of the 
unbound form with a maximum absorbance peak at 465nm (red colour) shifts towards a 
longer wavelength (blue in colour) upon protein binding (red shift), with a maximum 
absorbance of 595nm.
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Figure 2.4: Coomassie Brilliant Blue G-250 (CBBG) dye.
The binding of CBBG to the protein occurs with two different mechanisms. Firstly, when 
the dye binds, a free electron in the red form of the dye is donated to ionisable groups 
within the protein prompting a disruption in the 3D nature of the protein causing it to 
expose its hydrophobic regions to the dye. The CBBG then binds non-covalently via van 
der Waals forces and ionic interactions to amine groups in close proximity to the 
negatively charged dye. This binding stabilises the blue form of the dye and thus 
measuring the absorbance of this form is a direct method for determining protein 
concentration. The amount of dye binding is approximately proportional to the amount 
of positively charged amino acids within the protein.
The spectra of the bound and unbound forms of CBBG overlap. Consequently, the 
relationship between protein concentration and absorbance is not linear as with other 
methods. This is not a problem however, as a second order polynomial can be used to fit 
a standard curve. The assay range is generally 5-100pg/ml protein per test.
The Bradford assay is quick and easy, only needing one reagent. In addition, it is much 
less likely to be subject to interference from substances that can hamper other assays, 
such as chelating agents. It is however, still subject to interference from detergents such 
as SDS. In addition, the dye binds strongly to quartz cuvettes, so should be avoided 
where possible.
Measurement
Although commercial Bradford's Assay kits are available, it is simple to make the dye 
solution oneself. A 5X stock solution is made firstly by dissolving lOOmg CBBG into 50ml 
absolute ethanol. To this, 100ml of 85%(v/v) phosphoric acid should be added, followed 
by 50ml water to make it up to 200ml. The solution should be filtered through a 
Whatman Nol filter (or equivalent) before use, and can be stored at 4°C in an amber
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bottle. Prior to use, this stock should be diluted to the working concentration with 4x 
volume of distilled water.
A general protocol for measurement is to add 1ml of the working Bradford's reagent to 
0.02ml of the protein sample (this can be done in the cuvette). The sample and reagent 
should be mixed before being allowed to develop for 1 0  minutes at room temperature. 
At this point, either individual absorbances can be measured, or a spectrum for the 
sample can be obtained. If any of the samples have an absorbance of over one, they 
should be diluted.
As with the Lowry assay, a calibration curve using protein standards of known 
concentration should be constructed at the same time as measurement of the test 
sample. Unlike the Lowry assay, the calibration curve is not linear, but can be fitted using 
a second order polynomial (y=a+bx+cx2). Figure 2.5 shows the correlation between BSA 
concentration and absorbance, both as a spectrum and at a discrete wavelength.
Wavelength (nm) Protein Concentration ((ig/ml)
Figure 2.5: (A) Absorbance spectra for bovine serum albumin (BSA) standards using Bradford's 
assay. Standards are 125,250,500,750,1000,1500,2000 pg/ml, with the 2000 pg/ml line 
drawn thicker for orientation. (B) Exemplar standard curves for BSA (open squares) and bovine 
gamma globulin (BGG) (closed squares).
2.2.5 Fluorescence-based Assays
Fluorescence is the phenomenon that occurs through the release of a photon by a 
molecule as a result of relaxation after excitation. Three distinctive stages contribute to 
fluorescence, shown in the diagram in Figure 2.6. Firstly, a fluorophore (generally 
polyaromatic hydrocarbons or heterocyclic molecules) becomes excited by photons of a 
particular wavelength and energy. This causes the promotion of electrons to an excited 
electronic singlet state (Si' in Figure 2.6). In the first 10 nanoseconds after excitation, the 
fluorophore undergoes both conformational changes and interactions with its local 
environment. The energy held by the Si' state is partially dissipated through heat or
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molecular vibrations and rotations, yielding a relaxed excited singlet state (Si). From this 
point, the fluorophore relaxes back down to the ground state and a photon is emitted. 
Due to the loss of energy between states Si' and Si, the energy associated with this 
emitted photon is less than that used to excite the fluorophore. This difference in 
energies is known as the Stokes shift (hvEX -  bvEM). It is the reason why the wavelengths 
of fluorescent emissions are longer than those needed to excite the fluorophore.
Figure 2.6: iablonski diagram for the typical progression of energy throughout a molecule 
resulting in fluorescence
The measurement of fluorescence relies upon the same parameters of absorbance, and 
therefore is subject to the Lambert-Beer law. This therefore means that measurement is 
dependent upon the fluorophore concentration and therefore upon the concentration of 
the molecule of interest, if tagged with a fluorophore. In addition to concentration, path 
length and the extinction coefficient, the other factors that affect fluorescence 
measurement are the fluorescence quantum yield of the dye, the excitation source 
intensity and the fluorescence collection efficiency of the instrument. The fluorescence 
quantum yield is defined as the ratio of the number of photons emitted to the number of 
photons absorbed. Below a sample absorbance value of 0.05, the fluorescence intensity 
is linearly proportional to these factors*233’. Using fluorophores therefore has a great 
advantage in situations where the absorbance of a molecule within a mixed solution is 
not easily measured. Measuring fluorescence is a more sensitive method than measuring 
absorbance alone, and therefore smaller quantities of the substance of interest can be 
measured. In addition, the measurement of fluorescence is far less subject to 
interference from detergents etc.
Using fluorescence for measurement instead of simple absorption is a lot more specific to 
the molecule that needs quantifying.
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Many commercial fluorescent dyes exist, with their properties being tailored to specific 
purposes. In this thesis, the fluorescein derivative fluorescein isothiocyanate (FITC, 
Sigma-Aldrich, St. Louis, MO) has been used to label bovine serum albumin. Fluorescein is 
a widely used dye, with relatively high absorptivity, excellent fluorescence quantum yield 
and good water solubility. Drawbacks of fluorescein however, include photobleaching, 
pH sensitive fluorescence and a relatively wide emission spectrum. Fluorescein has an 
absorption maximum at 494nm and an emission maximum at 518nm, as demonstrated in 
Figure 2.7.
Wavelength (nm)
Figure 2.7: The absorption (first peak) and emission (second peak) spectra for fluorescein at pH 
9.
Conjugation and Measurement
This protocol describes in general the conjugation of FITC with proteins. Details on the 
exact amounts used in this thesis are given in section 3.2.4. A stock solution of the 
protein in question at a concentration of at least 2mg/ml should be prepared in 0.1M pH9 
carbonate buffer (8.4g NaHC03 and 10.6g Na2C03 in 1L distilled water). FITC should be 
dissolved in anhydrous DMSO at lmg/ml. To each ml of the BSA solution, 50pl of the FITC 
should be added slowly whilst mixing. This should then left to mix and react for two 
hours at room temperature in the dark. After this time, unreacted FITC can be removed 
either through gel filtration or through dialysis against the buffer of choice. In this thesis, 
0.01M phosphate buffer pH7.2 is used (19.5ml 0.2M NaFi2 P04  (24g in 1L), 30.5ml 0.2M 
Na2HP04  (29g in 1L) 950ml distilled water). The final stock tagged protein solution is 
frozen in 1 ml aliquots to be used when required.
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The following equations (2.4-2.8) detail the calculations for the degree of labelling and 
conjugation efficiency for FITC, although they can be adapted for any fluorophore. 
Initially, the absorbance of the working solution at 280nm and 495nm is measured 3 
times, and averaged. The absorbance of the protein is measured at 280nm, however, one 
has to also correct for the absorbance of the FITC at the same wavelength.
A p ro te in  =  ^ 2 8 0 nm ~  ^ 4 9 5  (CF) 2.4
where CF is the correction factor of the fluorophore, which for FITC is 0.3. From this, the 
Lambert-Beer law can be used to determine the concentration of the protein in mass 
terms;
C ( mg/ ml )  =  ( x 10
V £i% /
2.5
where C is the concentration of the protein in mass units, Aprotein is the corrected 
absorbance of the protein calculated using equation 2.4 and e% is the extinction 
coefficient of the protein at 1 %.
To calculate the protein molar concentration, the following equation can be used:
Protein Concentration (M) = — — ---  ^— ------  x dilution factor
£m o lar
2.6
The degree of labelling is calculated thus:
i4495 of the labelled protein
Moles f  lour ophore/mole protein = — : ;--— —- x dilution factors' x protein concentration (M)
2.7
where s' is the molar extinction coefficient for the fluorophore.
The efficiency of fluorophore conjugation expressed as a percentage can be calculated 
thus:
, v initial mass o f  fluorophore (g/I)
E fficien cy (%) = — —  ------ —        x 100
fin a l mass o f  fluorophore (g / l)
2.8
With the protein and fluorophore concentrations and the conjugation efficiency 
calculated, one can construct a calibration curve for protein concentration against 
fluorescence. A calibration curve must be constructed as it is fluorescence that is being 
monitored, not absorbance. Concentration determination using the Lambert-Beer law
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can only be applied to absorbance measurements. As fluorescence intensity is dependent 
upon absorbance, a linear range exists for all fluorophores. For fluorescein, this range is 
between 0.07 and 2.5pg/ml<234). Once plotted, a fit for the calibration data can be 
established and the equation of the fit is then used to determine the fluorophore 
concentration and therefore protein concentration in the experimental sample.
2.3 Polyacrylamide Gel Electrophoresis
Electrophoresis is the movement of charged particles or molecules in a conductive 
environment under the influence of an applied electric field (electromotive force, EMF). 
It is a commonly used method to separate analytes based on their differences in mobility 
(size to charge ratio) and is applied to many biomolecules, including carbohydrates, 
nucleic acids, proteins and amino acids(235>. Electrophoretic separation can either be 
carried out in a free solution (generally contained within a narrow capillary) or in an 
environment which contains a non-conductive matrix, such as a gel. Using gels in 
electrophoresis has several advantages. The gel matrix prevents diffusion of samples and 
keeps the loaded samples separate, so several different samples can be run on a gel at 
the same time. They can dissipate the heat generated by the current (joule heating) 
which interferes with the separation process and causes band broadening. In addition, 
gels have a sieving effect, as larger molecules are more retarded than smaller ones. This 
therefore means that molecules with the same charge to size ratio are still separated as 
long as their sizes are different.
The gel composition depends upon the material to be separated, as well as the size range 
and resolution that is to be achieved. Agarose is composed of long unbranched 
carbohydrate chains that are not cross-linked. This results in a fairly large pore size, and 
thus agarose is used to separate the higher molecular weight DNA molecules. The second 
gel type used for proteins and smaller oligonucleotides is polyacrylamide. Only 
polyacrylamide gel electrophoresis (PAGE) is used in this thesis (chapter 4).
A polyacrylamide gel is formed by the polymerization of acrylamide monomers into long 
chains. These chains are then further cross-linked with N,N'-methylenebisacrylamide. 
The polymerization is initiated by free radicals provided by ammonium persulfate, with 
the reaction being catalysed byTEMED.
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The amount of acrylamide and the acrylamide:bisacrylamide ratio determines the pore 
size of the gel, which in turn determines the gel separation range and resolution. An 
increase in acrylamide concentration leads to a smaller pore size, making the higher 
percentage gels better for separation of lower molecular weight proteins and DNA. Table 
2.1 shows the acrylamide concentrations used for the separation of DNA oligonucleotides 
in terms of their length (base pairs). Table 2.2 shows the acrylamide concentrations used 
in protein separation, along with their separation ranges in Daltons. In this thesis, 10% 
gels will be used for DNA separation and 6% gels for protein separation.
Gel acrylamide DNA fragment sizes
concentration^) separated (bases)
30 2-8
20 8-25
10 25-35
8 35-45
6 45-70
5 70-300
4 100-500
Table 2.1: Gel acrylamide concentrations (19:1 acrylamide:bisacrylamide ratio) for DNA 
oligonucleotide separation (reproduced from Current Protocols in Molecular Biology12361)
Gel acrylamide Protein size separation
concentration (%) range (kDa)
15 12r43
10 16-68
7.5 36-94
5.0 57-212
Table 2.2: Gel acrylamide concentration (37.5:1 acrylamide:bisacrylamide ratio) for protein 
linear separation ranges (reproduced from Qiagen bench guide*2371)
The selection of acrylamide concentration therefore depends upon the size of the analyte 
that needs isolating. In this thesis, PAGE will be used to analyse both short DNA 
oligonucleotides and the protein BSA. The percentage of acrylamide used therefore 
depends upon their sizes. In addition, the ratio of acrylamide to bisacrylamide used is 
determined by the biomolecule of interest. DNA gels tend to use a 19:1 acrylamide:bis 
ratio, whereas protein gels require a ratio of 37.5:1.
In addition to the choice of gel matrix, the buffer system in which samples are carried
through the gels is extremely important, as it carries the charge that allows for
electrophoretic separation. The buffer must be chosen such that the analyte molecules
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are charged, stable and soluble. To obtain negatively charged proteins, buffers with high 
pH values are used. Typical examples include Tris-glycine, pH 9.1 (protein gels) and Tris- 
borate, pH 8.3 (DNA gels). Buffer concentrations are typically 50 to 100 mM.
In order to assure that all molecules will flow through the gel at the same rate (i.e. have 
the same mobility), they must be treated prior to loading. In the case of proteins, this 
treatment generally involves the addition of a surfactant such as sodium dodecyl sulphate 
(SDS) to the sample, the gel, or both (SDS-PAGE). SDS ensures the denaturation of the 
protein as it wraps around the polypeptide backbone and gives an overall uniformly 
negative charge to the protein. To further denature the protein, 2-mercaptoethanol can 
be used to break any disulphide bridges. For DNA, the three dimensional structure is less 
complex, and therefore requires less pre-treatment. For the majority of samples, simply 
heating it to 95°C is enough to denature the DNA.
The volumes given here are enough to construct two mini-gels using the Bio-Rad mini- 
PROTEAN tetra system (Hemel Hempstead, UK), 8.3x7.3xlmm (HxWxD) in size. For the 
DNA gels, an acrylamide concentration of 10% is used (5mls 19:1 acrylamide/bis, 2mls 
10X TBE stock (TBE = Tris (107.78 g/l, 0.89 M) Boric acid (55.0 g/l, 0.89 M), EDTA (5.85 g/l, 
0.02M) pH8), 200pl of 10% APS in deionised water, 20pl TEMED and 13ml deionised 
water) with lx  TBE as the running buffer. lOpI of each of the samples to be run is mixed 
with 2pl loading dye (Promega Blue/Orange loading dye, 6X) and loaded onto the gel. 
Gels are run at 100V for approximately 1 hour, then visualised using ethidium bromide 
staining (0.5pg/ml in lxTBE) and imaged under UV using the Syngene bio-imaging 
Geneflash gel documentation system.
The protein gels are based on the Lamelli system(Z38), in which a layered gel is constructed 
with the top layer (stacking gel) consisting of a lower acrylamide concentration and pH of 
the lower layer (separating gel). A 6% separating gel (3ml 30% 37.5:1 
acrylamide/bisacrylamide, 3.75ml 1.5M Tris-HCI (23.64g/100ml pH 8.8) 150pl 10% SDS, 
150pl APS, 15pl TEMED, 8ml deionised water) is made first, as this is at the base of the 
final gel. Once poured, a thin layer of water-saturated butanol is placed on the top to 
prevent contact with the air. Once set, the butanol is removed and the gel washed with 
tris-glycine running buffer (10X stock = 2M glycine (150.14g/l), 250mM Tris-HCI (39.27g/l) 
1% SDS (10g/l) final volume 1 litre). The 5% stacking gel (1.7ml 30% 37.5:1 
acrylamide/bisacrylamide, 1.25ml of 1M Tris-HCI (15.76g/100ml pH 6.8), lOOpI 10% SDS,
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lOOpI APS, lOpI TEMED, 6.8ml deionised water) is then placed on top with the comb to 
create the wells. The tank is filled with the running buffer and the samples are loaded. 
The samples to be run are mixed with loading buffer (10% w/v SDS, lOmM 2- 
mercaptoethanol, 20% v/v glycerol, 0.2M Tris-HCI pH 6.8, 0.05% w/v bromophenol blue, 
5x stock, 10ml final volume made up with water) prior to loading (lp l loading buffer, 5pl 
sample). Gels are run at 200V for approximately 30 minutes, after which they are stained 
with coomassie (0.05% (w/v) coomassie brilliant blue R-250, 50% methanol, 10% acetic 
acid, 40% water) for 1 hour by rocking the gel gently in the solution. The gel is washed 
with destain (30% methanol, 10% acetic acid, 60% water), changing the solution several 
times until the background is clear, and imaged with a digital camera.
The gels are analysed through a comparison of the position of the bands to the position of 
bands containing material of known molecular weights. Markers must therefore be run 
concurrently to the samples on each gel made. Gels are generally analysed through 
calibrating the log molecular weight of the markers to the distance travelled within the 
gel. However, as the markers that will be used for the protein gel in particular are not 
comprised of both protein and DNA, a calibration curve of log apparent molecular weight 
(from the markers) versus relative mobility (Rjf) is constructed. The values for R/  are 
calculated by dividing the distance that the band in question has migrated down the gel 
by the total distance moved by the dye front. Each measurement is taken from the top of 
the separating gel. The R/values for the experimental samples can then be compared to 
those of the markers and an apparent molecular weight can be established.
2.4 Enzyme Concentration Measurement
Enzymes such as urease used in chapter five are proteinaceous catalysts, and as with all 
catalysts, they speed up the rate of the target reaction. The rate of a reaction is affected 
by several factors, including the concentration of reactants in solution, temperature, 
pressure, and the presence and amount of a catalyst. One can measure the amount of an 
enzyme through its catalytic action. The rate of reaction for any enzyme remains 
constant unless external factors influence it. For example, as with any reaction, an 
increase in temperature will increase the rate, but for enzymes, there is an optimal 
working temperature, above which the enzyme will start to denature.
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Enzymes contain specific catalytic sites within them where their target reactions take 
place. The rate of the overall reaction rate depends on the frequency of contact of the 
reactants (the enzyme and its substrate). The availability of the catalytic sites is limited 
by the amount of the enzyme, and the maximum rate is therefore dependent upon the 
enzyme amount and concentration. Concentration is after all a measure of the amount of 
molecules in a given unit area or volume.
In addition to the amount and concentration of the enzyme, the amount and 
concentration of the substrate(s) also determines the reaction rate. If the rate remains 
the same despite a change in concentration (not mass) of a substrate, then the reaction is 
said to be 'zero-order'. If the reaction is dependent on the concentration of one 
substrate, it is a 'first-order' reaction, with a 'second-order' reaction being dependent on 
two substrates, and so on. The enzymatic catalysis of a reagent often has more than one 
reaction rate, depending upon the substrate concentration. At low concentrations, 
reactions are often 'first-order', but at higher concentrations, the reactions are 'zero- 
order' (Figure 2.8).
Figure 2.8: A plot of initial reaction velocities versus substrate concentration [S] for an enzyme 
catalysed reaction. In the first order region, the velocity is linearly dependent upon the lower 
substrate concentrations, whereas at higher concentrations it is independent1239’.
Figure 2.8 shows a typical curve for the speed of a reaction catalysed by an enzyme using 
known concentrations of the substrate. At a constant concentration of enzyme, the 
reaction rate increases with increasing substrate concentration until a maximum velocity 
is reached. This saturation effect is not shown in un-catalysed reactions, and accounts for 
the relationship between velocity and substrate concentration not being linear. In 1913,
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Leonor Michaelis and Maud Menten proposed a simple model to explain these kinetic 
characteristics.
fej .
E + S ^ H E S - ^ E - ^ P
fc_i
The enzyme E combines with the substrate S to form the ES complex with a rate constant 
of ki. This complex can either dissociate back to E and S with the rate constant k_i, or go 
on to give E and P, with a rate constant of k2.
The catalytic rate for this process is equal to the product of the concentration of the ES 
complex and k2. ES however, is difficult to quantify directly, so the following equations 
are used:
Rate o f  formation o f  ES = fci[i?][S]
Rate o f  breakdown o f  ES = (/r_x + fc2)[£S]
The rate of ES formation is equal to the concentration of the enzyme multiplied by the 
concentration of the substrate multiplied by the rate constant ki. The rate of ES 
breakdown is equal to the concentration of the enzyme-substrate complex multiplied by
the additions of the rate constants k.i and k2. Under steady conditions, these two
equations are balanced, giving (2.9);
[ES] = — —  2.9
This can be simplified by defining a new constant Km, the Michaelis constant (2.10)
r  _  fc-l +  ^ 2
m ~  r------ 2.10
k\
Further working of the rate constants produced a formula that is the basis of activity for 
every enzyme, and is known as the Michaelis-Menten Equation (2.11).
F _  K « K !
V  — --------------  2 11
[S] + Km 211
V is the velocity of the reaction, [S] is the substrate concentration, Km is the Michaelis 
constant as detailed in Equation 2.10, and Vmax is the maximum velocity attainable by the 
enzyme.
Vmax is only attainable in theory; it is the point at which the enzyme is working at its 
maximum rate, independent of the substrate concentration. As Vmax is the theoretical
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maximum rate, it is never reached. Vmax is asymptotically approached as the substrate 
concentration in increased, as shown in Figure 2.8.
Although Km is defined in Equation 2.10, its meaning is not evident. From Equation 2.11 
however, one can derive that Km is equal to the substrate concentration at which the rate 
is half of its maximum value, thus;
K,„=V^/2  2.12
Km is an estimate for the strength of binding of the enzyme to its substrate. A high Km 
value indicates a weak binding between the enzyme and substrate, and vice versa. Km is 
also seen as the amount of substrate needed for the enzyme to reach Vmax/2.
Although not essential to the measurement of enzyme concentration, knowing the kinetic 
parameters for an enzyme are important. They show that for any particular enzyme 
under particular environmental conditions, the enzyme will always catalyse the reaction 
at the same rate. Clinical laboratories rely upon knowing Km and Vmax in order to be able 
to determine the substrate concentration in a clinical sample.
As stated previously, higher substrate concentrations ensure that the enzyme can work at 
its maximum rate. At sufficiently high substrate concentrations, the catalytic sites of the 
enzymes are always filled and the reaction rate reaches a maximum. It is at this 
substrate-uninhibited point where the relative concentration of an enzyme can be 
determined through monitoring its catalytic activity.
Measurement
The amount of enzyme present in a reaction is measured by the activity it catalyzes. 
Enzyme assays measure either the consumption of a substrate or the production of a 
product over time. An enzyme assay must be designed so that the observed activity is 
proportional to the amount of enzyme present in order that the enzyme concentration is 
the only limiting factor. This is satisfied only when the reaction is in a steady state (zero 
order) and the rate is constant over time.
It is difficult to measure the amount of a substrate or product directly in the presence of 
other molecules that may be needed for the enzyme to function. The amount is 
therefore often determined through changes they make to the local environment such as 
a change in absorbance, fluorescence, pH, conductivity or temperature. The type of 
measurement depends upon the reaction the enzyme catalyses. Two basic different 
types of enzyme assays exist: stop and real-time. Stop assays halt the reaction after a
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defined amount of time, whereas real-time assays monitor the reaction as it happens 
until completion. Both real-time and stopped assays can be used for all of the 
measurement types. Assays can either measure the substrate or product directly, or 
employ a secondary coupled assay to measure the product concentration. Such coupled 
assays are often used when measurement of the product directly is only achieved using 
relatively complicated methods or when the method is not sensitive enough.
Almost all methods employed consist of measuring something that is proportional to the 
amount of substrate or product. Calibration curves must therefore be made before the 
test is run in order to ascertain the relationship between the measurement type and the 
agent being measured. Such plots are generally constructed as velocity versus 
concentration. In this thesis, it is the concentration of the enzyme urease that will be 
varied.
In chapter five, the enzyme urease will be attached to carbon nanotubes. As per the aim 
of this thesis, (to determine the amount of protein loading onto SWNTs and compare 
methods for conjugation) the concentration of urease bound to SWNTs will be 
determined. It is important to note that the kinetics of urease are not being investigated 
in this thesis, only the rate at which it catalyses a constant urea concentration.
Urease catalyses the hydrolysis of urea to ammonia and carbon dioxide. Various methods 
exist for the detection of ammonia, but for this thesis, a coupled assay will be used with a 
secondary enzyme that uses the ammonia for its reaction'2401. In conjunction with urease, 
the enzyme glutamate dehydrogenase (GLDH) is utilised in the assay that is used to 
determine urea concentration in many clinical laboratories. GLDH converts a- 
ketoglutarate to glutamate, in the presence of ammonia and reduced nicotinamide 
adenine dinucleotide (NADH). The oxidation of NADH to NAD+ in this reaction is easily 
observed by monitoring the decrease in absorbance at 340nm. At this wavelength, only 
NADH is absorbant, therefore a decrease in absorbance at this wavelength implies that 
the NADH concentration has decreased.
To gather the data for a calibration curve, two-fold serial dilutions will be used to create 
approximately ten samples of varying concentrations of urease from a stock solution. 
0.1ml of each of these will then be added to the reaction mix that has been pre-prepared 
for measurement (0.25M urea, 2.4mM NADH, 8.6mM a-ketoglutarate, 10U GLDH in 0.1M 
phosphate buffer pH 7.4, final volume 1ml with urease). A spectrophotometer at a
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wavelength of 340nm is blanked with water and zeroed using a control reaction with 
0.1ml water added instead of urease. Each sample (minus the urease) is placed into a UV 
transparent plastic cuvette, which is then placed in the spectrophotometer. As soon as 
the urease is added, measurement of the absorbance at 340nm due to NADH begins. The 
reaction is allowed to progress to completion; either ammonia production ceases due to a 
lack of urea, or glutamate production is halted due to the loss of NADH. Multiple curves 
are produced for absorbance versus time for each urease concentration. For each of 
these curves, the gradient of the line (change in absorbance over time) where the 
reaction is at a steady state is taken as the velocity of the reaction. These velocities 
should then be plotted against urease concentration to give a velocity versus 
concentration calibration curve.
2.5 Atomic Force Microscopy
A further technique that will be employed in chapter five of this thesis is atomic force 
microscopy (AFM). AFM falls under the bracket of scanning probe microscopy (SPM), in 
which a sharp probe is scanned across a surface and the interactions between the probe 
and the surface are monitored. Developed from the scanning tunnelling microscope 
(STM) in the 1980s, the AFM is an important tool for imaging, measuring, and 
manipulating matter on the nanoscale. Resolutions of less than lnm have been 
demonstrated, more than 1000 times better than the optical diffraction limit in light 
microscopes.
The principle of STM is that the tunnelling current between a conductive tip and sample is 
exponentially dependent on their separation. As the tip scans the sample surface, it 
encounters sample features of different heights, resulting in an exponential change in the 
tunnelling current. The tip is brought into close proximity with the sample (within 
nanometres) using an ultrasensitive piezoelectric mechanism. Electrons tunnel between 
the tip and the sample. A feedback loop is used to keep the tunnelling current constant 
while scanning over the sample by automatically adjusting the separation distance. STM 
however, is limited to metallic and semiconducting surface, as it relies on a conducting 
sample and a tip only a few atoms wide.
AFM works in a similar way, but instead of relying on the tunnelling current, atomic force 
microscopy uses the force between a very sharp tip (ideally less than lOnm diameter) and
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the sample surface. This therefore means that the sample does not need to be 
conducting. Knowing the force between the tip and the sample is essential for proper 
imaging. The tip used in imaging is on the end of a flexible cantilever. By measuring the 
deflection of the cantilever, one can measure the forces, as long as the stiffness of the 
cantilever is known. Hook's law, F=-kz, where F is the force, k is the stiffness of the lever, 
and z is the distance the lever is bent, is therefore used to calculate the force between 
the tip and the sample.
The deflection of the cantilever is measured using laser light that is bounced off its back. 
Changes in the reflection of the laser, detected by a split photodiode, lead to the imaging 
of the sample being investigated. The photodiode measures both deflection and torsion 
of the cantilever. Figure 2.9 shows the general principle of AFM.
Figure 2.9: Atomic force microscopy principles. The deflection of a laser as a result of changes in 
the topography of the sample surface detected by photodiodes leads to sample imaging.
Two main modes for AFM exist; contact and non-contact mode. In both instances, as 
with STM, a feedback loop is used to ensure that the tip follows the topography of the 
sample. Contact mode AFM is performed by constantly keeping the tip in contact with 
the sample surface. Non-contact mode is where the tip oscillates near the resonant 
frequency of the cantilever to generate an AC signal from the cantilever. Although not in 
contact with the sample, changes in the force between the sample and the tip are 
measured as changes in the resonant frequency of the cantilever.
Within this thesis, non-contact (tapping mode) AFM is used. Contact AFM damages 
fragile biological materials, as the tip digs into the relatively soft matter. Non-contact 
AFM uses an oscillating cantilever with an amplitude of less than lOnm to probe the
i— x.y»
Piezo movement
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sample in question. The tip is held very close to the sample but importantly does not 
touch it. When in free space, i.e. not near enough the sample surface to effect a change 
on the cantilever, the oscillation remains at the same frequency to which it was set. 
When close to a surface, the electrostatic interactions between the sample and the tip 
cause the frequency of the oscillations to change, altering the reflection of the laser that 
is measured by the photodiodes. In tapping mode AFM, the tip lightly taps on the surface 
of the sample whilst the cantilever is oscillating at an amplitude typically between 10 and 
lOOnm. During scanning, the vertically oscillating tip alternately contacts the surface and 
lifts off, generally at a frequency of 50,000 to 500,000 cycles per second. As the oscillating 
cantilever begins to intermittently contact the surface, the cantilever oscillation is 
reduced due to energy loss caused by the tip contacting the surface. The reduction in 
oscillation amplitude is used to identify and measure surface features. Tapping mode 
allows high resolution topographic imaging of sample surfaces that are easily damaged, 
loosely hold to their substrate, or difficult to image. It overcomes problems associated 
with friction, adhesion, electrostatic forces, and other difficulties that can plague 
conventional AFM scanning methods by alternately placing the tip in contact with the 
surface to provide high resolution and then lifting the tip off the surface to avoid dragging 
the tip across the surface as with contact mode.
Topographic images of a sample is not the only useful images that are produced by the 
AFM in tapping mode. Phase images allow one to visualise differences in the composite 
materials in the sample being analysed, such as variations in composition, adhesion, 
friction or viscoelasticity. During imaging, the amplitude of the cantilever oscillations is 
kept constant by the piezoelectric driver attached to the cantilever itself. The phase lag 
between the oscillation output of the cantilever and the signal that drives the cantilever 
oscillation is measured and recorded by the controller. Figure 2.10 shows a topographic 
and phase image of the same sample taken by the author.
The samples in this image, like all the images taken for this thesis were prepared by 
dropping 2pl of the required sample onto freshly cleaved mica pieces (Agar Scientific, 
Stansted UK). A flow of nitrogen is used to dry the samples before imaging. The AFM 
used was a Dimension 3100 AFM (D1 Veeco, Santa Barbara, CA USA) operated in tapping 
mode and the images were analysed using Nanotec WSxM software.
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Figure 2.10: Height (left) and phase (right) images for a single walled carbon nanotube coated 
with 1-pyrenebutanoic acid succinimidyl ester (PBSE). Note the difference in texture on and 
around the nanotube in the phase image.
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Chapter 3. Functionalization of Single Walled 
Carbon Nanotubes with Bovine Serum 
Albumin -  A comparison of Methods and 
Estimation of Protein Load
3.1 Introduction
When designing novel platforms for medical technologies, such as a surface for proteins 
to be anchored to, one needs to assess the suitability of the platform to the job. 
Desirable properties for a novel platform could include a high surface area, ease of 
functionalization, ease of use or compatibility with the target material. Carbon 
nanotubes, with their high surface area, compatibility with biomolecules and similar size 
make an ideal platform for protein immobilization. When trying to design a new device 
that could incorporate many different components, all parts of the potential technology 
need to be scrutinized for, amongst other things, their efficiency. When the main 
component of a device is the protein platform, one needs to assess how easily and how 
well the protein can be bound to the platform. The efficiency of the binding of proteins 
to a platform such as carbon nanotubes needs to be determined if the complex is to go 
further towards being used in novel technologies.
Different methods for the functionalization of single walled carbon nanotubes (SWNTs) 
with an exemplar protein bovine serum albumin (BSA) will be explored in this thesis. The 
three methods used are non-specific binding (physisorption), non-covalent conjugation 
and covalent functionalization.
Non-specific binding (NSB) is a phenomenon which occurs when a molecule simply 
adheres to the target surface without any kind of specificity. This particularly occurs with 
albumins, as they are naturally sticky proteins. Cheng et al.(241) have shown that the 
hydrophobicity of peptides in addition to van der Waals forces were responsible for the 
interactions between proteins and nanotubes. In a further study, Friddle et al.(242) have
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compared the strength of binding of various chemical groups to carbon nanotubes, and 
found that the amino group has the strongest interactions.
The second method, non-covalent conjugation, involves using the linker molecule 1- 
pyrenebutanoic acid succinimidyl ester (PBSE) to join BSA to SWNTs. This was first used 
by Chen et al.(243) to bind ferritin and streptavidin to SWNTs. The pyrene group within 
PBSE stacks onto the surface of the nanotube through n-stacking(66).
The third method, covalent bonding, is based on that of Jiang et al.(113). Carboxyl groups 
on oxidised SWNTs are activated using a zero length cross linker such as EDAC. This 
activated site is then available for conjugation to free amino groups.
Several methods for the estimation of protein loading on the nanotubes using the 
different functionalization methods have been investigated, including simple protein 
concentration assays and a fluorescence assay. Using the protein concentration assays, 
an attempt has been made to determine which of the three methods is the most efficient 
for protein binding.
3.1.1 Bovine Serum Albumin
The protein being used for this investigation is bovine serum albumin (BSA). It is often 
used as a model protein, as it is here. Serum albumins are non-gylcoproteins (lacking 
carbohydrates), and are the most abundant proteins found in the plasma of humans 
(HSA), beef (BSA) sheep (OSA), horses (ESA) and many other animals, it has various roles 
within the body including maintaining osmotic pressure and pH in the blood and carrying 
fatty acids and other compounds such as metals, amino acids, steroids and drugs that are 
otherwise insoluble in the circulating blood(244). Albumin is an acidic, highly soluble and 
stable protein. BSA is widely used due to its low production cost, its stability and 
inertness.
The amino acid sequence for BSA was determined independently by two different 
research groups during the mid-1970s. Albumins have a low methionine and tryptophan 
content, and a high cystine and acidic amino acid content. BSA contains 2 tryptophan 
residues (responsible for UV absorbance) and 60 lysine residues. The lysine content is of 
particular importance as it is the main target for functionalization due to the presence of 
the primary amine group. The mature BSA protein consists of 582 amino acids, and 607 
including the signal peptide (residues 1-18) and propeptide (residues 19-24). The
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molecular weight of BSA has been calculated as 66399Da through amino acid analysis*245’, 
and 66700 ± 400 through experimental methods*246’. The discrepancy between the two 
may be accounted for through the fact that albumin prepared from serum fractions is not 
always the pure protein, and often has different adducts and modifications, such as the 
presence of tightly bound water.
Structure studies of BSA have revealed its shape to be ellipsoid, with dimensions of 4 lA  
tall and 14lA  wide. This shape, although determined by a variety of methods*246’ is more 
indicative of the structure of the outstretched protein. Although BSA itself has not been 
crystallised to determine its 3D structure, the related protein (76% homologous, Figure 
3.1) human serum albumin (HSA), has. It is through this data that BSA can be seen as a 
roughly heart-shaped protein. This can be approximated to an equilateral triangle, with 
sides of ~80A and a depth of ~30A*247’. BSA has a net negative charge of -18 at pH 7*246’ 
(pi 4.7), and the extinction coefficient at 1% has been determined as 6.6*248’ at 280nm.
Figure 3.1: The three dimensional structure of human serum albumin, with 76% homology to 
bovine serum albumin.
3.1.2 Protein Concentration Assays
One aim of this chapter is to establish a method to determine the concentration of the 
exemplar protein BSA that has been attached to SWNTs in a variety of ways. Protein 
concentration assays have been developed for many years. The accurate determination 
of protein concentration can be essential in biochemical techniques, especially when the 
results are needed for other applications, such as the calculation of enzyme activity.
As detailed in section 2.2, protein assays fall into three main categories. Firstly, the UV 
absorbance of an individual protein can be measured. Using the Lambert-Beer law, one
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can calculate protein concentration so long as the extinction coefficient for the protein in 
question is known. UV spectroscopy can be performed on the sample without the 
addition of any extra reagents, it is fast in comparison with other methods as there are 
no reactions to perform, and the relation between absorbance and protein concentration 
is linear(226).
Colorimetric assays such as Lowry, BCA and Bradford's are all well known and widely 
used. The Lowry and the Smith (BCA) assays both employ the reduction of copper. Under 
alkaline conditions a complex is formed between Cu2+ ions and peptide bonds, reducing 
the copper to the monovalent ion. The Lowry Assay (249) then involves the reduction of 
the Folin-Ciocalteu reagent by the copper ion complex and by tryptophan, tyrosine and 
cysteine residues. The reduced Folin-Ciocalteu reagent has a blue colour, and absorbs 
live over a range of 500-750nm. The assay is sensitive (2pg detection limit), but suffers 
from interference from a wide variety of chemicals (226'250>. The BCA assay varies only in 
that it employs bicinchoninic acid instead of the Folin-Ciocalteu reagent. BCA forms a 
strong complex with the copper that absorbs at 562nm. BCA is more stable under 
alkaline conditions, and is less susceptible to reacting with contaminants such as 
detergents. Bradford's assay is based on the binding of Coomassie brilliant blue G-250 
dye (CBBG) to arginine and to a lesser extent tryptophan, tyrosine, histidine and 
phenylalanine. Under acidic conditions, the absorbance spectrum of the unbound form 
(peak at 465nm) shifts to the blue upon protein binding, with a maximum absorbance of 
595nm. The spectra of the bound and unbound forms of CBBG overlap making, the 
relationship between protein concentration and absorbance non-linear. This is overcome 
using a second order polynomial to fit the standard curve. The Bradford assay is quick 
and easy, with only one reagent being needed.
In this chapter, only UV absorbance and a modified Lowry assay (the Bio-Rad DC assay) 
will be used to examine BSA concentration in the presence of SWNTs.
3.1.3 Fluorescence and Fluorescein Properties
In addition to the use of the conventional protein assays, fluorescein tagged bovine serum 
albumin is used in an attempt to determine the concentration of bovine serum albumin 
on SWNTs in the experiments described below.
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When a molecule absorbs a photon of light, its electrons can become excited enough so 
that they jump from their ground state to a singlet state. When the electron loses energy 
it falls back to its ground state and in the process a photon is emitted. It is this emission 
of the photon (the elementary particle of light) that causes the emission of light and is 
seen as fluorescence. The energy of the photon emitted is less than that of the photon 
that was initially absorbed. With less energy, the photon has a longer wavelength, and 
thus the emission wavelengths of fluorescent molecules are longer than those for 
absorption.
The fluorescein dye is very commonly used, owing to its high absorptivity at the 
wavelength of the argon laser (488nm). It is pH sensitive, with the phenol and carboxyl 
groups being totally ionised in solutions above pH9 to yield the dianionic form. 
Decreasing the pH first protonates the phenol group (pK3 = 6.43), changing the dianion to 
the monoanion. The carboxyl group is then protonated to form the neutral species (pK2 = 
4.31). This neutral species can exist in three different forms; neutral quinoid, zwitterion 
and lactone (251). A further decrease in pH generates the cationic form (pKx = 2.08). These 
changes are illustrated in Figure 3.2.
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Figure 3.2: The forms of fluorescein in solution, with pK values.
These values however also change with the presence of other ionic species, such as salts. 
The dianion is responsible for the majority of fluorescence within the sample, as it has the 
highest quantum yield of all the forms at 0.93. The absorption spectrum of the dianion 
shows the highest peak at 490nm, with a shoulder at 475nm. Other peaks are present at 
322, 283 and 239nm. The molar absorptivity has been measured at 490nm as 76900 M~
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^m '1 in 0.1M NaOH. The anion has a quantum yield of 0.37, with absorption peaks at 
472, 543, 310 and 273nm. Its molar absorptivity is 29000 at both 472 and
453nm. The neutral species is by far the least absorbent, with peaks at 434 (maximum, e 
= 11000 M^cm'1) and 475nm. The cationic form has peaks at 437, 297 and 250nm, with 
the absorptivity of 53000 M xcm 1 at 437nm <252). An isoabsorptive point, where the 
absorption is the same for all pH values, exists at 460nm. The spectra of the four forms is 
illustrated in Figure 3.3.
Wavelength (run)
Figure 3.3: Spectra of the dianionic (— ), anionic (— ), neutral (■ ) and cationic (------) forms of
fluorescein, adapted from Sjoback et z\JIS3>
The spectra for general fluorescein absorption and emission (fluorescence) is shown in 
Figure 3.4, along with the change in absorption and emission over a pH range (Figure 3.5).
488nm
Figure 3.4: Excitation (dashed line) and emission (solid line) spectra of fluorescein in pH 9 buffer 
(green) and FITC conjugated to an antibody (blue). The line at 488nm indicates the wavelength 
at which the argon laser works.
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Figure 3.5: Absorption (A) and emission (B) spectra for fluorescein over a range of pH values.
The absorption spectrum for the pH 5 sample has the characteristic shape of the anionic form, 
whereas all other samples are closer to the dianionic form|2S4>.
Fluorescein isothiocyanate (FITC) is an amine reactive fluorescein derivative that is widely 
used for fluorescent labelling. Two different isomers exist, where the isothiocyanate 
group is on either the fourth carbon of the benzene ring (isomer I) or the fifth carbon 
(isomer II). The isomers are undistinguishable spectrally, in both wavelength and 
intensity. The isothiocyanate group reacts readily with primary amine groups, such as 
that found on the amino acid lysine.
r»W Q n nm
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3.2 Materials and Methods
Within this chapter, two techniques have been employed to assess the efficiencies of 
different methods in conjugating bovine serum albumin to single-walled carbon 
nanotubes. Initially, a standard protein concentration assay (DC assay, Bio-Rad) will be 
used to assay non-specifically bound BSA to SWNTs. Fluorescently tagged BSA will then 
be used to compare the non-specific binding, non-covalent binding and covalent binding 
of BSA to SWNTs.
All chemicals used in the experiments are from Sigma-Aldrich, unless otherwise stated, 
and all data and graphs have been constructed using OriginPro 8.
3.2.1 Preparation of Samples for Bio-Rad DC Assay
0.5mg as-produced SWNTs (Carbon Solutions, Riverside, California) were added to either 
lm l of a 1.5mg/ml BSA solution in 0.1M phosphate buffer pH 7.2 or to buffer alone. Half 
of the samples were then sonicated for ten minutes with a tip sonicator (Sanyo MSE 
soniprep 150, 23KHz, amplitude ~7pm) to break up nanotube bundles and aid dispersion. 
All samples were then mixed overnight on a rotating mixer. The samples were then 
filtered for ten minutes through centrifugal filters with a 300KDa MWCO (Pall, New York), 
and washed with buffer three times. The samples were resuspended off the filter by the 
addition of 200pl water and the use of a tip sonicator as required. Samples are recovered 
by pipetting off the resuspended sample.
3.2.2 Bio-Rad Protein Concentration Assay
As described in chapter 2.2.3, the DC assay (Bio-Rad, Hercules, California) is a variation on 
the Lowry assay for protein concentration determination. The DC assay has a shorter 
reaction time and more stable colour development than the standard assay. In addition, 
it is more suitable for small volume work used in the microplate assays described below. 
The DC assay kit was used as per manufacturers' instructions for 96 well plates to 
determine the protein concentration in samples. The working reagent was prepared, 
consisting of 20pl reagent S (SDS) added to lm l reagent A (alkaline copper tartrate 
solution). 5pl of the standard or sample was added to a microplate well, along with 25nl 
of the working reagent and 200pl or reagent B (Folin-Ciocalteu). This was allowed to
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react at room temperature for at least 10 minutes, after which the absorbance at 690nm 
was measured (Perkin-Elmer Victor3 plate reader).
3.2.3 Preparation of oxidised single-walled carbon nanotubes
200mg of SWNTs (Carbon Solutions) was added to 30ml neat nitric acid (16M) and the 
sample was sonicated using a tip sonicator (Sanyo MSE soniprep 150) to disperse the 
nanotubes in solution. This was then incubated at 90°C in a water bath for 2 hours. 
170ml distilled water was then added to the solution, to cool and dilute the acid. The 
nanotubes were centrifuged for 30minutes at 3000 x g, the supernatant was discarded 
and the process was repeated. The centrifuged nanotubes were then combined with 
36ml of neat sulphuric acid (18M) and 12 ml neat nitric acid (16M), which was then 
incubated at 90°C for a further two hours. This was then made up to 200ml with water 
and the sample was centrifuged as before. The first step is designed to simply purify the 
nanotubes to some degree, whereas the second step with the sulphuric acid introduces 
the majority of oxidation on the nanotube surface.
After oxidation, the sample was filtered through 0.2pm pore size polycarbonate filters 
using a vacuum filtration system. The eluent was discarded, and the sample was washed 
with water until the eluent is pH neutral. Vacuum was applied for a further two hours 
after all liquid has passed through the filter, which caused the nanotube mat gathered on 
the surface of the filter to loosen. This was allowed to dry overnight and weighed. This 
filter-cake was then resuspended in water to a final concentration of 5mg/ml.
3.2.4 Preparation of Fluorescein isothiocyanate tagged BSA
The tagging of BSA with fluorescein isothiocyanate (FITC) follows well-used protocols 
from many sources. Briefly, 2mg FITC was dissolved in 1ml dimethyl sulfoxide (DMSO). 
This was then added to 15ml of a lOmg/ml BSA solution in 0.1M carbonate buffer pH9.6. 
This solution was mixed continuously for 2 hours at room temperature. The solution was 
then dialysed against 2L of 0.01M phosphate buffer pH 7.2 overnight using dialysis tubing 
with a MWCO of 6-8KDa. After dialysis, the FITC-BSA was recovered and aliquotted into 
lm l volumes as a lOx stock solution. These aliquots are stored at -20°C. Final 
concentrations before dialysis were 9.38mg/ml BSA and 0.125mg/ml FITC.
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The degree of FITC labelling and the final FITC and protein concentrations are calculated 
using the equations as stated in chapter 2.2.5. The absorbance of the working solution 
(1/10 dilution of stock) at 280nm and 495nm was measured 3 times, and an average 
taken. Using Equation 2.4, the corrected absorbance of the BSA was calculated. The BSA 
concentration was then determined using Equations 2.5 and 2.6 (by mass and molar 
respectively). The degree of labelling (moles fluorophore per mole protein) was 
calculated with Equation 2.7, and the efficiency of conjugation was determined using 
Equation 2.8.
3.2.5 Preparation of Fluorescein isothiocyanate -Ethanolamine and SWNTs
in order to test control solutions for the complete binding of FITC (to make sure that FITC 
itself does not contribute to any suspension of the nanotubes and to make sure that the 
controls are equal), FITC was conjugated to ethanolamine. Briefly, a stock solution was 
made containing 2mg FITC and 8mg ethanolamine (1:5 molar ratio). These were 
dissolved in 1ml of 0.1M carbonate buffer pH9.6, and left to mix for 2 hours at room 
temperature.
3pl of this stock solution (0.5mM) was used to give a final concentration in a 1ml sample 
of 1.5 x 1(T5M.
3.2.6 Non-Specific Binding of BSA to SWNTs
Briefly, oxidised SWNTs were mixed together with either untagged BSA or the FITC 
labelled BSA. 100pl of the 5mg/ml stock of acid functionalized SWNTs was added to a 
1.5ml capacity eppendorf tube. Both the plain BSA and FITC-BSA were stored as lOx stock 
solutions, and thus lOOpI of the required stock solution was added to the nanotubes, 
along with 800pl of 0.1M phosphate buffer (pH7.2) to give a final volume of 1ml. The 
samples were mixed overnight on a rotating mixer. After mixing, 0.5ml of the samples 
was filtered using 300KDa MWCO centrifugal filters (Pall, New York). All samples were 
centrifuged at 14000 x g in blocks of five minutes. All of the samples were then washed 
by adding 400pl of phosphate buffer and pipetting the sample up and down to resuspend 
any material held by the filter. This stage was repeated several times. Any samples which 
have passed through the filters completely (i.e. there is a minimal amount of the sample 
solution left on top of the filter) were removed from the centrifuge at the end of each five
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minute block. All eluants were collected and reserved for analysis. After filtration, the 
final samples consisting of the washed nanotubes were recovered by the addition of 
400pl buffer and sonication with a tip sonicator (Sanyo MSE soniprep 150) as needed. 
The samples were then removed from the filter with a pipette.
3.2.7 Functionalization with l-pyrenebutanoic acid succinimidyl ester 
(PBSE)
0.1ml of a lOmg/ml PBSE solution in DMSO was added to either lm l of the lOx stock FITC- 
BSA solution or the same concentration of unlabeled BSA. This was reacted together for 
lh r with continual stirring at room temperature, and the stock solutions was then frozen 
at -20°C for future use.
0.5mg of acid functionalized SWNTs was added to 0.1ml of each of the stock solutions, 
and made up to lm l with 0.1M phosphate buffer pH7.2. These samples were then mixed 
overnight on a rolling mixer at room temperature. All the samples were centrifuged and 
washed through 300KDa MWCO filters as per the non-specific binding method. The 
filtrates were retained, and the final samples were recovered as before.
3.2.8 Covalent Functionalization of SW NTs with BSA
Oxidised SWNTs were activated for carbodiimide coupling using l-ethyl-3-(3- 
dimethylaminopropyl)carbodiimide (EDAC) and N-hydroxysuccinimide (NHS). 0.1ml of 
the 5mg/ml oxidised SWNT stock solution was added to 0.9ml MES buffer (0.1M pH5.5). 
To this, either lOOpI EDAC (20mM in water), lOOpI NHS (50mM in water) or a 
combination of both were added. These reagents were reacted together to activate the 
carboxyl groups on the oxidised carbon nanotubes for 30 minutes. The reaction was then 
quenched by the addition of 1.4pl 2-mercaptoethanol (final concentration 20mM). The 
BSA (both labelled and unlabelled with FITC) was then added in amounts so as to 
maintain the same ratio of nanotubes to protein as in previous experiments (0.5mg SWNT 
to 0.93mg BSA). The samples were mixed overnight, filtered with 300KDa MWCO 
centrifugal filters and washed with phosphate buffer. The final samples were recovered 
as before, with the addition of 400pl buffer and sonication.
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3.2.9 UV-Vis Absorbance measurements
Absorbance spectra of samples were determined using a Varian Cary 5000 UV-Vis-NIR 
spectrophotometer. The machine was blanked first with air, then the appropriate 
solvent/buffer. The absorbance of 800pl of the sample was measured in a UV 
transparent cuvette, over a wavelength range of 200 to 800 nanometres.
3.2.10 Fluorescence measurements
A Perkin-Elmer Victor3 plate reader was used to measure the fluorescence of the samples 
prepared. 100pl of a sample was pippetted into the well of a black 96 well plate, and the 
inbuilt software program was used to read the fluorescence. The program uses an 
excitation wavelength of 485nm, emission wavelength of 535nm. All readings were read 
from the bottom of the plate for 0.1 second.
3.3 Results and Discussion
BSA has been bound to SWNTs in a variety of ways. Different methods have been used to 
evaluate the quantity of BSA bound to the SWNTs. The conjugation techniques will be 
examined and the best apparent method for conjugation will be discussed.
3.3.1 Determination of BSA concentration on SWNTs using the Bio-Rad DC 
protein assay
The DC assay (Bio-Rad, Hercules, California) has been used in order to estimate the 
amount of BSA bound non-specifically on SWNTs. 0.5mg of as produced SWNTs was 
mixed with 1ml of a 1.5mg/ml BSA solution. The BSA-nanotube mix was filtered to 
remove any unbound protein and washed to remove any protein that is only loosely 
bound. Filtration and washing were carried out simultaneously using centrifugal filters 
with a molecular weight cut-off of 300KDa, spun at 12000g for approximately 10 minutes 
or until all liquid had passed through the filter. Initial experiments with filers with a 
lOOKDa MWCO showed retention of the protein by the filter. The filtrate from the initial 
filtration step to remove the buffer in which the nanotubes and BSA were first suspended 
is recovered and assayed for protein concentration. This sample is referred to in the text 
as 'flow through'. The washing was carried out by adding 0.5ml of deionised water to the 
centrifuge filter unit, pipetting the sample up and down to resuspend any matter retained
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by the filter and then centrifuging the sample to remove the water and thus wash the 
sample. The filtrate washed off at each wash (herein referred to as wash 1, wash 2 etc) 
was removed and retained for protein concentration analysis. Protein concentration was 
determined with the DC protein assay, as per manufacturer's instructions.
In order to determine the protein concentration in an experimental sample, a calibration 
curve of known BSA standard concentrations, ranging from 0 to 1.5mg/ml was 
constructed. Triplicate readings of the known BSA concentrations were taken and the 
standard curve was constructed as shown in Figure 3.6. The standard deviation of the 
standard samples at each concentration is shown as the error bars in the graph. A linear 
fit was applied, with an R-squared value of 0.988.
Standard Concentration (mg/ml)
Figure 3.6: Calibration curve for absorbance versus protein concentration
The fit line for this graph gives the equation
protein  concentration  =  (absorbance — A ) / B  3.1
where A = 0.061 ± 0.002 and B = 0.647 ± 0.008
The reader may notice that the fit of the data generated does not pass through the origin. 
The fit suggests that at a protein concentration of zero, an absorbance of 0.04 is 
measured. The data shown in Figure 3.6 has been adjusted so that the absorbance for 
the sample containing no BSA is zero, with the subsequent data points having been 
adjusted accordingly. Before measurement, the plate reader was zeroed on air and 
buffer alone. However, it was not possible to establish a baseline absorbance for the zero 
protein standard control with the microplate reader. This therefore alters data read by 
the plate reader and subsequently affects any fit of the data.
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Using Equation 3.1, it was possible to work out the estimated protein concentration of 
BSA carbon nanotubes. These concentrations are as shown in Table 3.1 and Figure 3.7 
below. Errors shown are the calculated average error for each sample, due to the 
intrinsic error produced by using a fit line on a graph.
Sample BSA Not Sonicated
Protein Concentration (mg/ml)
BSA , SWNTs + BSA . + + +
“ Sonicated ~ Not Sonicated
SWNTs + BSA 
Sonicated
+
Unfiltered
Sample
1.664 0.130 1.718 0.133 1.779 0.136 2.440 0.168
Flow
Through
1.572 0.126 1.636 0.129 1.551 0.125 0.864 0.091
Wash 1 0.324 0.065 0.108 0.055 0.130 0.056 0.350 0.067
Wash 2 0.026 0.051 0.025 0.051 0.023 0.051 0.042 0.052
Wash 3 0.023 0.051 0.021 0.051 0.028 0.051 0.028 0.051
Recovered
Sample
0.011 0.050 0.009 0.050 0.200 0.059 0.243 0.061
Table 3.1: Calculated protein concentration (mg/ml) as determined from Equation 3.1 and the 
calibration curve in Figure 3.6. Values shown in the ± columns indicate the errors in the 
calculation for each protein concentration shown.
The binding of BSA to SWNTs was evident as soon as the two were mixed -  without the 
BSA, the as-produced SWNTs did not disperse well in an aqueous solution. This binding of 
the BSA to the nanotubes is non-specific, as nothing was added to the samples to 
promote the binding of BSA to the nanotubes.
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Figure 3.7: A graphical representation of the calculated protein concentrations in Table 3.1.
Figure 3.7 shows the calculated BSA concentration for samples with and without 
nanotubes, and with and without sonication. The amount of BSA initially added to all 
samples was the same (1.5mg/ml). All of the unfiltered samples (i.e. those that have not 
been processed in any way) were calculated to have a protein concentration of higher 
than 1.5mg/ml. This is significant as the highest concentration used in the construction of 
the calibration curve was 1.5mg/ml. Those samples without nanotubes were the closest 
to the original BSA concentration of 1.5mg/ml. Although the equation to calculate the 
protein concentration is a linear one, the Lowry assay is known to be non-linear at higher 
protein concentrations. This could explain the discrepancy in the protein concentration 
calculations for the original BSA samples containing no nanotubes. The majority of BSA 
was removed from all of the samples in the flow-through and the first wash in the 
samples both with and without the SWNTs. The first filtration stage (flow through) sees 
the highest amount of protein being removed. By the second wash, all unbound BSA 
seems to have passed through the filters. Filters with a MWCO of 300KDa were found to 
be of adequate size so as to not cause the retention of free BSA. The amount of BSA 
found in the flow-through for the sample that contained SWNTs and was sonicated was 
lower than all the other samples. This difference indicated that the BSA has been bound 
to the nanotubes, and that sonication has aided in the binding.
The assay shows a higher protein concentration for the samples containing BSA and 
SWNTs that were sonicated. The difference between the sonicated and non-sonicated 
samples could be explained by the fact that sonication helps to break up bundles of
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nanotubes. Large bundles tend to flocculate and precipitate out of solution. This 
increase of solubilised nanotubes could explain the increase in absorption at 690nm and 
therefore a higher protein concentration measurement. Sonication of BSA alone does not 
affect the protein concentration, and the calculated BSA concentration in the presence of 
SWNTs that was not sonicated showed the same value as for the samples containing only 
BSA. It can therefore be said that the cause of the increase in absorbance and therefore 
calculated protein concentration is due to the presence of SWNTs that have been 
sonicated. In aqueous solution, nanotubes tend to precipitate out of solution. As the 
volume of the sample used in the assay is very small (5pl) the chance of there being more 
nanotubes in the solution is higher in the sonicated sample. Absorbance spectra show 
the absorbance of samples containing nanotubes to be high across the entire visible 
spectrum (see section 3.3.3).
Due to the absorption interference from the SWNTs within the samples, it is difficult to 
reliably calculate the amount of protein in the samples using the DC protein assay. A 
secondary method is therefore employed by the author to more accurately compare 
different conjugation techniques. The BSA was tagged with fluorescein isothiocyanate 
(FITC), a highly sensitive fluorophore, to try to measure the fluorescence of the sample in 
direct relation to the protein concentration. The amount of the fluorophore attached to 
each BSA molecule can be controlled through the concentration of FITC added to the 
reaction mix. In effect, it is possible to have approximately one fluorophore per BSA 
molecule.
3.3.2 Determination of Fluorescein isothiocyanate labelling of BSA
Before using FITC tagged BSA to estimate the amount of BSA attached to SWNTs, the 
coupling ratio of BSA to FITC must be established. The measurement of fluorescence will 
be used as a relative method to determine BSA concentration, therefore the ratio 
between the two must be established before measurements are taken.
Using the equations as detailed in section 2.2.5, the final concentrations of BSA and 
fluorescein were calculated, as was the degree of labelling and the coupling efficiency. 
15ml of lOmg/ml BSA in 0.1M carbonate buffer was combined with 1ml of 2mg/ml FITC in 
DMSO to give a lOx stock solution with a final protein concentration of 9.375mg/ml. 
After dialysis to remove any unreacted FITC, the absorbance of a lx  solution (1/10
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dilution) at 280 and 495nm was measured. These values were found to be 0.946 and 
1.107 respectively. Using Equation 2.4, the absorbance due to the protein component of 
the solution was corrected, and found to be 0.6139. Using this corrected absorbance 
value, the BSA concentration was calculated as 0.93mg/ml for the lx  solution using 
Equation 2.5. This value is in good accordance with the BSA concentration before dialysis 
of 0.9375mg/ml for a tenfold dilution. The BSA concentration was not expected to change 
greatly as the molecular weight cut-off of the dialysis tubing used was 6~8KDa, much 
smaller than BSA. The difference in the value measured before reaction and that 
afterwards can be attributed to user error. The BSA molar concentration within the lx  
solution was then calculated at 1.4 x 10'5M using Equation 2.6 with the molar extinction 
coefficient of BSA being 43824 M^cm1. This value was then inputted into Equation 2.7, 
which determined the molar ratio of FITC to BSA as 1.19:1 M. The FITC concentration in a 
IX  solution is therefore 1.67 x 10'5 M. In terms of mass, this translates to 6.49 x 10’6 g. 
With the original amount of FITC in a lx  solution being 1.25 x 10'5g, the efficiency of 
coupling was calculated as 52%, using Equation 2.8.
FITC reacts with nucleophiles within proteins, which include amine and thiol groups 
(Figure 3.8). The main target for labelling however has been found to be the N terminal 
amino acid. Maeda et al.(255) established that at pH values of less than 9.5 only the a- 
amino group (N terminal amino acid) is the target of the reaction. At higher pH, the e- 
amino groups such as lysine, with a pKa of 10.53 are also targeted by FITC.
R S R
^  I! ^  II II
Q 9 — N =  C =  S + NH2 — C — COOH -------------► (V )— NIH— C— NH~~C — COOH
Figure 3.8: The conjugation reaction of FITC to an a  amino acid.
Maeda et al.(256) conjugated FITC to insulin, a peptide hormone consisting of two strands, 
and thus having two a amino groups. They found the ratio of conjugation to be 1.8M FITC 
to 1M insulin, close to the predicted ratio of 2:1. The BSA monomer consists of a single 
chain of 582 amino acids, and has only one a amino group -  the N terminal alanine with a 
pKa of 9.9. At the working pH of 9.6 for the conjugation buffer, this terminus would 
undergo conjugation. Maeda also looked at the non specific binding of FITC to proteins, 
including to BSA, and found that FITC does indeed bind non-covalently to albumin. This 
fact is most likely to account for the presence of a higher than 1:1 ratio found in the
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experiments presented. At the pH of the conjugation buffer (9.6), it is less likely that any 
of the e amino groups are involved in conjugation. As an alternative, FITC can also 
conjugate to thiol groups found on cysteine residues. The pKa of the thiol side chain of 
cysteine is approximately 8.3, but this value does vary depending upon the surrounding 
environmental conditions. BSA contains 35 cysteine residues, and has a free residue that 
is not incorporated into the di-sulphide bridge of cystine. The half cystine is located at 
residue 34, close to the C terminus. Figure 3.9 shows the equivalent regions located on 
human serum albumin (75% homology with BSA).
Figure 3.9: Human Serum Albumin (HSA) structure highlighting the locations or the termini and 
the % cystine residue.
3.3.3 UV-Vis Absorbance of Fluorescein isothiocyanate-BSA and SWNTs
Perhaps the simplest (although not always the most accurate) way of determining the 
concentration of a protein is to measure the absorbance of a solution at 280nm. At this 
wavelength, aromatic residues such as tyrosine and tryptophan are easily excited by the 
photons of UV light and therefore absorb the light. If the extinction coefficient for the 
protein is known, the protein concentration can be calculated using the Lambert-Beer 
law. In addition, when graphed together the spectra of the samples can be compared to 
see how a chemical process affects the particular sample.
In accordance with sections 3.2.6, 3.2.7 or 3.2.8, oxidised SWNTs were mixed in various 
combinations with either phosphate buffer, FITC conjugated with ethanolamine, BSA, 
FITC conjugated BSA, PBSE, EDAC or NHS.
C terminus
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The absorbance spectra of all of the samples for non specific binding, PBSE binding and 
covalent binding with BSA both unconjugated and conjugated to fluorescein were 
measured from 200-800nm.
Figure 3.10 shows the problem behind not being able to simply measure the absorbance 
at 280nm in order to determine the concentration of BSA within the sample -  the 
absorbance or the carbon nanotubes is simply much higher than that of the protein. 
Carbon nanotubes consist of a great many aromatic carbon rings, much the same as the 
ring structures found in tryptophan and tyrosine -  the main amino acids that are 
responsible for the majority of absorption in the UV range. In addition, the shorter 
wavelengths of below 210nm, which excite peptide bonds within a protein, are also 
absorbed at great values by carbon nanotubes. In addition, there is no difference in 
absorbance between the plain SWNT sample and the SWNTs mixed with BSA.
The SWNTs used for the UV-Vis spectra and for all of the fluorescence samples were 
oxidised SWNTs. When oxidised, nanotubes will stay suspended in aqueous solutions. In 
addition, nanotubes have to be oxidised to be functionalized with carboxyl groups -  
essential for covalent coupling with EDAC and NHS. The oxidation of the nanotubes has 
no direct effect on their UV-Vis spectra, other than the signal obtained may be higher as a 
larger concentration of the tubes is able to stay in solution.
W avelength (nm)
Figure 3.10: UV-vis spectra for 0.1M phosphate buffer, BSA, SWNTs and SWNTs with BSA 
measure from 200 to 800nm. All samples were prepared in the same buffer, and the SWNTs 
were oxidised prior to measurement.
The UV-vis spectra for all of the samples involved in the three different functionalization 
methods were measured. The results are as shown in Figures 3.11 for the non-specifically 
bound (NSB) samples, 3.12 for the PBSE samples and 3.13 for the covalently
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functionalized samples. All samples were measured with a baseline correction using 0.1M 
phosphate buffer, calculated at the time of measurement. A small amount of 
precipitation had occurred in the samples containing SWNTs. Before measurement these 
samples were thoroughly mixed, and then allowed to stand for 30 minutes before being 
used. This allowed for the maximum number of nanotubes to be suspended in solution 
but also gave them time to precipitate to the bottom of the reaction vessel as necessary. 
As lOOOpI of the sample was made and only 800pl of the sample was used for 
measurement, a minimal amount of precipitates were present in the cuvette during 
measurement. In addition, in those PBSE samples that did not contain any protein or 
SWNTs, some precipitation also occurred, as PBSE is only soluble in small amounts in 
aqueous solutions. The concentrations used in samples here (2.6mM final concentration) 
would go back into solution with mixing. No precipitation occurred in all samples that 
contained the BSA and the SWNTs. As proteins are highly water soluble they are able to 
facilitate the suspension of the nanotubes and PBSE.
Wavelength (nm)
Figure 3.11: UV-vis spectra for the non-specific binding (NSB) samples, (a) Buffer (blank) (b)
FITC (c)BSA (d) FITC-BSA (e) SWNTs (f) SWNTs with FITC (g) SWNTs with BSA (h) SWNTs with 
FITC-BSA
The peaks for traces b and d at 490nm in Figure 3.11 show the presence of fluorescein in 
the sample in its dianionic form. It is clear from the graph that the binding of BSA to 
fluorescein causes a blue shift in the absorbance of the sample (traces b and d). This is 
also seen in Figure 3.4 where the absorption and emission of fluorescein and FITC bound 
to an antibody is shown. This is a good indication that the fluorescein is bound to the
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protein. The peak may appear slightly broader than that of pure fluorescein at the same 
concentration as there could be small amount of unbound fluorescein in the sample. This 
amount however should be minimal as the FITC-BSA was prepared beforehand and 
dialysed against clean buffer to remove the unbound fluorescein. A peak at 280nm is also 
clearly visible in those samples containing BSA (traces c and d), as was expected.
Wavelength (nm)
Figure 3.12: UV-vis spectra for the PBSE samples, (a) Buffer (blank) (b) PBSE (c)PBSE-BSA (d) 
PBSE-FITC (e) PBSE-FITC-BSA (f) SWNTs with PBSE (g) SWNTs with PBSE-BSA (h) SWNTs with 
PBSE-FITC (i) SWNTs with PBSE-FITC-BSA.
1-pyrenebutanoic acid succinimidyl ester (PBSE) produces a characteristic absorbance 
spectrum (Figure 3.12 trace b). Upon binding to protein, this spectrum changes greatly 
with the appearance of a double peak around 340nm. An increase of the peak around 
340nm is also seen within the PBSE and FITC sample, but the absorbance does not have 
the intensity of the samples with BSA. The same can be said for the absorbance at 
shorter wavelengths into the UV range. Again, the peak at 490nm corresponding to 
fluorescein absorbance can be clearly seen in those samples containing it and without 
SWNTs. As with the NSB samples, no evidence for the presence of fluorescein or BSA is 
seen, as the absorbance of the nanotubes hides the previous spectra obtained. In 
addition, all of the SWNT spectra show minimal differences at the wavelengths concerned 
for fluorescein and BSA determination.
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Wavelength (nm)
Figure 3.13: UV-vis spectra for the covalently conjugated samples, (a) 0.1M phosphate buffer 
(blank) (b) EDAC (c) NHS (d) EDAC-NHS (e) EDAC-FITC (f) NHS-FITC (g) EDAC-NHS-FITC (h) EDAC- 
BSA (i) NHS-BSA (j) EDAC-NHS-BSA (k) EDAC-FITC-BSA (I) NHS-FITC-BSA (m) EDAC-NHS-FITC-BSA 
(n) SWNT-EDAC (o) SWNT-NHS (p) SWNT-EDAC-NHS (q) SWNT-EDAC-FITC (r) SWNT-NHS-FITC (s) 
SWNT-EDAC-NHS-FITC (t) SWNT-EDAC-BSA (u) SWNT-NHS-BSA (v) SWNT-EDAC-NHS-BSA (w) 
SWNT-EDAC-FITC-BSA (x) SWNT-NHS-FITC-BSA (y) SWNT-EDAC-NHS-FITC-BSA. (EDAC = 1-ethyl- 
3-(3-dimethylaminopropyl)carbodiimide and NHS = N-hydroxysuccinimide)
The third spectrum set (Figure 3.13) shows those values that have been subjected to 
covalent conjugation. Although NHS itself does not play a direct role in the conjugation of 
carboxyl to amine groups, one must investigate the effect that it has on the sample. 
Traces c, d, f, g, i, j, I and m are all the samples without nanotubes that contain NHS. At 
around 300nm, the absorbance of these samples sharply increases to reach a maximum 
absorbance of 3.5 for all the samples. The samples containing no NHS or SWNTs (traces 
b, e, h and k) all have a high absorbance around 220nm. This value ties in with known 
properties of EDAC, stating an absorption maxima of 214nm (257). Traces h and k also have 
a shoulder at around 280nm, corresponding to the presence of BSA in the sample. Due to 
the absorbance of both EDAC and NHS in the near UV range (<220nm), one cannot see 
the absorption of the sample due to the peptide bond within the protein. Most 
interestingly, peaks for fluorescein absorption can be seen in the samples containing 
carbon nanotubes. The nanotubes in these samples appear to have an overall lower 
absorbance at the relevant wavelength, which may have allowed the peaks to become 
visible. This could potentially be due to the pH of the solution and its ionic composition. 
All of these samples were initially reacted in MES buffer (pH 5.5) to allow the activation of
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the carboxyl groups with the EDAC. The pH was raised slightly when the coupling partner 
(BSA) or buffer was added, but not sufficiently so as to become neutral. An additional 
50pl of 1M phosphate buffer had to be added in order to increase the pH to above pH7. 
The pH of the samples was tested before spectroscopy was performed to ensure that all 
were at the same level. The blue shift between FITC (traces q r and s) and BSA-FITC 
(traces w, x and y) can still be seen with the SWNT samples. There is still no evidence in 
the SWNT samples for absorption due to the excitation of the aromatic residues in the 
protein.
These absorbance spectra show that it is impossible to determine the protein 
concentration of a sample that contains carbon nanotubes as the nanotubes mask any 
differences in the absorbance at a wavelength of either 280 or 205nm that are used to 
measure protein concentration.
3.3.4 Measurement of fluorescence of FITC tagged BSA conjugated with 
SWNTs
It has previously been shown that one cannot determine the protein concentration of BSA 
functionalized SWNTs using simple spectroscopy, or by using a more involved method of 
the Lowry protein concentration assay. Carbon nanotubes absorb greatly at UV 
wavelengths, thus rendering the measurement of absorbance at 280 or 210nm useless. 
The Lowry assay was able to detect those proteins washed off the nanotubes, but again, 
the assay suffered from interference from the nanotubes, producing anomalous results. 
Bovine serum albumin (BSA), both unconjugated and conjugated to fluorescein was 
bound to SWNTs in three different ways; non-specifically, non-covalently using PBSE and 
covalently. The samples were washed through centrifugal filters, with the eluants being 
collected, and then measured for fluorescence, with the results being presented here 
(Figures 3.14, 3.15 3.16 and 3.18). All data has been corrected using lOOpI of 0.1M 
phosphate buffer as a blank. In addition, each graph has been normalised to the highest 
result within the dataset. All samples referred to in this section are inclusive of SWNTs, 
unless otherwise stated.
The conjugation of FITC to BSA did not alter the ability of the protein to attach to the 
nanotubes, as no physical differences were seen between that containing FITC-BSA and
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that with unlabelled BSA. The same can be said for those samples containing FITC- 
ethanolamine.
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Figure 3.14: Graph showing fluorescence intensity for all samples created to investigate non­
specific loading of BSA on SWNTs.
All samples, including those with FITC showed low levels of fluorescence for the original 
samples. The amount of fluorescence increased when nanotubes were removed from the 
samples through filtration. This would seem to indicate that the lack of fluorescence is 
not because the samples do not contain any fluorophore, it is more likely that the 
nanotubes are quenching the fluorescence. Several studies have shown this to be the 
case, including some which have used the quenching properties of nanotubes to their 
advantage (258'259). it has been found that certain nanotube chiralities (those lending 
themselves to being semi-conducting) exhibit fluorescence themselves I260-266*. These 
nanotubes absorb in the UV and visible wavelength ranges, but emit in the near infrared 
wavelength range. None of the fluorescence therefore seen within the samples here 
would be as a result of the nanotubes, but the decrease in fluorescence could be caused 
by them. Interestingly, all samples showed some fluorescence in the flow through, even 
if there was no fluorophore present. Apart from this anomaly, both the buffer and BSA 
samples in Figure 3.14 showed no further fluorescence in their samples, including the 
recovered samples that contain the resuspended nanotubes. The FITC-BSA samples 
showed the highest fluorescence throughout the different experimental stages. The 
amount of fluorescence shown as being washed off is much greater than that found in the
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recovered sample. The increase in the level of fluorescence for the FITC-BSA sample 
would seem to indicate that BSA binds more strongly to the nanotubes than the FITC- 
ethanolamine (FITC). The amount of FITC added to the samples was marginally less than 
that in the FITC-BSA samples (1.5 x 10'5M as opposed to 1.67 x 10 5M), but as seen with 
the absorbance spectra (Figure 3.11) the absorbance between the two samples does not 
differ greatly, with the FITC sample actually having a higher peak. Absorbance is 
proportional to FITC concentration, as is fluorescence, so therefore samples with the 
same absorbance should have the same fluorescence count. The amount of fluorescence 
counted for the washes with the FITC-BSA sample did not fall to zero, even after eight 
washes. This shows that this method is much more sensitive than that of the DC assay, as 
there the protein concentration washed off went to zero after the first wash.
Figure 3.15: Graph showing fluorescence intensity for all samples created to investigate PBSE 
mediated non-covalent loading of BSA on SWNTs
As shown by Figure 3.15, in the presence of PBSE, the FITC-ethanolamine shows more 
fluorescence. Again, the samples with no fluorophore showed a negligible level of 
fluorescence for all the washes and the recovered sample. As with the non-specific 
binding samples, the flow through showed a small level of fluorescence. Both the FITC- 
PBSE and FITC-BSA-PBSE samples show higher fluorescence in the unfiltered samples than 
in the non-specific samples. The binding of FITC-ethanolamine to the succinimidyl ester 
group of PBSE is unlikely, as the FITC-ethanolamine complex has no ligands to which the 
ester group would attach. Free ethanolamine in the sample may well react with PBSE, as
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it has a primary amine group to which the ester can attach. This functionalization 
however, does not affect either the fluorescence or solubility of the sample. PBSE is, 
however, only slightly soluble in aqueous media. A small amount of precipitation was 
seen in the FITC-PBSE samples, but this was easily resuspended by mixing. No 
precipitation was observed with BSA, as it is sufficiently hydrophilic to stay in solution. 
The lack of precipitation is also further evidence of the binding of PBSE to BSA or FITC- 
BSA.
The PBSE molecule is also fluorescent, with an excitation wavelength of 340nm and an 
emission wavelength of 376nm. At these wavelengths, no contribution should be 
observed in the fluorescence of the samples, as the excitation wavelength being used is 
485nm. In addition, the n-stacking of the pyrene onto the nanotubes could mean that 
any excitation of the fluorophore would be absorbed by the nanotubes themselves, 
acting as electron acceptors. Kim et al.<267) have however, looked at the fluorescence of 
PBSE on nanotubes, and found this not to be the case, as they were able to image the 
samples. It is therefore most likely that the PBSE is not excited at the wavelength used. 
The samples containing only PBSE show only a very small amount of fluorescence in the 
flow through and first wash. This result is mirrored in the BSA sample, so is more a 
feature of the sample preparation rather than the sample components themselves.
Figure 3.16: Graph showing fluorescence intensity for all samples created to investigate the 
covalent loading of BSA on SWNTs.
Figure 3.16 shows the normalised fluorescence measurements for all of the samples 
created to assess the binding of FITC-BSA to SWNTs covalently. l-ethyl-3-(3-
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dimethylaminopropyl) carbodiimide hydrochloride (EDAC) is a carbodiimide which is 
frequently used in protein coupling. An O-acyliosurea group is formed at the site of 
conjugation (a carboxyl group), which then either reacts with an available amine group, or 
it hydrolyses to reform the original carboxyl group and an N-substituted urea (268>. The 
addition of NHS into the reaction mix ensures that the carbodiimide does not hydrolyse to 
the amine form, and converts the carboxyl to a succinimidyl ester. 2-mercaptoethanol, a 
reducing agent, is used to halt the reaction. Left in the reaction mix, 2-mercaptoethanol 
also prevents the activation of any carboxyl groups that were not originally activated, and 
thus further prevents potential cross-linking. In protein-protein coupling, the two step 
process helps to prevent unwanted cross-linking of the primary coupling partner to itself. 
The addition of the amine containing secondary coupling partner (in this case the protein) 
results in isopeptide bond formation, and the regeneration of N-hydroxysuccinimide 
(NHS). The amine target for coupling in the secondary partner is both the N-terminal 
amino group and the e-amino group found in lysine residues. The scheme for protein- 
nanotube coupling is shown in Figure 3.17.
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Figure 3.17: Protein immobilization on carbon nanotubes using EDAC and NHS (reproduced 
from Jiang et al.<113)).
The use of the two step method decreases the likelihood of cross-linking within the 
sample. Proteins in themselves consist of many amino and carboxyl groups. As it is these 
groups that are conjugated with the EDAC, if the protein was to be added to the reaction 
mix at the same time as the EDAC, there is a high possibility of cross-linking between 
protein molecules, as well as to the nanotubes. The reaction between the nanotubes, 
EDAC and NHS was completed first, and then the protein was added to the mix. The 
activated nanotubes were not filtered before protein addition, mainly due to the low 
concentration of nanotubes in solution and the difficulty of resuspending them. Excess
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EDAC was reduced using 2-mercaptoethanol, to try to ensure that cross-linking between 
protein molecules could not take place.
When conjugated to the carbon nanotubes, the NHS group used to stabilise the reaction 
is the target for the covalent functionalization, and the point at which the amino groups 
of the protein joins to the nanotubes. NHS alone is unable to react with free carboxyl 
groups as the presence of a dehydrating agent such as EDAC is needed, as the reaction of 
NHS to carboxyl groups is a condensation type. Free NHS, either unreacted from the 
initial mix or regenerated through the binding of the protein to the nanotubes, would 
only react further in the presence of EDAC. This however, will not happen when the 
reaction mix also contains 2-mercaptoethanol.
A comparison of the covalent functionalization samples in Figure 3.16 shows higher 
relative fluorescence values for the samples containing FITC-ethanolamine than those 
with FITC-BSA. It is unlikely that the FITC-ethanolamine is reacting with the activated 
nanotubes. Ethanolamine alone is highly likely to react with the activated tubes, as it is a 
primary amine. However, it is also this primary amine that is conjugate to the FITC, with a 
1:1 ratio. The terminal group for this complex is therefore an alcohol, which is unreactive 
with the NHS group.
Figure 3.18 shows all for the results for the three conjugation techniques. It is clear when 
comparing the results from all of the methods that the highest amount of fluorescence 
comes from the non-covalent (PBSE) and covalent methods. The non specific conjugation 
method showed low levels of fluorescence, despite containing the same amount of FITC- 
ethanolamine or FITC-BSA. One potential explanation for this could be the quenching of 
the fluorescence by the carbon nanotubes. It may be that when in contact with the 
nanotubes, the structure of BSA could have resorted back to the cigar like shape of the 
stretched polypeptide. If this were the case, then the fluorophore would be a lot closer 
to the nanotubes than with the other methods.
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>111
Figure 3.18: Graph showing the normalised fluorescence for SWNTs with all conjugation 
techniques.
Nakayama-Ratchford et al.<269) have conjugated fluorescein to polyethylene glycol (PEG), 
and added it to SWNTs in a similar fashion with the PBSE. The PEG molecule allows the 
fluorescein to be lifted away from the nanotube surface, and thus fluorescence could be 
observed. The fluorescence quenching abilities of carbon nanotubes have been studied 
by Lin et al.(270). They found that upon binding to the nanotubes, the fluorescence of 
tagged lysophospholipids was red-shifted and quenched due to the high absorption of the 
nanotubes. Yang et al.(271) have employed the quenching properties of nanotubes to their 
advantage. They bound fluorescently tagged DNA oligonucleotides to nanotubes, which 
upon binding to the complementary strand, would again fluoresce.
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Figure 3.19: FITC-BSA fluorescence for all functionalization methods for (a) all sample types (b) 
recovered nanotubes samples.
The gradual removal of the FITC with either ethanolamine or BSA could be due to two 
reasons. They were either being washed off slowly from the nanotubes, or the nanotubes 
created a mat on the filters through which the conjugates could pass, but not as quickly 
as for the controls without nanotubes. From the data gathered with UV-Vis spectroscopy, 
one can see that nanotubes absorb light at a greater level than fluorescein. It is possible 
that the decreased level of fluorescence in the unfiltered samples could be due to the 
light not being available to the fluorophore to be absorbed, in addition to the quenching 
effect.
Figure 3.19a shows the results for all of the methods with FITC tagged BSA, and Figure 
3.19b shows a comparison of the results for the recovered nanotube samples containing 
FITC tagged BSA. The fluorescence counts have been normalised against each other, to 
allow a better comparison. It can be seen from Figure 3.19b that the method that has 
the highest relative fluorescence for the samples containing the recovered nanotubes is 
the use of PBSE in the non-covalent method. The amount of fluorescence seen for the 
covalent method recovered samples (EDAC, NHS and EDAC-NHS) shows the highest level 
with the NHS sample. NHS alone was not being used as a coupling molecule, and would 
not have reacted with the carboxyl groups on the oxidised nanotubes. Due to the 
presence of the 2-mercaptoethanol in the samples, no cross-linking of the proteins should 
have taken place. Non-specific binding could contribute in some ways to the fluorescence 
present in the sample. However, as is shown by the NSB sample (FITC BSA), the amount 
seen is low in comparison to the non-covalent and covalent samples. The reason why the
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fluorescence is higher for the covalent sample containing NHS alone is therefore 
unexplained.
Figure 3.20: Fluorescence of all unfiltered samples without SWNTs
Controls using samples without nanotubes (Figure 3.20) showed that initially a high level 
of fluorescence was observed in those samples containing FITC, whereas the samples 
without the fluorophore showed a baseline level. All samples showed the fluorescence 
counts dropped to zero after the first wash, and none was recovered from the filters.
The assumption has been made that all of the fluorescein in the stock solution is bound to 
the BSA, and thus none of the fluorescence from the measurements is as a result of free 
fluorescein, apart from in those samples to which it has been added on its own. Filtration 
of fluorescein without nanotubes showed it to be washed through the filter very quickly, 
with none being recovered.
In addition, very small nanotubes could be potentially washed out with the protein and 
fluorescein. With a 300KDa MWCO, the pore size is approximately 35nm (information 
from suppliers). SWNTs are generally 1-2 nm in diameter, with their length being 
anything up to a few microns. In spite of the oxidation, nanotubes are still often found in 
bundles (2-10nm diameter) in aqueous solution. The oxidation used for these samples 
however, was not particularly harsh compared with some methods <272). This would imply 
that fewer functional groups would be added to the nanotubes and therefore there is still 
a high degree of bundling.
The SWNTs have been oxidised and filtered to remove contaminants such as catalyst 
particle and amorphous carbon. There is the possibility however, that small amounts of
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these contaminants are still retained within the sample that are removed with the further 
washing steps employed here. These contaminants could also influence the absorbance 
and thus the fluorescence of the samples.
3.3.5 BSA Concentration Estimation and Methodology Comparison
The molar ratio of BSA-Fluorescein was calculated as 1:1.19, and the protein 
concentration added to all samples was calculated at 1.4 x 10 SM, or 0.93mg/ml. Using a 
stock solution, twelve samples with a concentration between 0 and 0.93mg/m! BSA were 
made. These protein concentrations translate to concentrations of between 0 and 1.67 x 
10 5M for fluorescein.
Calibration curves (Figure 3.21) for known concentrations of fluorescein labelled BSA 
were constructed to allow the calculation of fluorescein concentration and therefore the 
protein concentration.
BSA Concentration (mq/ml) BSA C o n c en tra te  (mg/ml)
Figure 3.21: Calibration data generated using known concentrations of FITC conjugated BSA. 
Figure A shows the entire data range used (0-0.93mg/ml BSA) with the best fir generated using 
the equation y=A*eA(-x/t) + y0 (R2=0.989). Figure B shows the linear subset of the data (0-0.093 
mg/ml BSA) with a linear fit of y=a+bx (R2=0.994).
The linear fit for Figure 3.21b generated Equation 3.2;
protein  concentration  =  (absorbance  — A ) / B  (3.2)
where the values for A and B were calculated as 4.13 x 107 ± 0.03 x 107 and -209 ± 300 
respectively.
BSA concentrations of less than O.lmg/ml (FITC concentration of 0.7pg/ml) led to a linear 
relationship for fluorescence against concentration. Fluorescein has been shown to have 
a linear range up to 2.5 pg/ml <273>. For the values used here, this is a BSA concentration 
of 0.36mg/ml. This value lies in between that of the highest point for the linear portion of
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the graph and then next point, where the relationship becomes exponential. For all 
fluorescent dyes, at lower concentrations the level of fluorescence is directly proportional 
to the excitation intensity. At higher concentrations, light is less able to pass uniformly 
through the solution and a decrease in the fluorescence intensity is observed.
Using Equation 3.2, the fluorescence counts for all samples were converted to an 
estimated BSA concentration. Those values, which after being calculated had a negative 
concentration, were said to have a protein concentration of zero. Figure 3.22 shows 
these results.
Figure 3.22: BSA concentration for all of the samples generated for all conjugation techniques, 
calculated using Equation 3.2 determined from Figure 3.21
In theory, if one converts the fluorescence counts for each sample to protein 
concentration, and then adds up all of the amounts, then the total amount should add up 
to 0.93mg, since 0.93mg is the amount of BSA that was initially added to the samples 
before any processing. Control samples showed just that -  the total amount of protein 
washed through the filters added up to the same as that for the unfiltered samples, 
showing that the method for adding up the data gathered from the washes is feasible for 
assessing protein concentration in samples not containing carbon nanotubes. The
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amount of protein calculated from the unfiltered samples should have been 0.93mg/ml. 
However, all of the samples showed much lower values. The proteins concentrations for 
those samples containing unlabelled BSA cannot be calculated, as these samples do not 
have any fluorescence.
Concentrations for eluents, washes and recovered samples added up are more than those 
calculated for the unfiltered samples. The only possible explanation for this is there is 
some quenching of the fluorescence signal.
Although the calculated values have for some samples been calculated as having a higher 
protein concentration than O.lmg/ml protein (the concentration of the highest point 
within the linear range generated by the data in this study, equivalent of 0.7pg/ml FITC), 
the linear range for fluorescein extends to 2.5pg/ml. This calibrates to a BSA 
concentration of 0.36mg/ml. None of the values calculated in any of the individual 
experiments exceed this value. Table 3.2 shows the calculated BSA concentrations 
(mg/ml) of each sample set created for the unfiltered samples, the sum of the flow 
through and all the washes, the recovered samples and the sum of the flow through, 
washes and recovered samples. With no individual values exceeding the upper limit of 
the linear range for fluorescein, all values can be used without any further dilution or 
measurement needed. The data shown has been manipulated to remove any apparent 
protein concentration as a result of background fluorescence reading measured in any of 
the control samples (i.e. those without BSA or FITC).
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Sample
Unfiltered sample 
protein
Total protein 
concentration in
Protein 
concentration in
Total protein 
concentration in 
washes and 
recovered sample 
(mg/ml)
concentration
(mg/ml)
washes and flow 
through (mg/ml)
recovered sample 
(mg/ml)
Buffer 0 0 0 0
FITC 0 0.019 0 0.019
BSA 0 0 . 0 0 1 0 0 . 0 0 1
FITC-BSA 0 . 0 0 2 0.187 0 0.187
PBSE 0 0 0 0
PBSE FITC 0.104 0.302 0.005 0.307
PBSE BSA 0 0.003 0 0.003
PBSE FITC 
BSA
0 . 1 0 2 0.424 0 . 0 1 2 0.436
EDAC 0
0 0 0
NHS 0 0 0 0
EDAC NHS 0 0 0 0
EDAC FITC 0.092 0.4971 0.019 0.5161
NHS FITC 0.015 0.4266 0 . 0 2 1 0.4476
EDAC NHS 
FITC
0.066 0.5333 0.019 0.5523
EDAC BSA 0 0 0 0
NHS BSA 0 0 0 0
EDAC NHS 
BSA
0 0 0 0
EDAC FITC 
BSA
0.066 0.3631 0.005 0.3681
NHS FITC 
BSA
0.072 0.5506 0.007 0.5576
EDAC NHS 
FITC BSA
0.052 0.3693 0.005 0.3743
Table 3.2: A comparison of the calculated protein concentration for the washes and flow 
through, recovered samples and unfiltered samples.
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None of the samples showed that the BSA was totally removed from the nanotubes. 
Filtration controls have shown that no protein is retained by the filter, and that the total 
amount of protein washed through is approximately equal to that of the starting 
concentration. The most feasible explanation for the difference in the starting 
concentration of BSA and the total concentrations calculated for the samples used in the 
experiments therefore, is that the nanotubes are causing a quenching of the fluorescence 
signal.
Those samples that did not contain any fluorophore were found to have a very low 
fluorescence level in the unfiltered samples. When converted to protein concentration, it 
was found that these values were less than zero, and thus interpreted as having no 
protein in the sample. For the samples containing BSA alone, this would not have been 
true, but as the protein was not labelled, no signal was measured. These samples also act 
as a fluorescence control for the experiments, showing that BSA alone is not fluorescent, 
and that its addition to SWNTs also causes no fluorescence. The same can be said for 
those samples containing only PBSE, EDAC or NHS.
0 .6 -
05
E  0.5 -
I Washes 
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I Total
Figure 3.23: A comparison of the amount of BSA removed from each sample in the washing 
stages. The red bars represent the sum of the concentrations for all washes, the pink bars show 
the concentration calculated in the recovered samples and the blue bars are the sum of the 
washes and the recovered samples.
Figure 3.23 shows a comparison of the amount of BSA that has been washed off the 
nanotubes for the three functionalization methods. The NHS FITC-BSA sample showed
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the greatest amount of protein washed off, followed by the PBSE sample, then the EDAC 
containing samples, and finally that of only FITC-BSA (the non-specific binding sample). If 
it is the case that these samples represent the total amount of protein that has been 
washed off, then it should be possible to subtract this amount from the starting 
concentration of BSA, which was 0.93mg/ml. This gives the values as shown in Table 3.3. 
The data in Table 3.3 shows the estimated amount of protein that has been left on the 
SWNTs. Results seem to indicate that the best method for the functionalization of SWNTs 
with BSA is non-specific binding. This is then followed by covalent binding, with the least 
effective method being non-covalent binding using PBSE.
Sample
BSA concentration in washes Estimated remaining BSA
(mg/ml) concentration (mg/ml)
FITC-BSA 0.193 0.737
PBSE FITC BSA 0.427 0.503
EDAC FITC BSA 0.364 0.566
NHS FITC BSA 0.551 0.379
EDAC NHS FITC BSA 0.37 0.56
Table 3.3: An estimation of the amount of BSA remaining on the SWNTs for each of the 
conjugation methods used. Shown are the amounts of BSA removed from the SWNTs by 
washing, and the estimated BSA concentration remaining on the SWNTs after washing. The
estimated remaining concentration was calculated with the values for the initial concentration 
of BSA minus that removed through washing and filtering.
The value for the non-specific binding sample (0.737 mg/ml) seems anomalously high. 
The fluorescence counts for these samples were lower than that of the other 
functionalization methods, and consequently the value for the amount of protein left on 
the nanotubes is high. This difference in the fluorescence is also seen in the replicates for 
this method. It may be that the non-specific binding of BSA to SWNTs has the highest 
efficiency, as at least in this method there are multiple places where the proteins and 
nanotubes might interact. Nanotubes are in general hydrophobic, aside from those sites 
that are functionalized with carboxyl groups. As the oxidation method employed for 
these nanotubes was not particularly strong, it may be that the number of carboxyl 
groups is low, but not so low so as the nanotubes drop out of aqueous solutions at a high 
rate. BSA in the blood transports lipids round the body -  lipids are hydrophobic and so 
BSA therefore must have hydrophobic regions within its structure. Out of all the amino
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acids, 43% are those with a hydrophobic side chain. As the 3D structure of BSA is 
unknown, one can only speculate as to where these residues are located, with the aid of 
the human serum albumin (HSA) model (Figure 3.24). These could align themselves to 
the nanotubes, and thus coat the nanotubes. A second reason for the higher amount of 
BSA joined to the carbon nanotubes non-specifically could be that the proteins are 
stacking on the surface of the nanotube. This would be made easier by the availability of 
the surface of the nanotubes to the protein, without any other potential chemicals being 
present to interfere in this. If the BSA remains in its native state and is not denatured 
through interactions with the nanotubes, then the nanotubes may sit in the cleft of the 
heart shaped structure of the BSA molecule.
Figure 3.24: The HSA monomer with the hydrophobic residues highlighted in green. HSA is 
analogous to BSA, with 75% homology. BSA has not been crystallised successfully and no 
structural model exists.
With the other methods of functionalization, chemicals are used to join the proteins to 
the nanotubes at specific amino acid sites. The availability of these sites is of great 
importance, as if they are not available, they cannot be used in attachment. This 
however, should not be a problem, as the amino acid residues that are most likely to be 
involved in attachment are the lysine residues. These are hydrophilic in nature, and thus 
generally align themselves to the outer surface of the protein.
PBSE coats the surface of the nanotubes. The stacking of PBSE on the surface of the 
nanotubes would prevent the nanotube surface being available to the BSA so it can bind 
directly. This is, of course, providing that the PBSE concentration is high enough to cover 
all of the nanotubes present. In addition, PBSE contains a short hydrocarbon chain, which 
lifts the protein slightly away from the nanotube surface. As the distance from the
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surface decreases, so does the likelihood of the protein denaturing as a result of the 
hydrophobic nature of the nanotubes. This may alter the amount of protein that is able 
to pack around the nanotubes.
A simulation study by Tatke et al.(133> was performed for PBSE and protein binding on 
SWNTs. They found that when PBSE is bound to the nanotubes, it could not be removed 
from the nanotubes through the binding of the protein to the PBSE. In addition, the 3D 
structure of the protein they used in the simulations (cytochrome C) remained intact 
upon binding. They also simulate the covalent binding of the protein to the nanotube. 
Again, they use a 'spacer7 molecule, but the molecule being used is not stated, although it 
appears to be a short molecule, allowing the protein to be in close contact with the 
nanotube. They find again, that the structure of the protein is unchanged upon binding. 
The EDAC and NHS molecules are small, and thus would not prevent non-specific binding 
through nanotube availability. However, the orientation of the BSA to the nanotube may 
change, as only either lysine residues or the N-terminus would react with the 
functionalized carboxyl groups. The N terminal groups however, are likely to have already 
been occupied with the labelling of FITC.
As no research has been published on such a comparison of functionalization methods of 
proteins to carbon nanotubes, there is nothing to which the results can be compared, 
other than each other.
If one accepts the values for the amount of BSA bound to the nanotubes, then the 
efficiency of functionalization can be calculated. The results for this are shown in Table
3.4.
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Sample
Estimated protein concentration 
remaining on SWNTs (mg/ml)
Efficiency of binding (%)
FITC-BSA 0.737 79.25
PBSE FITC BSA 0.503 54.09
EDAC FITC BSA 0.566 60.86
NHS FITC BSA 0.379 40.75
EDAC NHS FITC BSA 0.56 60.22
Table 3.4: a comparison of the binding efficiencies for each conjugation technique. The 
efficiency was calculated as a percentage of the original BSA remaining conjugated to the 
SWNTs.
As shown in Table 3.4, the most efficient method is non-specific binding of BSA to single 
walled carbon nanotubes, followed by covalent functionalization and then non-covalent 
functionalization using PBSE.
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3.4 Conclusions
Bovine serum albumin (BSA) has been conjugated to single walled carbon nanotubes 
(SWNTs) in three different ways -  non specific binding (physisorption), non-covalent 
binding (using PBSE) and covalent binding (through carbodiimide coupling). Efforts have 
been made to use a simple method to determine the protein concentration bound to the 
SWNTs, and thus determine the most efficient method of binding.
Initially, the DC assay from Bio-Rad was used to try to assay BSA concentration in the 
presence of SWNTs. It was found that the presence of SWNTs greatly interfered with the 
assay, purely because they absorbed strongly at the same wavelength of light required to 
measure the protein concentration. This interference also rules out the simplest method 
for protein concentration determination -  UV absorbance at 280nm. The aromatic ring 
structure of tryptophan and tyrosine that is responsible for UV absorbance is mirrored 
many times over within carbon nanotubes, and thus the nanotubes give falsely high 
signals.
Huang et al.(112) used a modified Lowry assay to evaluate the conjugation of BSA to SWNTs 
using carbodiimide coupling. They claimed they were able to determine that 
approximately 90% of the BSA that they had attached to nanotubes was still bioactive. 
As has been shown in this chapter however, the presence of carbon nanotubes 
contributes to the absorbance reading, thus giving falsely high results. In addition, the 
assay used does not give information on bioactivity, only the presence of certain amino 
acids within the sample and therefore protein concentration.
UV-Vis absorbance spectra for each of the samples created to investigate the different 
methods of binding of BSA to SWNTs were generated. These showed the masking of the 
BSA by the SWNTs, as well as masking any other absorbance peaks characteristic of the 
reagents used to conjugate the BSA to the SWNTs. The use of absorbance methods alone 
therefore are not sufficient to determine the concentration of BSA bound to SWNTs. 
Burch et al.(139> were successful however in using UV-vis spectroscopy in determining 
protein concentration on nanotubes by assessing how much was removed after high 
speed centrifugation and washing of their samples. They determined that approximately 
8 % of the original cytochrome cthat they had added to the nitrogen doped carboxylated
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MWNTs was adsorbed to the tubes, and that 20% of the azurin that they had initially 
added remained bound.
In addition to the presence of BSA, the conjugation reagents and SWNTs in the UV-vis 
spectra samples, fluorescein isothiocyanate (FITC) and FITC tagged BSA had also been 
included. The conclusion had already been reached that the simple absorption methods 
for protein concentration determination were not adequate, so a fluorescent method 
would be used. FITC has a characteristic absorption peak at 495nm, but again this was 
not visible in the spectra. The fluorescent properties of FITC were then used in an 
attempt to determine the amount of BSA that was conjugated to SWNTs.
The ratio of FITC to BSA was established, as was a calibration curve for fluorescence 
versus BSA concentration. This curve was then used to calculate the apparent BSA 
concentrations in each of the stages involved in the production of the samples to 
investigate the three different conjugation techniques.
The data gathered using the fluorescein tagged BSA showed that the method that 
seemed to be most efficient for the binding of the BSA onto the carbon nanotubes was 
non-specific binding, with approximately 80% of the starting concentration of protein 
remaining on or around the carbon nanotubes. Although this result was unexpected, 
repeats showed similar results. This result is backed by the findings of Cang-Rong et 
al.(116), who compared the non-specific and covalent binding of the enzyme 
amyloglucosidase to carbon nanotubes.
The use of absorbance and potentially other forms of optical spectroscopy including 
fluorescence in samples containing carbon nanotubes is an inexact science. Samples can 
be prepared in the same way, but no two results will ever be the same. This is partially 
because nanotubes are produced as a mixed bunch of metallic and semi-conducting 
tubes, with many different chiralities and diameters being present in any one sample. 
Due to this fact, the amount of protein bound to the nanotubes in a particular sample will 
never be the same from sample to sample. Thus, it is only possible to give an estimate for 
the amount of protein bound and which functionalization method is best.
Covalent and non-covalent functionalization both have their advantages and 
disadvantages. Covalent functionalization disrupts the nanotube structure altering its 
properties since a specific linker and chemistry is needed to join the nanotube with the 
protein. Non-covalent methods are simpler by far, but suffer from weaker interactions
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between the protein and the nanotube. A hybrid approach of non-covalent bonding to 
the nanotubes and simple covalent linkage to the protein allows the nanotube structure 
to remain intact whilst having a stronger bond to the protein. Although carboxylated 
nanotubes have been used for all the samples constructed here, this is only essential for 
covalent bonding and therefore can be dispensed with for other binding methods.
The main drawback of using the fluorescence method is that the protein has to be 
labelled with a fluorophore beforehand. It is a simple method, but can be time 
consuming as the fluorescent proteins need to be prepared beforehand. Sample 
preparation takes longer than simply reading the UV absorbance, but no extra reagents 
are needed, as with the DC protein assay. The fact that the nanotubes seem to quench 
the fluorescence of the fluorescein makes it impossible to determine the protein load on 
the nanotubes directly, and hence one must look at the amount of protein that is 
removed from the nanotubes. Even after eight washes, some fluorescence was being 
detected in the wash samples. One cannot be sure if small amounts of the protein are 
continually washed off, or if the protein is washed off relatively quickly and the slow 
decrease in the fluorescence counts over the washes is due to unbound fluorescein being 
washed off. The samples containing fluorescein alone showed this slow washing effect, 
as well as those samples containing FITC-BSA. An alternative to fluorescently labelling the 
protein is using a reagent such as o-phthalaldehyde, which in the presence of 
mercaptoethanol reacts with the primary amines found in proteins forming a highly 
fluorescent product. Although this method could still be subject to quenching from the 
SWNTs, it would avoid the need to tag the protein being investigated.
Many other methods exist in protein analysis that might be applied to the samples 
prepared in this chapter, but the majority of them are quite complicated. One method 
that is employed in molecular biology when an accurate protein concentration cannot be 
determined due to contaminants or incompatible elements within the sample is to 
precipitate out the protein and then analyse it. Precipitation however, would not work as 
it would also mean that the nanotubes also precipitate as it is the presence of the protein 
that keeps the nanotubes suspended. Asuri et al.(274) have used elemental analysis of 
samples before and after functionalization of MWNTs with soybean peroxidase using 
carbodiimide coupling. They claim to have achieved a loading of 0.17g of the enzyme per
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gram of MWNTs. However, there is no elaboration on how this was done, as their 
samples were analysed by a private company.
Better protein coverage could be achieved using a variety of methods. Burch et al.(139) 
found that if doped with nitrogen and carboxylated, the coverage of multi-walled 
nanotubes with metalloproteins can be increased whilst protein conformation is retained. 
Atomic force microscopy showed a greater frequency of protein on the nanotubes as 
opposed to those left in a raw state. They were also able to show using circular dichroism 
spectroscopy and antibody binding studies that the association of the proteins assayed 
with the MWNTs does not prompt denaturation. They concluded that the presence of 
the nitrogen in the MWNTs led to a higher frequency of defect sites that were then 
oxidised and carboxylated. Enhanced carboxylation leads directly to more extensive 
protein coverage, with hydrogen bonds forming between the carboxyl groups and the 
hydrophilic side chains of the amino acids present on the outer surface of a protein. 
Overall, this chapter has shown that all of the methods used to bind BSA to SWNTs are 
feasible. The seemingly most efficient method was non-specific binding, or physisorption, 
perhaps due to its general nature and the ability of the BSA to form more than one layer 
around the SWNTs*139*. The methods that have been employed to try to quantify the 
amount of BSA bound to the SWNTs have only proved useful insofar as being able to 
provide a benchmark for comparison of the methods.
Further investigation into the binding of BSA to SWNTs would most likely involve circular 
dichroism and FTIR spectroscopy, which are able to detect change in protein 
conformation and provide clues as to which method is the most amenable for protein 
structure retention.
The results gained in this chapter will now be used in a comparison to a novel method of 
conjugation mediated by a DNA linker.
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Chapter 4. DNA Mediated Functionalization of 
Single Walled Carbon Nanotubes with BSA
4.1 Introduction
In the previous chapter, three different methods were used to attach the model protein 
bovine serum albumin (BSA) labelled with fluorescein isothiocyanate (FITC) to single 
walled carbon nanotubes (SWNTs). The aim was to find a simple method to assess the 
amount of BSA binding to the nanotubes, and thereby give some clue as to the efficiency 
and efficacy of each of three different conjugation methods. Two main conclusions could 
be drawn from the previous chapter. Conventional methods of protein concentration 
determination are not a viable option in the presence of carbon nanotubes, as the 
nanotubes themselves interfere with the measurements. This led to the tagging of the 
protein with FITC to aid in protein concentration measurement. Secondly, of the three 
differing conjugation techniques, non-specific binding (physisorption) of the FITC tagged 
BSA to the nanotubes was the most efficient method of attachment in terms of the 
amount of protein left on the nanotubes after washing (80%). This chapter will use the 
same methodology to assess a novel conjugation method: anchoring BSA to SWNTs using 
a short single stranded DNA oligonucleotide.
DNA is a naturally occurring polymer that has a central role in biology. Its unique 
properties have spurred many researchers into finding novel non-biological uses for it.
The first demonstration of carbon nanotubes bound with DNA was published in 1997 by 
Tsang et al.<78). From then on, many research projects marrying DNA with carbon 
nanotubes were initiated with a variety of purposes. Baker et al.(96,275) covalently joined 
DNA oligos to SWNTs to create devices to sense DNA hybridization events. SWNT-DNA 
complexes have been used to stabilise colloidal particles1276’. DNA based separation of 
nanotubes<277,278> has allowed more detailed research into individual nanotube 
properties*279,280’. The effect that the nanotubes can have on DNA has been investigated, 
for example by Cui et al.*281’, who looked at the effect of nanotubes on the polymerase 
chain reaction, a method for DNA amplification.
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A more extensive review of the methods and applications of functionalization of carbon 
nanotubes with nucleic acids is given by Daniel et al.(282'. For a more in depth discussion of 
DNA bound to carbon nanotubes in this thesis, the reader is referred to chapter 1.5.1. 
Chen et al.<283) used Tween 20 to wrap around the carbon nanotubes and prevent non­
specific binding of proteins to carbon nanotubes. Tween, with a hydrophobic tail and 
hydrophilic head, is well known for its protein repelling properties. The tail theoretically 
sits aligned along the length of a nanotube, with the head reaching into the space around 
the tube. As this head is reactive, it can and was used by Chen to act as an anchor for 
protein attachment. It is in this similar role that DNA could also be used to attach 
proteins to carbon nanotubes.
4.1.1 Experimental Design
Many research groups have looked into attaching DNA to carbon nanotubes through both 
physisorption and covalent linkage, with the merits and drawbacks of both methods being 
discussed. In this thesis, however, DNA is being used in a chemical as opposed to a 
biological capacity, providing an anchoring point for the protein to the carbon nanotubes. 
In this way, this method is comparable to that of using 1-pyrene butanoic acid 
succinimidyl ester (PBSE) in the previous chapter.
The DNA oligonucleotide that will be used has three main functions. It helps to facilitate 
nanotube dispersal in aqueous solutions, provides anchorage of the protein to the 
nanotube, and helps hold the protein slightly aloft from the nanotube surface. This 
spacing role of the DNA could have a significant role. Research has shown that when in 
direct contact with the nanotubes, proteins may have a tendency to denature, and thus 
not work to their maximum efficiency, potentially stopping their actions altogether*116'128'. 
This would mean that any device created would not work to the full potential, even if the 
protein load on the nanotube was high. By having the protein attached to the nanotube 
through a spacer, this denaturation could potentially be averted as the force exerted on 
the protein by the nanotube would not be so great.
If the complex were to be used as a successful sensor platform, it is important that the 
spacer does not interfere with any signal to be transduced. Research into the ability of 
DNA to conduct electrical signals has been conducted and shown contradictory results. 
There are two schools of thought as to how DNA can conduct electricity; through the pi
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stacked bases*284* within the double helix, or through the phosphate backbone*285*. There 
are also differing reports on whether DNA is semi-conducting*286*, metallic*287*, or even an 
insulator*288’. DNA wrapped carbon nanotubes have however, been able to sense gas 
odours, showing that wrapping does not impede the sensitivity of the nanotubes*289’. 
Regardless of the physical properties of DNA, it has been conclusively shown that nucleic 
materials aid in the dispersion and suspension of carbon nanotubes of all types in 
aqueous solutions.
Single stranded DNA is more flexible than more natural double stranded genomic DNA -  
the bonds are more apt to twisting. This flexibility allows the oligonucleotide to find the 
lowest energy conformation needed to maximise base-nanotube interactions, whilst still 
allowing the hydrophilic phosphate backbone to be exposed to the aqueous 
environment*40*. This aids the dispersal of the nanotubes into an aqueous environment. 
With single stranded DNA more likely to achieve fuller wrapping, a single strand 
oligonucleotide will be chosen as the protein tether.
Zheng et al.*40* found experimentally that the best homopolymer of DNA for nanotube 
dispersion consisted of thymine bases. In addition, they found that the best length of 
polymer was 30 bases long. Although other sequences and lengths have been 
investigated*90'92'290 292*, for the purposes of this research the decision was made to use a 
T30 (thirty thymine bases) oligonucleotide.
The method for conjugation between the oligo and the protein influences whether any 
functionalization of the DNA needs to occur beforehand. There are three options when 
choosing to conjugate to proteins, or rather there are three different functional groups to 
which molecules can be attached. These are amino groups (NH2), such as those found on 
lysine residues, carboxyl (COOH) groups found in aspartic and glutamic acids, and thiol 
groups found in cysteine residues. Cysteine residues are responsible for the sulphur 
bridges found in proteins to help keep their three dimensional structure intact. They are 
generally buried with a protein, and are thus often inaccessible. The carboxyl and amine 
groups on the other hand are readily available on a proteins' surface. They generally play 
no structural role, and are thus most often used in the conjugation of proteins. The 
chemistry used to conjugate the DNA to the protein will invariably use either the free 
amine or carboxyl groups.
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As amine and carboxyl groups will react with each other, we will aim to first functionalise 
the DNA molecule before reacting it with the protein to avoid protein cross-linking.
The phosphate group at the 5' (5 prime) end of DNA is easily modified. Ethyl-3-(3- 
dimethylaminopropyl)carbodiimide-HCl (EDAC), for example, activates the phosphate 
group, which can then be reacted with imidazole to form a phosphorylimidazolide. This 
reaction is similar to that of EDAC and N-hydroxysuccinimide (NHS) which utilises carboxyl 
groups. Subsequent coupling to any amine containing molecules then allows the 
formation of a stable phosphoramidate linkage. Further options include modifying the 
phosphate with a diamine allowing a heterobifunctional reagent to be used to conjugate 
the protein, or modifying the phosphate with an amine containing a thiol group, which 
can be targeted with maleimide activated proteins. Biotin can also be conjugated either 
by using a diamine and an amine reactive biotin compound. Biotin allows materials that 
have been previously functionalised with the protein streptavidin to be attached. For the 
purpose of protein conjugation, the 3' (hydroxyl terminus) of DNA is not generally used. 
The use of DNA as a protein tether has been applied in other areas of research. Boozer et 
al.(293) covalently coupled single stranded DNA oligos to antibodies for the purposes of 
biosensing. Thiol terminated oligos were attached to the antibodies which had been 
previously functionalised with maleimide groups. This method is relatively accurate, as 
few groups exist within proteins that can form a bond with thiol moieties. However, the 
process of functionalising the protein with maleimide groups prior to conjugation can be 
time consuming. Guo et al.(294) used EDAC and NHS to conjugate DNA and protein, 
although their method of mixing all reagents and reactants together overnight can lead to 
unwanted cross-linking.
The method that has been chosen for DNA-protein conjugation in this thesis is 
carbodiimide coupling. A carboxyl group on the end of the DNA oligo will be joined to an 
amino group on the target protein. The T30 oligo will be purchased labelled at the 5' 
terminus with an amino group on a chain of 6  carbons (T30 C6-NH2, Figure 4.1). This will 
be substituted for a carboxyl group prior to any reaction with the protein. If free carboxyl 
groups within a protein are activated using a carbodiimide coupling agent such as EDAC 
there is a danger that the free amine groups would bond with the activated carboxyl 
groups within other protein molecules and cause cross-linking.
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Figure 4.1: Structure of amino C6 -  the six carbon amino tag incorporated at the 5' terminus of 
the thirty thymine oligonucleotide sequence to be used as a protein linker. The wavy line 
indicates the T30 oligonucleotide to which the group is attached
The protein to be conjugated to the oligos for final addition to single walled carbon 
nanotubes will be the same FITC labelled bovine serum albumin that was used in the 
previous chapter (chapter 3.2.4). The main aim for this chapter is to produce a nanotube- 
BSA composite comparable to those made in the previous chapter. The amount of 
protein conjugated to the nanotubes can be estimated, and the efficiency compared to 
those of the previously explored methods.
4.2 Materials and Methods
A DNA oligonucleotide and bovine serum albumin tagged with fluorescein isothiocyanate 
will be conjugated covalently using carbodiimide coupling. A carboxyl group is first 
activated using an agent such as Ethyl-3-(3-dimethylaminopropyl)carbodiimide-HCI 
(EDAC), and upon introduction of a primary amine, an amide bond is formed. In order to 
reduce the risk of cross-linking between protein molecules (as they contain both free 
carboxyl and amine groups), the DNA will be activated first and the protein will be added 
as the amide containing molecule. If the free carboxyl groups of the protein were to be 
activated first, free amino groups would react quickly with these activated carboxyls 
creating conjugated protein molecules. As it is not possible to purchase oligos with a 
carboxyl group terminus, an amino tagged oligo will be used, and the amino group will be 
replaced with a carboxyl group prior to introduction to the protein. This will be 
accomplished using succinic anhydride (SA) and triethylamine (TEA) in acetonitrile. A 
similar scheme was used by Liu et al. to introduce carboxyl groups onto the surface of 
silica nanoparticles(295). After the substitution of the carboxyl group, the solvent used will 
be evaporated, and the residue is resuspended. The DNA is then precipitated and washed 
to remove any unreacted reagents and resuspended in either TE (Tris-EDTA) buffer or 
MES (2-(N-morpholino)ethanesulfonic acid ) buffer. MES buffer is used for all samples
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containing the coupling agent EDAC. Samples will be made to test each stage in this 
process, with each being run on a polyacrylamide electrophoresis gel.
The DNA samples produced with varying methods will then be mixed with bovine serum 
albumin that has previously been tagged with fluorescein isothiocyanate (FITC). This was 
accomplished by mixing a pure solution of bovine serum albumin and FITC together in 
carbonate buffer. For an in-depth explanation of this method, the reader is referred to 
section 3.2.4. The DNA-BSA samples will then be run on a polyacrylamide electrophoresis 
gel and stained as appropriate to assess binding. The protein-DNA complexes will then be 
added to lightly oxidised SWNTs, and the mix will be washed using centrifugal filters to 
remove any unbound DNA and protein. In addition to the original unfiltered sample and 
the final washed SWNTs, all filtrates (the washes) will be collected and analysed for 
fluorescence.
4.2.1 Chemicals
The 5' amino C6  tagged T30 oligonucleotide was purchased from Eurofins MWG Operon 
(Ebersberg, Germany) at lpmol synthesis scale, with desalting as the oligonucleotide 
purification. The DNA received was resuspended in 1ml TE buffer and diluted accordingly 
to create a final stock concentration of 0.8mg/ml (MW = 9243 g/mol, concentration = 
8 . 6 6  x 10'5 mol/l). FITC tagged BSA used in this chapter was the same as that created in 
the previous chapter. Stock solution concentration was 9.3mg/ml BSA with 6.5pg/ml 
FITC, giving a molar ratio of 1.19:1 FITC:BSA.
All other chemicals used were of laboratory grade supplied by Sigma-Aldrich.
4.2.2 DNA Oligonucleotide amine substitution
To covalently attach the DNA and protein, carbodiimide chemistry was used. This method 
employed the activation of carboxyl groups, which then react with an amine to form an 
amide bond. To reduce the likelihood of protein cross-linkage, the DNA was activated 
first and the protein was then added. Carboxyl terminated oligos cannot be purchased 
however, so an amino group on a six carbon spacer was added to the 5' terminus of the 
oligo during manufacture. This was reacted with succinic anhydride in the method 
described below to yield a carboxyl terminated oligonucleotide.
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120pl of the stock DNA solution at a concentration of 0.8mg/ml was used in each sample 
created to give 0.96pg of DNA in each sample. The original solvent was evaporated and 
the DNA was resuspended in the same volume of acetonitrile. To this, l lp l  of a lmg/ml 
stock of succinic anhydride (SA) in acetonitrile and 24pl of a 1 in 1000 solution of neat 
triethylamine (TEA) in acetonitrile were added. These amounts give a 1.2:1 molar ratio to 
DNA for each reagent. This was left to react for two hours at room temperature. The 
acetonitrile was then evaporated and the DNA was resuspended in either water in 
preparation for DNA precipitation and washing, Tris-EDTA (TE) buffer pH 8.0 or 2-(N- 
morpholino)ethanesulfonic acid (MES) buffer pH 5.5 depending upon how the sample 
was to be used.
4.2.3 Solvent removal
At several stages in the functionalization process, the evaporation of solvents was 
employed so that the solvent may be changed. For this, vacuum concentrator 5301 from 
Eppendorf (Hamburg, Germany) was used. For water evaporation, the preset program 
designed for aqueous solvent evaporation was used. For acetonitrile and ethanol 
evaporation, a set temperature of 60°C was used. All solvents were evaporated to 
dryness.
4.2.4 DNA precipitation
To remove unreacted succinic anhydride and triethylamine, precipitation of the DNA was 
used. To the resuspended DNA in water (from acetonitrile), 1/10 volume 3M sodium 
acetate was added, and mixed briefly by vortexing. 5x volume of ice cold 100% ethanol 
was added and the sample was left at -80°C for two hours. The sample was then 
centrifuged at maximum g for 5 minutes and the supernatant removed, taking care not to 
disturb the pellet. 1ml of 70% ethanol at room temperature was added to the pellet, 
which was resuspended and then centrifuged for a further 5 minutes. The supernatant 
was removed and the pellet was dried using an evaporator. The purified DNA was 
resuspended in either TE buffer of MES buffer, depending upon the sample being 
prepared.
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4.2.5 DNA and BSA conjugation
Carbodiimide coupling has been used to conjugate FITC-BSA with the carboxylated DNA 
oligonucleotide. The FITC tagged BSA being used was that created as per section 3.2.4 
(BSA concentration 9.3mg/ml, molar coupling ratio 1.19:1, FITC:BSA).
Prior to the addition of the BSA, the relevant DNA samples had 12pl of 20mM EDAC (in 
water) and 12pl of 50mM NHS (in water) added. These samples were allowed to react at 
room temperature for thirty minutes, after which lp l of 2 -mercaptoethanol was added to 
quench any unreacted EDAC. After this, lOOpI of the stock FITC-BSA solution was added 
to each of the DNA solutions. The samples were mixed by vortexing and left to react 
overnight at 4°C, before being used for further experiments.
The amount of BSA added to the DNA was such that the ratio between the two (by mass) 
was approximately 1:1 (96pg of DNA present in the solution, and 93pg of BSA was added). 
Molar concentrations are approximately 7.4:1 DNA:BSA
4.2.6 Attachment of DNA-BSA complex to single walled carbon nanotubes
The DNA-BSA samples were mixed with lOOpI of a stock suspension (5mg/ml) of lightly 
oxidised SWNTs produced as detailed in section 3.2.3. Each DNA-BSA-SWNT sample was 
sonicated in an iced bath sonicator for thirty minutes to ensure a good bind between the 
nanotubes and the DNA/protein. 200pl of each of the DNA-BSA-SWNT samples was 
added to centrifugal filters with a 300KDa molecular weight cut-off (Nanosep filters, Pall, 
New York). These were spun at 16000 x g for ten minutes, or until all liquid has passed 
through the filter. 400pl deionised water was added to the filter to resuspend the 
nanotube mat, and the samples were centrifuged again. This was repeated until the 
nanotubes have been washed eight times. The filtrates from each stage were retained for 
further analysis.
4.2.7 Electrophoresis
Both DNA and protein electrophoresis were used to investigate the alteration of the 
terminal amino group of the DNA to a carboxyl one and the conjugation of the DNA to the 
BSA.
All DNA samples were run on a 10% polyacrylamide electrophoresis gel made using 19:1 
acrylamide/bisacrylamide (Bio-Rad). Gels were cast as described in section 2.3. The gel
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was run with a 10 base pair (bp) DNA step ladder from Promega (Madison, USA) with a 
range of 10-100bp. Ip l of the markers was mixed with 0.2pl of loading dye (Blue/Orange 
loading dye, 6 X) and 4.8pl of TE buffer per lane. 5pl of each sample was mixed with lp l of 
loading dye before loading. Gels were run using the Mini-PROTEAN Tetra Electrophoresis 
System (Bio-Rad) with TBE (tris-borate-EDTA) as the running buffer at 100V for 
approximately 1 hour. The gels was then stained using ethidium bromide at a 
concentration of 0.5ug/ml in running buffer (TBE) and imaged using the Syngene bio­
imaging Geneflash gel documentation system.
After the addition of the FITC-BSA, protein electrophoresis was performed using the 
Lamelli system(238). The stacking gel was made using 37.5:1 acrylamide/bisacrylamide at 
5% and the separating gel was made at 6 % using the same acrylamide/bisacrylamide 
ratio. Once set, the tank was loaded with Tris-glycine running buffer and the samples 
were loaded. The samples were mixed with loading buffer (lpl loading buffer, 5pl 
sample) prior to loading. Two marker ladders were used, Spectra™ Multicolor Broad 
Range Protein Ladder (Fermentas 10-260KDa range) and Prestained protein marker, 
broad range (New England Biolabs, 7-175KDa range). All samples (with loading buffer) 
and the markers from NEB were heated to 95°C for 3 minutes and cooled on ice prior to 
loading. The gels were run at 200V for approximately 30 minutes, stained with coomassie 
brilliant blue R-250 for 1 hour, and washed with destain, changing the solution several 
times until the background is clear. The gels were photographed with a digital camera.
4.2.8 Fluorescence measurement
Fluorescence counts for all samples were taken using a Perkin Elmer Victor 3 plate reader 
(Waltham, Massachusetts) with an excitation wavelength of 485nm and an emission 
wavelength of 535nm. Measurements were conducted in black walled 96 well plates with 
a measurement time of 0.1s per well. A calibration curve was constructed using FITC 
conjugated BSA of known FITC and BSA concentrations, thereby allowing the calibration 
of fluorescence to protein concentration. Three replicates for each sample were created 
(unfiltered sample, filtrates, washes and the recovered portion), with each well measured 
twice.
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4.3 Results and Discussion
A novel method for the conjugation of proteins to single walled carbon nanotubes has 
been investigated, using the methodology as described in section 4.2. FITC tagged BSA 
was attached in a novel manner to carbon nanotubes using DNA as a molecular tether. 
All samples were subject to polyacrylamide gel electrophoresis, with the results shown in 
sections 4.3.11 and 4.3.2.1. The DNA-BSA conjugates were mixed with oxidised SWNTs, 
sonicated, and filtered to remove any unbound protein and DNA from the SWNTs. The 
fluorescence of all collected portions was measured to assess the amount of BSA 
remaining on the SWNTs, and thus examine the efficacy of the functionalization method.
4.3.1 DNA functionalization
In total, nineteen differing samples were constructed to be joined to the FITC tagged BSA. 
Of these samples, only one was in effect the 'test' solution, encompassing all of the 
reagents and methods deemed necessary to substitute the terminal amino group for a 
carboxyl one and to purify that activated DNA. Table 4.1 describes the various 
combinations and permutations of reagents and methods used for each sample, and the 
order in which these steps were carried out.
Before conjugation with the BSA, one needs to be confident that the method employed 
for conjugation will be successful, and that the methods used in the production of the 
carboxylated have not had any negative effects on the DNA that would hamper 
conjugation. These steps include evaporation of solvents, the precipitation and washing 
of the DNA, and resuspension in buffers with differing pH values. Electrophoresis allows 
one to visualise the DNA in each of the samples and thus identify its presence in solution. 
The addition of the carboxyl group changes both the mass and the charge (albeit only 
slightly) on the DNA oligo and can also be assessed with gel electrophoresis.
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Sample Treatment
Sample
Number
Water
Evaporated
Resuspension 
in Acetonitrile
SA and TEA 
added
Acetonitrile
Evaporated
Resuspension 
in Water
DNA
Precipitated
Resuspension 
in TE Buffer
Resuspension 
in MES Buffer
EDAC and 
NHS addet
1
2 1 2
3 1 2
4 1 2 3
5 1 2
6 1 2
7 1 2 3
8 1 2 3 4
9 1 2 3 4
1 0 1 2 3 4 5
1 1 1 2 3 4 5
1 2 1 2 3 4 5
13 1 2 3 4 5 6
14 1 2 3 4 5 6 7
15 1 2 3 4 5 6 7
16 1 2 3 4 5 6 7 8
17 1 2 3 4 5 6
18 1 2 3 4 5 6
19 1 2 3 4 5 6 7
Table 4.1: Chart detailing reagents and methods used to create the DNA samples to be combined with FITC tagged BSA to evaluate a novel binding 
mechanism to single walled carbon nanotubes. Numbers in the chart refer to the processes involved in the making of each sample and the order in 
which they were undertaken. A blank cell indicates that the step was not done. Sample one for instance, contains only the original DNA. Each
sample contains 96pg of NH2-C6-T30 oligonucleotide. The methodology of each step is as described in section 4.3. SA = succinic anhydride, TEA = 
triethanolamine, TE = Tris EDTA, MES = 2-(N-morpholino)ethanesulfonic acid, EDAC = l-ethyl-3-(3-dimethylaminopropyl)carbodiimide, NHS = N- 
hydroxysuccinimide
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4.3.1.1 DNA Electrophoresis
The nineteen DNA samples made as described in Table 4.1 were analysed using 
polyacrylamide gel electrophoresis. Agarose gels, normally used for DNA analysis, do not 
provide the same resolution as acrylamide gels for DNA strands of short lengths.
EDAC and NHS were added to the relevant samples (no's 4, 7, 10, 13, 16 and 19) just 
before being run on the gels. The EDAC and NHS were allowed to react with the DNA for 
thirty minutes, after which excess and unreacted EDAC was quenched by the addition of 
lp l of 2 -mercaptoethanol.
To assess whether the terminal amino group of the T30 C6  NH2 oligonucleotide had been 
substituted for a carboxyl one, all samples were subject to polyacrylamide gel 
electrophoresis (PAGE), as opposed to agarose gel electrophoresis. The gel, at 10%, 
separates small fractions of DNA over the range of 25-35 base pairs(296). 5pl of each DNA 
sample was mixed with lp l of the loading dye for running on the gel. This would give a 
DNA concentration of approximately 3pg/pl. The concentration of DNA in the markers is 
O.lpg/pl. The gels were run for a maximum of one hour at a constant current and a 
voltage of 100V. A lObp step ladder (Promega) was used as molecular weight markers, 
and the gel was stained with ethidium bromide at lpg/ml final concentration and imaged 
using the Syngene bio-imaging Geneflash gel documentation system. An example of the 
developed gel is shown in Figure 4.2.
112
Chapter 4. DNA Mediated Functionalization
1 2 3 4 5 6  7 8  9 10 11 12
LOO
Wk
m-
iO
0
0
Figure 4.2:10% acrylamide gel loaded with DNA only samples one through eleven as described 
by Table 4.1. Column one contains the lObp step ladder, with the number of bases in each 
band indicated on the left hand side. The gel shows no discernable difference in the band 
placement between samples, and thus no evidence is presented for amino group substitution. 
Only faint bands are visible for all of the samples. This is presumably due to single stranded 
DNA having a low affinity for ethidium bromide. All gel samples are shown in Appendix 1.
Two gels were made for each set of samples, as each gel contained twelve wells. A single 
band of DNA was present in each of the lanes, with a base pair length of approximately 
thirty bases. The bands on the gel are not in exactly the same place as the ladder, as the 
ladder consists of double stranded DNA, which runs at a slower rate than single stranded 
DNA. All samples were heated to denature them prior to being loaded on the gel 
(including markers), but as the complementary strands in the markers are not removed, 
the double strands could reform. The bands can only be seen faintly, but on close 
examination, all are present in the gel. The faintness is due to ethidium bromide only 
having a slight affinity for single stranded DNA.
The presence of every band along the same line in the gel indicated that none of the 
methods used to manipulate the DNA have destroyed it or vastly changed the properties 
of the DNA. All of the samples contain enough DNA to be visible on the gel, although the 
exact amount is unknown. It has been assumed that for all experimental samples where 
no precipitation of the DNA is involved, the amount of DNA remains constant throughout. 
For those samples in which the DNA was precipitated and washed with ethanol as part of
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the methodology (samples 5-7 and 14-19), it was estimated experimentally that 
approximately 90% of the original DNA sample would be recovered.
The method used for substitution of the amino group for a carboxyl one would have 
added to the molecular weight of the final DNA samples by 10 Daltons (Da, one Dalton is 
one atomic mass unit). This is equivalent to approximately one third of a thymine 
nucleotide. This difference in the molecular weight is difficult to visualise using gel 
electrophoresis, so even if the substitution had taken place, it could not be shown using 
this method.
Assays exist which test for the presence of primary amines within a sample. One such 
method is to use ninhydrin, as per the Kaiser test. This assay was investigated, but found 
not to be of use as the sensitivity was not high enough.
The decision was made to couple the DNA with FITC tagged BSA and observe the 
outcome. A gel shift of over 9000 Daltons is much easier to visualise than one of 100.
4.3.2 DNA-BSA conjugation
Every one of the nineteen samples created as described by the methods in section 4.2 
was mixed with FITC tagged BSA. The various samples created were made to address 
several questions in the process of joining the oligo to the protein. First of all, does the 
method work, is there evidence for conjugation between the DNA and the BSA? 
Secondly, given the molar ratio of DNA to BSA, what is the apparent binding rate between 
the two? These questions are answered over the next sections.
Figure 4.3 shows a representation of the reaction scheme for DNA functionalization and 
BSA attachment.
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Figure 4.3: Scheme detailing the attachment of FITC tagged BSA to the carboxyl substituted T30 
C6 NH2 oligonucleotide, as outlined by Table 4.1.
4.3.2.1 Protein Electrophoresis
As shown in the previous section, electrophoresis of the DNA samples created was unable 
to show whether the terminal amino group in the relevant samples (numbers 11-16) was 
substituted for a carboxyl one. The decision was made to mix the DNA with FITC tagged 
BSA anyway, and to analyse the result using further electrophoresis. The carboxyl group 
addition to the DNA was neither proved nor disproved in the previous section. Providing 
at least one oligo attached to the protein, a mass change of approximately 9000Da should 
be visible on the gels.
To each of the DNA samples produced as per sections 4.2.2-4.2.4, 0.1ml of the 9.3mg/ml 
stock solution of fluorescein isothiocyanate (FITC) tagged bovine serum albumin (BSA)
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created as described in section 3.2.4 was added. With the initial mass of the DNA in each 
of the solutions being 0.96mg, the mass ratio for DNA.-BSA is roughly 1:1. The molar ratio 
is however approximately 7:1; i.e. for every molecule of BSA, seven DNA oligos were 
available or conjugation to it. It is expected that not every DNA oligo will conjugate with 
the BSA, as to achieve a 100% conjugation efficiency is virtually impossible. However, it is 
possible for more than one oligo to conjugate with the protein, which would be shown as 
multiple bands within the electrophoresis gels.
Six percent polyacrylamide gels were made as detailed in section 2.3 for analysis of the 
DNA-BSA samples. A lower acrylamide percentage provides higher resolution of protein 
bands at lower molecular weights. Once set, each of the samples containing DNA and 
FITC-BSA (nineteen in total) were loaded onto the gels (two gels with fifteen lanes each 
were created for each sample set). Those samples containing EDAC and NHS had a larger 
volume than those without (lOOpI of each stock solution was added to the DNA). For this 
reason, 9pl of those samples were mixed with 2pl of loading dye. For those samples 
without EDAC and NHS, 3pl was loaded onto the gel, along with lp! of loading dye and 2pl 
of running buffer. This was added to make the samples easier to load due to the small 
volume. The differing volumes of the samples loaded was to ensure that the bands would 
contain the same amount of protein across the gel. In addition, two different protein 
molecular weight markers were loaded, and a control sample containing BSA alone. The 
remaining wells were filled with loading dye mixed with running buffer. Gel 1 therefore 
contained, in order, Spectra multicolour broad range protein ladder (Fermentas), 
prestained protein marker (broad range, New England Biolabs), and DNA-BSA samples 
one to eleven. Gel 2 contained the markers, samples 12-19, and FITC-BSA alone. The gels 
were then run simultaneously using tris-glycine running buffer, at a constant 200V for 
approximately thirty minutes. The gels were then stained with coomassie blue and 
destained before being imaged.
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Figure 4.4: A typical protein PAGE gel generated after the separation of DNA-FITC-BSA samples 
stained with coomassie blue. The samples in wells 4 ,7  and 10 have a different mobility to the 
other samples on the gel. This difference is also seen in samples 13,16 and 19, all of which 
included EDAC and NHS as well as the DNA and BSA. The shift in the band position is indicative 
of a mobility difference in those samples, which in itself can be indicative of a higher molecular 
mass. All samples not containing EDAC and NHS occupied the same level as the control FITC- 
BSA lane. Also shown is the position of the marker band corresponding to a mass of 58kDa. 
Images of all gels created for this sample set can be seen in Appendix 1, along with more details 
of the molecular mass markers.
As Figure 4.4 demonstrates, the gel images show the presence of a protein in every lane 
of the gels that were loaded with protein. The position of the molecular weight markers 
indicates that these bands are approximately 58KDa in mass. The molecular weight of 
BSA is 6 6 KDa. However, these markers cannot be seen as accurate indicators of mass, as 
they consist purely of protein and the experimental samples potentially contain both DNA 
and protein. As electrophoresis is really a measure of the mobility of molecules (which in 
turn is affected by their molecular weight), one can only truly say that the bands have the 
same apparent mobility as the marker bands that correspond to approximately 58kDa. In 
addition, for those samples that included EDAC and NHS, a difference in mobility from the 
other samples can be seen (lanes 4, 7 and 10 in Figure 4.4). This result was not wholly 
expected. This difference corresponds to a retardation of the sample that generally 
implies a larger molecular weight.
It was predicted that this would happen for all samples where the terminal amine group 
on the DNA was being substituted for a carboxyl group (samples 13 and 16). However, as 
every sample that contained EDAC and NHS (samples 4, 7, 10, 14, 16 and 19) showed a 
mass change, it is possible that another functional group may also influence the
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conjugation. Without EDAC and NHS, there was no mass change and therefore no 
conjugation is observed, indicating that it is the EDAC and NHS that are responsible for 
the conjugation.
Although the primary target for EDAC are the carboxyl groups, they are not the only 
target. EDAC can react with thiol groups, such as those found in tyrosine(297), and 
phosphate groups1298*.
Conjugation to phosphate groups is of particular interest in this research, as phosphate 
groups are present in DNA. Ordinarily, EDAC can only activate the phosphate group 
found at the 5' terminus of DNA, forming a phosphoramidate linkage. It cannot activate 
phosphate groups internal to the DNA structure due to the pH conditions utilised by EDAC 
not being favourable*299*. Usually, when one orders chemically synthesised 
oligonucleotides, they do not contain a terminal 5' phosphate, due to the way in which 
they are synthesised. However, the addition of the terminal amino group with carbon 
linker is facilitated through a phosphate group. Although not truly at the end of the DNA 
chain, this phosphate group is still more available for functionalization using EDAC than 
those internal to the structure. The six carbon spacer does not provide the same 
environment for the phosphate as it would encounter in the middle of the DNA chain. It 
is therefore possible that this phosphate group is amenable to functionalization, and 
hence may be the functional group that facilitates attachment of the protein to the DNA. 
Figure 4.5 shows a schematic for the possible reaction mechanism between the DNA and 
BSA using the phosphate group activated with EDAC and NHS
The gel seems to show that in the samples with EDAC and NHS, the protein and DNA are 
being conjugated. Analysis of the shift in molecular weight between like samples gives 
more indication of how the mass is changing. Using the markers with known molecular 
weights, a calibration curve for relative molecular mobility was constructed. As stated 
previously (section 2.3) electrophoresis gels are more commonly analysed through the 
calibration of log molecular weight of the markers versus distance travelled by band. 
However, as the markers do not contain DNA, it was decided to use the relative mobility 
against molecular weight. Relative mobility (the R/ value) is calculated by dividing the 
distance that the band in question has migrated down the gel by the total distance moved 
by the dye front. Each one of these measurements is taken from the top of the
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separating gel. Table 4.2 shows the estimated molecular weights for each of the samples 
produced.
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Figure 4.5: Reaction progression for the conjugation of a protein to an amino C6 tagged DNA 
oligonucleotide. EDAC and NHS activate the phosphate group near the terminus of the DNA. 
This NHS ester formed on the phosphate group is similar to the well established scheme for 
using imidazole with EDAC to facilitate conjugation.
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Sample R/Value Apparent
Molecular
Weight
1 0.79 54675.33
2 0.80 53865.41
3 0.78 56401.99
4 0.70 66517.63
5 0.79 55330.88
6 0.77 57241.56
7 0.71 65022.63
8 0.76 58078.02
9 0.77 56994.95
1 0 0.75 60286.39
Sample R/Value Apparent
Molecular
Weight
1 1 0.77 57646.09
1 2 0 . 8 6 52922.79
13 0.80 60040.72
14 0.85 53996.34
15 0.85 53996.34
16 0.79 62202.30
17 0.83 57112.26
18 0.82 57772.15
19 0.78 63677.02
2 0 0.84 55175.25
Table 4.2: R/ values and calculated relative molecular weight for DNA-BSA samples one to 
twenty. Values were calculated using calibration curves with R/values of markers with known 
molecular weights. For a detailed description of each sample, the reader is referred to Table 4.1
It is important to note that in comparison to the samples with no EDAC or NHS but the 
same buffer (MES), there is a definite difference in the mobility and therefore apparent 
molecular weights between these samples. For example, the difference between samples 
fifteen and sixteen is approximately 8000Da. The mass of the DNA oligo is approximately 
9500Da. Due to the inexact nature of measuring molecular weights on electrophoresis 
gels, it can be presumed the mass change between samples fifteen and sixteen is 
equivalent to the addition of one DNA strand. In fact, the mass difference is equivalent to 
one oligonucleotide addition per protein molecule. This result suggests that despite the 
7:1 molar ratio of the DNA to the protein, only one strand conjugates to a protein 
molecule. If a sample had had more than one DNA molecule attached to the protein, 
then multiple bands should be visible on the gel of a comparable separation distance. 
Multiple bands are seen, but they do not correspond to a single BSA molecule conjugated 
with multiples of the DNA molecule. Three more bands can be seen at a much higher 
molecular weigh in all of the gel lanes. These could be attributed to one of two factors; 
dimers of BSA in spite of agents in the loading buffer for the prevention of this, or 
contaminants of other proteins in the original BSA preparation. Such contaminants are 
usually due to the process that is used for the separation of BSA from whole serum, 
however their presence is unlikely as the BSA used was of a high purity (electrophoresis 
grade, 99% pure). The marker band corresponding to the position of the second band 
seen in all samples has a molecular weight of 135KDa. A dimer of BSA would have a
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molecular weight of 132KDa, and is therefore the most likely reason for the second band 
shown on the gel. The two further bands are likely to be further polymers of the BSA, but 
without the presence of further molecular weight markers it is difficult to confirm that is 
the case.
4.3.3 Fluorescence measurements
The aim of this chapter is to create a novel method of protein conjugation to carbon 
nanotubes, and to compare it to the methods assessed in Chapter 3. To do this, the DNA- 
BSA samples were mixed with 0.1ml of the stock SWNT solution created as per section 
3.2.3. The samples were sonicated in a bath sonicator for thirty minutes to allow the 
protein and DNA to coat the nanotubes and aid further in their dispersion. The samples 
were then mixed overnight on a rotary mixer. lOOpI of each of the samples was then 
filtered and washed with water using centrifugal filters with a molecular weight cut-off of 
300KDa. The portion of each sample that was not filtered and washed was retained, and 
is from this point referred to as 'unfiltered'. The DNA-BSA-SWNT samples were washed a 
total of eight times with 0.4ml of deionised water, with the filtrates being retained after 
each stage for analysis. Each one of these filtrates is referred to as wash 1, 2 etc. The 
first filtrate is referred to as 'flow through'. After filtration and washing, any material 
retained by the filters (i.e. the nanotubes with attached proteins) was resuspended, and is 
thus named 'recovered'.
As the protein bound to the nanotubes (bovine serum albumin in this case) has been 
previously tagged with fluorescein, the method used to determine the amount of BSA 
attached to the nanotubes is fluorescence. Each sample was measured for fluorescence 
on a 96 well plate reader, with an excitation wavelength of 485nm and an emission 
wavelength of 535nm. In addition to the experimental samples, FITC-BSA standards of a 
known protein and FITC concentration were measured.
Figure 4.6 shows the fluorescence results for the nineteen differing DNA-BSA samples. All 
contain FITC-BSA and single walled carbon nanotubes.
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Figure 4.6: Graph showing normalised fluorescence values for all nineteen of the samples 
created for the DNA mediated attachment of BSA to single walled carbon nanotubes. The 
values are expressed as a percentage of the highest fluorescence measurement taken. The 
sample treatments are as described in section 4.2 and Table 41. 'Unfiltered' refers to the 
fluorescence measurement of a portion of each sample created that was not subject to 
filtration and washing through 300KDa MWCO centrifugal filters. 'Flow through' refers to the 
first filtrate, it the medium in which the nanotubes and DNA-BSA was originally suspended. All 
subsequent washes were done using sterilised deionised water. The recovered sample was 
made by the resuspension of the nanotube protein mix trapped on the upper side of the 
centrifugal filters.
In addition to the fluorescence measurements for the experimental samples, the 
fluorescence of standards containing known concentrations of FITC-BSA was measured. 
Using this information, a calibration curve for protein concentration versus fluorescence 
was constructed. Using this calibration curve, one can translate the fluorescence 
measurements of the nineteen experimental samples into protein concentrations. For 
any individual sample, (including the original unfiltered samples), these values were no 
more than 0.2mg/ml. As was observed in Chapter 3, the amount of fluorescence seen in 
all samples containing nanotubes is not as high as one would expect given the original 
protein concentrations; 1.8mg/ml for those samples containing EDAC and NHS, and 
2.9mg/ml for those samples without. These concentration values are higher than those
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used for the experiments in the previous chapter, due to the lower volumes used. The 
protein mass in the samples however has remained the same.
In order to ascertain the amount of protein that is attached to the carbon nanotubes, the 
total amount of protein washed off the nanotubes for each sample was calculated. As 
observed in Chapter 3, the presence of the nanotubes in the sample being measured by 
the plate reader greatly decreases the potential level of fluorescence in the sample. This 
is most likely due to absorption of the light at the excitation wavelength and that light 
therefore not being available to the fluorescein for excitation.
Sample Number
Figure 4.7: Calculated protein concentrations for the unfiltered portions and washes for all 
nineteen DNA-BSA samples combined with single walled carbon nanotubes. The 'washes and 
recovered protein' bars are produced through the summation of the result of the eight washes 
each sample underwent and the value from those portions recovered from the filters after 
washing. These portions together contain all protein originally added to a sample, and should 
thus total 0.93mg. Error bars are generated by the standard error introduced through the best 
fit data of the calibration curve. The sample numbers show in the graph are as described in 
Table 4.1, with the addition of FITC-BSA.
Figure 4.7 shows the calculated protein concentrations for the unfiltered portion (black 
bars) and for the washes combined with the recovered portion (red bars) for the nineteen 
samples generated. Sample 1 consists of the original DNA oligonucleotide (it has not 
been subjected to any of the processes involved in the amino group substitution) 
together with the FITC-BSA. This can be seen as a true control sample. All other samples 
(excluding sample 16) were meant as methodology controls. If one excludes sample 1 for
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a moment, a pattern emerges with the remaining samples on the graph. Each group of 
three samples (two, three and four, for instance) have a methodology in common but the 
final step in their individual protocol differs. The first of the three is resuspended in TE 
buffer (pH8 ), mainly to create favourable conditions for the DNA itself. The second and 
third are resuspended in MES buffer (pH5.5), with the third also containing EDAC and NHS 
for carbodiimide coupling. One can see in those samples originally containing TE buffer, 
the highest amount of protein has been washed from the nanotubes. TE buffer favours 
DNA solubilisation, and without the attachment of the protein, this could mean that the 
DNA wraps readily around the nanotubes, preventing non-specific adsorption of the 
protein to the nanotube sidewalls.
Of the two samples containing MES buffer, those containing EDAC and NHS have the least 
amount of protein removed during the washing. This may be due to either the protein 
covalently attaching directly to the nanotubes, or the DNA mediated binding is better for 
protein attachment to the nanotubes. It is unlikely however, that the protein has become 
covalently bound to the nanotubes as 2-mercaptoethanol, which quenches EDAC, was 
added to the DNA solutions containing EDAC prior to the addition of the protein, let alone 
the nanotubes. This therefore makes the scenario of the protein being well bound to the 
nanotubes through the DNA linker more probable.
Figure 4.8 shows a comparison of the estimated protein concentrations for all the 
samples containing EDAC and NHS as well as the DNA, FITC-BSA and carbon nanotubes. 
The graph shows in black the values of the unfiltered samples, i.e. those with all of the 
original ingredients with no washes. The red bars show the total wash values, 
determined through the addition of the protein concentrations from all washes, and the 
green bars show the amount of protein on the nanotubes recovered from the top of the 
filters.
The majority of these discussions will focus on the samples containing EDAC and NHS. 
Protein gel analysis showed a mass change for only these samples, indicating that these 
were the only ones in which the DNA had been covalently conjugated to the BSA, even 
though there is argument over the manner in which that conjugation has taken place.
The protein concentration in the unfiltered portion of the samples should equal that of 
the total of the washes and the recovered sample. In addition, the total protein 
concentration in either the unfiltered portion or the washes and recovered portion
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should sum up to the protein concentration added at the beginning of the experiments. 
This value was 0.93mg of protein per sample, regardless of the volume. Figure 4.8 shows 
that this value is not seen in either the unfiltered samples or the wash totals. Similar to 
the results seen for all conjugation methods investigated in Chapter 3, there is some 
quenching of the fluorescence in the original samples. It is known that the signal is 
quenched as without nanotubes, the fluorescence values are much higher. In addition, 
the amount of fluorescence measured in the recovered portion is low. This would be due 
to similar reasons.
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Figure 4.8: Protein concentration for samples 4, 7,10,13,16 and 19, all of which contain EDAC 
and NHS as carbodiimide coupling agents. These samples all showed evidence on protein PAGE 
gels of conjugation between the DNA oligonucleotide and FITC tagged BSA. Protein 
concentrations were calculated using a calibration curve for fluorescence versus known protein 
concentration. In addition, the values have been altered by a factor of 1.9 from the original 
measurements in order to make the values comparable to protein concentrations calculated in 
Chapter 3, section 3.3.5.
For sample thirteen in Figure 4.7, the amount of fluorescence observed in the unfiltered 
portion of the sample is higher than the others. This could indicate either that fewer 
nanotubes were held in solution, or that more protein molecules were held further away 
from the surface of the nanotubes, and were thus more able to absorb light for excitation 
of the fluorescein. The same can be said of sample sixteen. These two samples were the 
only ones to contain succinic anhydride and triethylamine -  the agents used in the 
substitution of the terminal amino group for a carboxyl one. This may indicate that for 
these two samples, the method of conjugation between the DNA and protein may have
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been the carboxyl group, as favoured by carbodiimide coupling agents. The reasoning 
behind this thought is that the chain length between the nanotube, the DNA and the 
protein may be longer. The photons emitted by the fluorescein as it relaxes down to the 
ground state are less likely to be absorbed by the nanotubes and therefore easier to 
detect by the plate reader.
The amount of protein washed off each of the samples shown in Figure 4.8 is roughly the 
same for all of the samples, as is the measurement for the amount of protein remaining 
on the nanotubes after washing.
The main observation that can be made from this graph is that the differing methods 
used in the preparation of these samples have not had a significant impact on the amount 
of protein washed from the nanotubes, and therefore the amount of protein that remains 
on the tubes.
4.3.4 Comparison of Functionalization Methods
In order to assess the novel conjugation method investigated in this work, a comparison is 
made between this method and those previously established and investigated in chapter 
three. As has been stated previously, the presence of carbon nanotubes in the unfiltered 
and recovered portions for all of the conjugation methods investigated does not give an 
accurate portrayal of the amount of protein bound to the nanotubes. As detailed in the 
previous chapter, the best way for measuring this was deemed to be the subtraction of
the amount of protein removed by the washes from the amount originally added.
Sample Protein 
concentration in 
washes (mg/ml)
Starting protein concentration 
minus wash protein 
concentration (mg/ml)
Amount of BSA 
remaining on 
SWNTs (%)
FITC-BSA 0.193 0.737 79
PBSE FITC BSA 0.427 0.503 54
EDAC NHS 0.37 0.56 60
FITC BSA
DNA FITC BSA 0.113 0.817 8 8
Table 4.3: Comparison of functionalization methods of single walled carbon nanotubes with 
FITC tagged BSA. Shown are the three methods investigated in chapter 3 as well as the novel 
DNA mediated conjugation. The amount of protein remaining on the nanotubes is calculated by 
subtracting the protein removed through washing from the original amount of protein added to 
the samples.
Table 4.3 shows a comparison of the amount of protein removed from the nanotubes. 
This is then used to calculate the amount of protein remaining on the nanotubes. It is
127
Chapter 4. DNA Mediated Functionalization
clear that the method that has the most protein remaining on the nanotubes is the novel 
DNA mediated attachment. The mechanism of attachment may be two-fold. The use of 
the DNA to anchor the protein to the nanotubes may be in addition to non-specific 
binding of the protein to the nanotubes. If all DNA molecules in the sample are bound to 
protein, they aid in anchoring the protein to the nanotube. If there are some free DNA 
molecules, it is likely that these would prevent some non-specific binding of the protein 
to the nanotube, as the binding of DNA to nanotubes is strong. With a higher amount of 
protein bound to the nanotubes, it is unlikely that non-specific binding is prevented, as 
the amount of protein on the nanotubes would be lower.
The novel method of DNA mediated binding of FITC-BSA is the most efficient method out 
of the four methods described both in this and the previous chapter, at 8 8 % of the BSA 
initially added being attached to the nanotubes.
4.4 Conclusions
The binding of FITC tagged BSA to single walled carbon nanotubes has been achieved 
through a novel method, using a short DNA oligonucleotide as a linker molecule. The 
interaction between DNA and with nanotubes and potential applications have been 
shown*84,93,102'300'302*. The research presented here only uses the DNA for its structural 
and binding properties to the nanotubes.
An attempt was made to couple an amino tagged T30 oligonucleotide to FITC tagged BSA. 
The amino group was reacted with succinic anhydride to create a terminal carboxyl 
group. Nineteen different samples were made to test the methodologies and reaction 
stages in the functionalization process. Each of these samples was run on a 
polyacrylamide electrophoresis gel, in order to analyse the samples. The gel showed the 
presence of DNA in all of the samples constructed, but no direct evidence for 
carboxylation. Simple assays, such as the Kaiser test can assess for the presence (and 
therefore absence) of amino groups. However, initial testing using an alternative primary 
amine at the DNA concentration and therefore amino group concentration that would be 
present in the samples showed that the assay was not sensitive enough. Despite being 
unable to confirm the carboxylation of the DNA, the decision was taken to mix the DNA 
and BSA and examine the result. Only two of the samples were expected to react with 
the BSA, samples 13 and 16 which both contained the succinic anhydride (SA) along with
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EDAC and NHS, the carbodiimide coupling agents. However, upon gel electrophoresis it 
was evident that all samples that contained the carbodiimide coupling agents (EDAC and 
NHS) caused a mass change in the gel. All of these bands were in the same position on 
the gel. Those samples without EDAC had a smaller mass equivalent to that of a BSA 
control. The difference in mass between the bands was equivalent to one DNA molecule 
being added to one BSA molecule. This is despite a 7:1 molar ratio of DNA:BSA. 
Carbodiimide coupling occurs between carboxyl and amino groups, with the carboxyl 
group being presented on the DNA and the amino groups present on the BSA. Even 
though the BSA has already been functionalised with FITC, which uses the same amino 
targets, BSA has 60 lysine residues that can be functionalised. The amino acid lysine is the 
principal donor of primary amines.
It has been proposed that the reason for functionalization of the BSA with DNA for all 
samples containing EDAC and NHS was the presence of the phosphate group at the 5' 
terminus of the DNA. Ordinarily, chemically synthesised DNA terminates in hydroxyl (OH) 
groups at either end of the molecule. However, the amino group at the 5' terminus of the 
linker oligo is attached to a phosphate group. Under normal conditions, the terminal 
phosphate group of DNA can be activated by EDAC for carbodiimide coupling, and 
internal phosphate groups are not activated. However, although not a true terminal 
phosphate group, due to the presence of the six carbon linker and the amino group, it is 
still more accessible to functionalization. In addition, the site at which the EDAC activates 
the phosphate group is not occupied by the terminal C6  amino group. It is possible to 
synthesise oligos with a terminal phosphate group. This would not however, allow the 
protein to be partially removed for surface contact with the nanotube. This spacing may 
have an important role to play as reports have suggested that for enzymes bound to 
nanotube the activity can be affected by the proximity to the nanotubes(n6,128).
It is possible that both mechanisms for attachment of the DNA to the protein are in use in 
the same sample. Those samples containing the potentially caboxylated DNA bound with 
BSA (numbers 13 and 16) showed higher levels of attachment of the protein to the 
nanotubes than those samples which contained only EDAC to bind the DNA and BSA. 
Fluorescence measurements of all sample portions to determine the concentration of BSA 
remaining bound to SWNTs after eight washes showed that the method employed for 
functionalization was effective. Only 12% of the original protein added to the nanotubes
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was washed from the nanotubes. With an apparent binding efficiency of 8 8 %, this 
method has the highest binding rate in comparison to the other methods explored in 
chapter three. A repeat of the experiments found a similar relationship in the order of 
binding efficiency.
The decision was made early on in the functionalization process to add the DNA to the 
protein before introducing the carbon nanotubes. Although DNA is known to wrap well 
around nanotubes, there is no data how the DNA termini interact with nanotubes, and 
therefore if they would be accessible to functionalization. In addition, due to the 
nanotubes already having been lightly oxidised, to couple the carboxylated DNA with the 
protein using EDAC whilst in the presence of carboxylated nanotubes would not result in 
the DNA alone becoming functionalised. Lahiji et al.(303) found that by chemically 
oxidising the nanotubes before sonication and DNA addition, the number of DNA 
molecules bound to the nanotube was actually increased. This implies that using oxidised 
nanotubes in no way hampers DNA binding to the nanotubes. Oxidising carbon 
nanotubes creates a hydrophilic environment that is more suited for the binding of 
biomolecules.
To the authors' knowledge, no one has used such a method as described here to attach a 
protein to single walled carbon nanotubes. The reverse of this method however, has 
been examined, Lyonnais et al.’304) coated SWNTs with streptavidin, to which biotinylated 
DNA oligos were added, creating a novel method for the attachment of DNA to 
nanotubes.
If nanotubes were functionalized with proteins in this manner, one needs to examine the 
potential applications for such a system*42,68,305*. Lenihan et al.(306) attached alkaline 
phosphatase to carbon nanotubes indirectly though using streptavidin on the nanotubes 
as an anchoring layer. The ALP was biontinylated, which attached itself to streptavidin 
covered MWNTs. They were able to show that despite the ALP not being directly in 
contact with the nanotubes surface, they were able to create a sensor capable of 
detecting the ALP enzymatic action. In addition, the signal measured for the device was 
influenced by the substrate concentration. It is therefore feasible that using DNA as an 
anchor to tether enzymes to nanotubes for purposes of biosensing would work.
The wrapping of nanotubes with nucleic acids not only makes them more suspendable in 
aqueous solutions, but can also aid with biocompatibility. This has implications in
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medicine, for example the role of nanotube as targeted carriers for chemotherapy agents. 
Certain tumour types express large numbers of markers on their surface, against which 
antibodies can be raised. These antibodies can be attached to nanotubes loaded with 
chemotherapy drugs, which will allow the selective targeting of cancer cells in the
body'42'47'307'308’.
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Chapter 5. Functionalization of Single Walled 
Carbon Nanotubes with the Enzyme Urease
5.1 Introduction
One of the greatest potential applications for carbon nanotubes in chemistry and 
medicine is molecular sensing. Carbon nanotubes have been shown to be sensitive to a 
wide variety of chemical species in both gaseous and liquid forms<152'153'159), making them 
suitable for both environmental(216,309) and medical’310'311* sensing.
In sensor devices, carbon nanotubes would act as the transducer, being the element 
sensitive to condition changes in the environs of the device. When coupled with an 
enzyme with specificity for a substrate, nanotubes can be made into a selective 
biosensor. Many enzymes have been attached to nanotubes to date, with research 
showing the sensitivity and specificity of such potential devices. Such biosensors could be 
used either in the large central laboratories for testing biochemical samples, or for testing 
a sample at the point of care.
Perhaps the most commonly performed test on blood and urine within a clinical 
biochemistry setting is for urea. Urea ((NH2)2CO) is the main nitrogen containing 
compound that is excreted by mammals. It is produced by the liver from ammonia, the 
result of the metabolism of amino acids and the breakdown of proteins. Ammonia is 
highly toxic, and is thus converted to the highly water soluble and relatively non-toxic 
urea in the mammalian urea cycle. From the liver, the urea is excreted from the blood 
into urine by the kidneys. The urea level is therefore a good indicator of both kidney and 
liver function, and as many other factors in the body can affect the function of these 
organs, it is also a good general indicator of health. In addition to measuring urea 
concentrations for human disease diagnosis and monitoring, urea sensing is also used in 
other disciplines. For example, dairy farmers can measure the milk urea nitrogen (MUN) 
level to investigate feeding efficiency within the herd. Urea is used as a nitrogen fertiliser, 
and so the monitoring of urea levels in soil can give an idea as to the health of a crop.
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The current methods used for urea sensing involve the enzymatic breakdown of urea into 
its constituents. This process is explained in section 5.1.1, along with sensor devices that 
have been previously investigated. This thesis is not aiming to create an actual sensor 
device. Instead, it aims to understand the basics of how an enzyme such as urease can be 
attached to nanotubes with a view to making devices such as sensors. In order to create 
a viable device, one needs to know that the enzyme involved can be attached in the 
highest quantities possible, that the method of attachment is stable so that the enzyme 
concentration will not decrease over time and that the method used does not seriously 
impede the catalytic activity of the enzyme. By examining the catalytic activity, one can 
compare and discover the best technique of those used in this thesis for urease 
immobilization on single walled carbon nanotubes
5.1.1 Urease and Urea Sensing
Urea sensing has long been a subject for scientific investigation due to its use in disease 
diagnosis and monitoring. In solution, urea is very stable. However, it does eventually 
decompose first to ammonium carbonate then to ammonia and carbon dioxide. The 
melting point of urea is 1S2.7°C, where it decomposes to form products including 
ammonia, oxides of nitrogen, cyanuric acid (C3 H3N3 O3), cyanic acid (CNOH), biuret 
(H2NCONHCONH2) and carbon dioxide.
Urea concentration can be determined through either directly detecting urea, or by 
detecting the products of its decomposition. Direct detection of urea involves the use of 
mass spectroscopy, which can be time consuming and costly. Both these factors are 
unwanted in a situation where speed is of the essence, such as a clinical environment. 
Indirect detection usually involves quantifying the amount of ammonia produced as a 
result of urea decomposition. Heating a sample would bring about decomposition, but it 
is not practical for clinical chemistry. Urea levels are measured in both the blood and in 
urine. In both fluids, there are other components that could also produce ammonia as a 
breakdown product, and thus falsify any results. One further option is the enzymatic 
breakdown of urea using urease. The enzyme is specific for urea and does not react with 
any of the other components found in blood and urine. Urease hydrolyses urea to form 
carbon dioxide and ammonia, with ammonia being the major target for detection and
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quantization of urea levels. The measurement of carbon dioxide is not generally used to 
measure urea concentration as it is simpler to measure ammonia concentration.
Ureases (EC 3.5.1.5) are enzymes that catalyse the hydrolysis of urea, initially to ammonia 
and carbamate, with the carbamate spontaneously decomposing to carbon dioxide. 
Ureases belong to the enzyme class 3.5.1.5. Ureases are hydrolases that catalyse the 
breakdown of C-N bonds in compounds other than peptides. Urease can also be called 
urea amidohydrolase. The reaction for the urease catalysed breakdown of urea is as 
shown in Figure 5.1
Figure 5.1: The breakdown of urea as catalysed by urease.
Ureases can be found from both microbial and plant sources. The role of ureases from 
any source is to allow the organism to generate nitrogen from externally or internally 
generated urea.
Jack bean urease (JBU, from Canavlia ensiformis), in particular, is in many ways one of the 
'firsts' of the enzymatic world. It was the first enzyme to be isolated as a crystal in 1926. 
It was the first example of a nickel metalloenzyme. The nickel centre is essential for the 
catalysis of urea breakdown. The actual mechanism used by urease to hydrolyse urea is 
unknown. The latest model has proposed the polarization of the urea carbonyl by one of 
the two nickel ions, which then allows a nucleophilic attack by an activated hydroxyl 
anion associated with the second nickel ion in urease(312).
Even with all of these 'firsts', very little of the physical structure of JBU is known. Fishbein 
et al.<313) first reported the molecular weight of JBU to be 480KDa, as determined through 
ultracentrifugation measurements and electrophoresis. The amino acid sequence of JBU 
was determined in 1988(314). JBU is 840 amino acids in length, with the molecular weight 
being calculated at 90770Da for a monomeric unit excluding the two nickel atoms 
associated with each monomer. JBU associates as monomers, trimers and, most 
commonly, hexamers. The molecular weight for the hexamer, (including two nickel 
atoms per subunit) is 545340Da, different to the value given by Fishbein. To this day, JBU
NH2
* 2 N H 3 + C 0 2
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providers still give differing information on the molecular weight of jack bean urease, 
although the generally accepted value is that derived from the amino acid content.
Some bacterial urease structures have been resolved, but not that of JBU. The isoelectric 
point for JBU is 5.0-5.1, meaning at pH7, JBU has a net negative charge. It is known that 
JBU does not bind well to Palmityl-Substituted Sepharose 4B, showing that in its native 
form JBU has little affinity for hydrophobic supports. This indicates that there is little or 
no availability of hydrophobic side chains on the surface of the urease protein(315),(315). 
This lack of hydrophobicity is an important consideration when binding urease to carbon 
nanotubes. Defect-free nanotubes are very hydrophobic, and are thus less susceptible to 
interact with hydrophilic species.
As previously stated, the method for determining the urea in clinical samples involves its 
enzymatic breakdown into the constituent components of ammonia and carbon dioxide. 
Various methods exist for the quantization of ammonia, produced by the hydrolysis of 
urea. Chemical reactions based on methods originally devised by Nessler’317* or 
Berthelot’318* are colorimetric, and are thus measurable using visible light spectroscopy. 
Ion selective electrodes for ammonium ions consisting of a hydrophobic membrane 
permeable to ammonia coupled with a potentiometric ion sensor are also used. pH 
values can be used to measure ammonia concentration, as an increase in these ions leads 
to an increase in pH. In addition, some enzymes (e.g. glutamate dehydrogenase or 
glutamine synthetase) use ammonia as a substrate in their reactions.
Methods to determine carbon dioxide concentration are not generally used. This is partly 
due to the ease with which ammonia can be measured, and partly due to potential 
interference from atmospheric C02
The urea biosensor that is in use today in many clinical biochemistry laboratories is an 
optical system based on that devised by Kaltwasser and Schlegel(319) in 1966 and further 
developed by Roch-Ramel in 1967(320). Urea is hydrolysed by urease to produce ammonia 
and carbon dioxide. The ammonia then reacts with 2-oxoglutarate (also known as a- 
ketoglutarate) in the presence of glutamate dehydrogenase (GLDH) and reduced 
nicotinamide adenine dinucleotide (NADH), to give glutamate, water and oxidised 
nicotinamide adenine dinucleotide (NAD+). The rate of decrease in the NADH 
concentration per unit time is directly proportional to the urea concentration, and is 
measured by absorbance at 340nm. For each molecule of urea hydrolysed, two
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molecules of ammonia are produced, each of which is then used by GLDH to make 
glutamate. Urea concentration is determined through assessing the initial velocity for the 
sample and comparing it to a calibration curve of known urea concentrations versus 
velocity. This coupled enzyme method will be used in this chapter to determine a 
relationship for urease concentration versus the initial velocity of the reaction.
It is important to note that in this system, urease is not immobilised, and therefore 
potentially wasted in the process. Urease is relatively cheap, but immobilization and 
reuse of a urea sensor could make the system cheaper. In addition, time is a large factor 
for this system. For a large clinical laboratory analyser such as the Bayer Advia° 1650 
chemistry system, it takes around 8  minutes to load the sample, analyse it and gather the 
results. However, in a clinical environment handling time such as sample centrifugation, 
bar-coding, information input on the computer system, and quality control all have to be 
taken into account, making the processing of a clinical sample much longer. Point of care 
testing drastically reduces these steps and thus samples are processed much more 
quickly.
5.1.2 Enzymes and Carbon Nanotubes
The attachment of enzymes to carbon nanotubes offers a whole new functionality of 
nanotubes that can be exploited for new technologies. Enzymes are proteinaceous 
catalysts found in every living organism and as such, they are greatly utilised in large 
numbers in industry, medicine, and scientific research. The immobilization of industrially 
and medically important enzymes on platforms such as carbon nanotubes provides 
several advantages over enzymes in solution. Immobilised enzymes retain their high 
catalytic rate; they are highly stable and can be reused. In addition, the surface to which 
the enzyme is immobilised can offer protection from temperatures and pH levels outside 
the normal range of an enzyme. Nanotubes themselves offer a high surface area to which 
an enzyme can attach, potentially leading to a high enzyme loading concentration.
Many different carbon nanotube based sensors using a wide variety of enzymes have 
been produced in the research community. In addition to the wide range of enzymes 
used, they also vary in their detection methodologies. Many sensors have been made 
which exploit the electronic properties of nanotubes, using them as electrodes for the
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acceptance or donation of electrons to the enzyme in question*201’321,3221. Other sensors 
rely upon a change in resistance being measured*323*.
This chapter however, is not aiming to create a biosensor, only establish the platform 
(urease functionalised nanotubes) with which it could be made. In addition, the method 
for determining the urease concentration conjugated to the nanotubes will rely upon the 
urease retaining its activity.
Several research groups have examined the impact that carbon nanotubes have on the 
activity of different enzymes. The results can vary widely, from a reduction in activity of 
99% for a-chymotrypsin*128), to no apparent decrease in activity for horseradish 
peroxidase*138’. It is difficult to predict how an enzyme will behave when immobilised on 
a support, purely due to the vast difference in enzyme structure and reaction 
mechanisms. It has however, been found that decreasing the size of the supporting 
material can improve the efficiency of the immobilised enzyme*116’.
Allen et al.*324’ have shown that horseradish peroxidase remained active for a period of at 
least four weeks, whilst they investigated the ability of the enzyme to degrade SWNTs. 
Cang-Rong and Pastorin*116’ used both physisorption and covalent chemistry to 
immobilise amyloglucosidase to SWNTs and MWNTs. Their results suggested that the 
highest protein load was for those samples prepared using physisorption. This result ties 
in with the findings of the author in chapter three. They did however, use an absorbance 
based concentration assay to determine this. When assessing the difference in activity 
for each functionalization method, they found, as would be expected, that the activity 
remained highest for samples where the enzyme was adsorbed to the nanotubes, with 
approximately 50% of the activity retained. For the covalent samples, high values of Km 
were calculated, indicating a decrease in substrate affinity, with a corresponding activity 
of less than 1 0 % when compared to the native enzyme.
Yi et al.*135’ have been able to prevent RNA cleavage by ribonuclease A (RNase A) by 
conjugating it to carbon nanotubes. Interestingly, RNase A has been used by Jeynes et 
al.*107’ in the presence of SWNTs to degrade the RNA which had been used to purify the 
nanotubes.
To the author's knowledge, there is only one publication by Xu et al.*325’ which has 
coupled urease with carbon nanotubes. They exploited the fact that an increase in 
ammonia concentration leads to an increase in pH, and thus created a pH sensitive
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voltammetric biosensor. They modified a glassy carbon electrode by coating it with 
carbon nanotubes, and then immobilised urease on top using sol-gel hybrid material. The 
sensor without the presence of urease showed no response to the addition of urea, 
whereas with urease they were able to create a calibration curve for potential change 
versus log urea concentration. The response however, was not entirely linear. The 
researchers were able to go on to use the device on clinical samples, which showed some 
correlation to urea concentrations determined using more conventional methods.
In this particular chapter, the reader will be presented with the functionalization of single 
walled carbon nanotubes with the hydrolytic enzyme urease. Two different methods will 
be used to achieve this, with the methods being compared to determine which is the 
most useful. Initially, a physical examination of SWNTs with urease attached using a 
pyrene based linker (non-covalent bonding) using atomic force microscopic imaging will 
be shown. Urease will then be attached to SWNTs using both physisorption (non-specific 
binding) and the pyrene linker. A comparison of urease concentration will be made 
between the two methods by examining the activity of the enzyme. Although this work 
will not go so far as to create an actual sensor, the aim is to provide the basic platform 
with which a sensor can be built.
5.2 Materials and Methods
Urease has been attached to single walled carbon nanotubes in two different ways. As 
demonstrated in chapter three, the most efficient method for the attachment of BSA to 
SWNTs was non-specific binding. In addition, the non-covalent linker 1-pyrenebutanoic 
acid succinimidyl ester (PBSE) and covalent binding using EDAC were demonstrated. The 
efficacy of these two methods was approximately the same. On that basis, only non­
specific binding and the non-covalent linker will be used to conjugate urease to SWNTs. 
Atomic force microscopy will be used to examine the binding of urease to SWNTs using 
PBSE. The amount of urease conjugated non-specifically and with PBSE to SWNTs will 
then be compared using calibration curves constructed using known urease 
concentrations. The calibration curve will be made using an enzymatic assay for ammonia 
concentration.
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5.2.1 Atomic Force M icroscopy of Urease conjugated SWNTs
To assess the manner of binding of urease to SWNTs using the linker PBSE, atomic force 
microscopy (AFM) will be performed. Four different sample types for examination will be 
constructed: oxidised SWNTs, oxidised SWNTs with PBSE, oxidised SWNTs with PBSE and 
urease, and plain urease. In all images, 2pl of the sample was placed onto 1cm2 pieces of 
freshly cleaved mica (Agar Scientific, Stansted UK). The samples were left to adhere to 
the surface for thirty minutes, after which any remaining liquid was removed by drying 
the mica under a flow of nitrogen. The samples were imaged using a Dimension 3100 
(Digital Instruments) atomic force microscope (AFM) in tapping mode in air. All images 
were analysed using WSxM software develop 7.71, from Nanotech Electronica S.L., freely 
available at http://www.nanotec.es. Approximately 40 height profiles were taken for 
each of the four samples.
Oxidised SWNTs are produced as described by section 3.2.3. A working concentration of 
lmg/ml was used for imaging.
For the samples that included SWNTs with PBSE, 2.5mg (6.5mM) of PBSE was added to 
lm l of a lmg/ml solution of oxidised nanotubes. The sample was sonicated in a bath 
sonicator for thirty minutes and mixed on a rotating mixer for two hours at room 
temperature. The SWNT-PBSE sample was then centrifuged at 13000 rpm (16060 x g), for 
90 minutes and the top 800pl was recovered, taking care not to disturb the pellet.
A solution of urease equivalent to 400 enzyme units per millilitre (U/ml) was made in 
0.1M phosphate buffer pH 7.2(195ml 0.2M NaH2P04  (24g in 1L), 305ml 0.2M Na2HP04 
(29g in 1L) 500ml distilled water). In this thesis, 400U/ml was equivalent to 13.5mg/ml 
protein.
To create the sample that included SWNTs, PBSE and urease, 2pl of the SWNT/PBSE 
sample was placed onto a mica piece and dried. 2 ml of the urease solution was then 
placed on top of the coated mica piece and left overnight. The excess liquid was 
removed, the mica was washed with water and the sample was then dried under a flow 
of nitrogen.
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5 .2.2 Preparation of urease-SW NT samples for conjugation technique 
comparison
In a similar manner to the techniques used in chapter three, two different methods for 
the conjugation of urease to SWNTs were compared. Solutions containing non- 
specifically bound urease and urease conjugated to SWNTs with PBSE were made. These 
samples were used to estimate the amount of urease bound to the SWNTs. In addition to 
the test samples, controls consisting of plain SWNTs, PBSE, SWNTs with PBSE and 
unconjugated urease were also made.
SWNTs were purified and oxidised as per the scheme described in section 3.2.3. A stock 
solution at a concentration of 2.5mg/ml was used as the source of all SWNTs. Stock 
solutions of PBSE (lOmg/ml in DMSO) and urease (1150 enzyme units/ml (U/ml), 
16mg/ml, 70SU (specific units:-units per mg protein) in 0.1M phosphate buffer pH 7.4) 
were also made. The final concentration of each reagent in the relevant sample was
0.25mg/ml SWNTs, 40pg/ml PBSE, 30U/ml urease. One unit is defined as the amount of 
urease that catalyses one micromole of urea per minute at 25°C and pH 7.6.
Urease was non-specifically bound to SWNTs by placing lOOpI of the stock SWNTs with 
26pl of the urease stock and adding phosphate buffer to a final volume of 1ml. The PBSE 
based samples were made by first mixing lOOpI SWNTs with 4pl of the PBSE stock 
solution on a rotating mixer for thirty minutes. The urease (26pl of the stock) was then 
added and all of the samples made were mixed overnight on a rotating mixer at room 
temperature. After mixing, 0.5ml of each sample was filtered using centrifugal filters with 
a pore size of 0.1pm (Ultrafree MC, Millipore, Billerica, MA) at 12000 x g for five minutes 
or until all liquid has flown through the filter. All filtrates were preserved for future use, 
and the material remaining on the filter (SWNTs with bound urease) was resuspended 
through adding 0.5ml phosphate buffer and tip-sonication (Sanyo MSE soniprep 150) to 
remove the material from the centrifugal filter.
5.2.3 Determination of urease concentration through activity when bound 
to SWNTs
As stated previously, the efficacy of a device employing enzymes not only depends upon 
the activity of the enzyme, but also the amount. As already found in chapter three, 
conventional methods for protein concentration determination could not be used in the
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presence of carbon nanotubes due to their interference in the assays. Fluorescently 
tagged proteins were shown to be useful in this case. However, this method can only be 
applied to proteins that have been tagged prior to use. In the case of enzymes, molecular 
manipulation such as tagging can alter their catalytic activity and therefore their kinetic 
properties. Fortunately, the catalytic activity of enzymes can be monitored as long as 
their substrate and/or products can be quantified, as discussed in chapter 2.4.
Urease activity is generally assessed by measuring the ammonia concentration as a result 
of the catalytic breakdown of urea. In this chapter, a coupled assay that utilised the 
ammonia produced through the breakdown of urea was used to monitor urease activity. 
The second enzyme, glutamate dehydrogenase (GLDH) used the ammonia in its own 
catalytic reaction, the conversion of a-ketoglutarate to glutamate. This two enzyme 
method is used to measure urea concentration in clinical biochemistry laboratories. 
When urea concentration is measured, the only variable in the reaction is the urea 
concentration itself. In this method, the urea concentration was kept constant and the 
urease concentration varies.
A calibration curve for reaction velocity versus known urease concentrations was 
constructed before using the assay to estimate the concentration of urease bound to 
SWNTs made as described in the previous section.
Two-fold serial dilutions of the stock urease solution (1150U/ml) were used to create 
eight different concentrations of urease for the calibration curve (287, 144, 72, 36, 18, 9,
4.5, 2.2 U/ml). The neat stock solution and the first dilution were not used, as these 
reactions progressed too quickly to be monitored accurately. In addition, a control with 
no urease was used as a OU/ml solution.
For each concentration, three cuvettes were prepared containing 0.25M urea, 2.4mM 
NADH ((3-Nicotinamide adenine dinucleotide, reduced dipotassium salt), 8.6mM a- 
ketoglutarate (a-Ketoglutaric acid potassium salt), lOU/ml GLDH in 0.1M phosphate 
buffer pH 7.4 to a volume of 0.9ml.
A spectrophotometer (Varian Carey 5000) was set to a wavelength of 340nm, blanked on 
air and phosphate buffer and zeroed on a solution that did not contain any NADH. The 
depletion of NADH is being monitored, therefore if the solution was zeroed with NADH 
present, absorbance would progress to negative figures. Each of these cuvettes was 
placed into the spectrophotometer, lOOpI of the relevant urease solution was added and
141
Chapter 5. Urease Functionalization
the absorbance over time was measured. The reaction was allowed to progress until the 
absorbance reached zero, at which point the NADH had been depleted and the reaction 
stopped. Measurement was stopped when the absorbance remained at zero for more 
than one minute.
Multiple curves were produced for absorbance versus time for each urease 
concentration. For each of these curves, the gradient of the line (change in absorbance 
over time) where the reaction is at a steady state was taken as the velocity of the 
reaction. These velocities were then plotted against urease concentration to give a 
velocity versus concentration calibration curve.
Once the calibration data had been collected, lOOpI of each of the experimental samples 
made to investigate binding to SWNTs (section 5.2.2) was measured in the same way as 
the calibration curve samples. The rates for each reaction were taken to determine the 
relative rate with urease of a known concentration.
These values were then used to compare the methods of functionalization used to 
conjugate urease to SWNTs.
5.3 Results and Discussion
The enzyme urease has been attached to single walled carbon nanotubes in two different 
manners. Atomic force microscopy was used to monitor the functionalization process in 
terms of moieties being added to increase the profile of SWNTs. An attempt was made to 
assess the activity of urease on SWNTs whilst on a mica surface, using a pH based assay. 
Lightly oxidised (and therefore suspendable in aqueous solvents) SWNTs were loaded 
with urease using either non-specific binding or non-covalent linkage using PBSE. A 
calibration curve of urease concentration versus activity was constructed in order to 
determine the amount of urease attached to the nanotubes. The two methods of 
functionalization were then compared.
5.3.1 Atomic Force Microscopy of SW NTs, SWNTs with 1-pyrenebutyric 
acid N-hydroxysuccinimide ester (PBSE) and Urease
Several images comprising of plain SWNTs, urease, SWNTs with PBSE and SWNTs with 
PBSE and urease were obtained using a Dimension 3100 (Digital Instruments) AFM in
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tapping mode. A representative height and phase image of each sample type is shown in 
Figure 5.2.
These images were analysed using WSxM software. The four different samples as 
described in section 5.2.1 were imaged and approximately 40 height profiles using the 
topographical images were taken for each sample. Table 5.1 shows the number of data 
sets for each sample the minimum and maximum heights, the height range, the mean 
height for each sample type, and the standard deviation of the heights. All values are in 
nm to two decimal places.
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Figure 5.2 AFM images of A: Urease B: Plain SWNTs C: SWNTs with PBSE D: SWNTs with PBSE 
and urease.
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Sample
Number of 
measurements
Minimum
height
(nm)
Maximum
height
(nm)
Height
range
(nm)
Average
height
(nm)
Standard
deviation
(nm)
Urease 40 1.67 6.31 4.64 3.28 1.25
Plain SWNTs 
SWNTs with
41 2.88 6.67 3.79 4.92 1.08
PBSE 
SWNTs with
40 3.72 10.60 6.88 6.88 2.05
PBSE and 
Urease
38 6.53 17.70 11.17 12.22 3.12
Table 5.1: Data on AFM images for urease, plain SWNTs, SWNTs with PBSE and SWNTs with 
PBSE and urease.
16 -i
14
Urease Plain SW NTs SWNTs with PBSE SWNTs. PB SE  and Urease
Sample
Figure 5.3: Graph showing average height of differing stages of SWNT functionalization as 
detailed in table 5.1. Error bars shown are the standard deviations for each sample set.
Figure 5.3 shows in graphic form the average heights of the samples. The error bars 
shown are the values for the standard deviation for each of the sample sets. It is clearly 
seen from the graph that the average height of the samples is increasing. This indicates 
that material is being functionalized. The average height for the SWNTs was 4.92nm, a 
height that corresponds to small bundles (3-4) of SWNTs. The increase in height between 
the plain SWNTs and those with PBSE was 1.96nm. Despite the fact that the arrangement 
of PBSE on SWNTs has been studied theoretically166’, the distance the succinimidyl ester 
group projects away from the surface and therefore the size that the PBSE molecule 
would add to the surface of the nanotube has not been revealed. It is therefore
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impossible to estimate the amount of PBSE molecules adhered to the sidewalls of the 
SWNTs.
The average height for the plain urease was measured at 3.28nm. The difference 
between the SWNTs with PBSE and those with PBSE and urease was 5.34nm. This height 
increase corresponds to a layer of urease that is 1.6 times the height of the native urease 
measured. However, although this particular type of urease was the first enzyme to be 
crystallised, there is still much debate as to its morphology and physical size. It is 
therefore difficult to estimate whether the urease is binding to the nanotubes in one or 
more layers, as one cannot assume that the native urease has been measured as 
individual molecules. In fact, this is unlikely as the urease was measured outside of its 
natural aqueous environment. In addition, as the nanotubes were functionalised with the 
urease when they were already on the surface, it is unlikely that the urease would cover 
the whole of the nanotube circumference.
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Figure 5.4: Histogram showing distributions of height taken from AFM images. A: Urease B:
Plain SWNTs C: SWNTs with PBSE D: SWNTs with PBSE and urease. Arrows M-P represent the 
different stages of functionalization.
Figure 5.4 shows a histogram of the distributions of heights from the AFM images. It can 
clearly be seen that there is in an increase in height, as the distributions are moving to the 
right. The graph shows Gaussian distributions for urease (A) and plain SWNTs (B). 
However, there are bi-modal distributions for the SWNTs with PBSE (C) and the SWNTs 
with PBSE and urease (D). Arrow M in plot C shows those SWNTs that may not have been
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functionalized with PBSE, or areas of a nanotube that have been missed by the PBSE. This 
distribution matches the heights measured for the SWNTs alone. The measurements 
represented by arrow N on plot C are most likely to be nanotubes that have been 
functionalised with the PBSE. Arrow O on plot 4 could represent either SWNTs that have 
only been functionalised with PBSE, or that have only been functionalised with urease. 
The height distributions in plot D do not show much evidence for plain SWNTs. Arrow P is 
most likely to represent those SWNTs that have been functionalised with both the PBSE 
and urease. From the distribution seen on plot D, one must assume that all the 
nanotubes are covered with either PBSE or urease but not necessarily both.
5.3.2 Estimation of Urease Concentration through Activity when 
Conjugated to SW NTs and Methodology Comparison
The concentration of urease bound to SWNTs can be investigated through an enzyme 
assay. A calibration curve was constructed with the velocities of known urease 
concentrations that was then used to estimate the relative amount of urease bound to 
the SWNTs.
For the calibration curve, eight different urease concentrations were created from a stock 
solution containing 1150U/ml. lOOpI of each dilution (287, 144, 72, 36, 18, 9, 4.5, 2.2 
U/ml) along with a negative control containing no urease was added to a pre-prepared 
assay mix containing 0.25M urea, 2.4mM NADH, 8.6mM a-ketoglutarate and lOU/ml 
GLDH in 0.1M phosphate buffer pH 7.4. The absorbance at 340nm over a period of time 
was measured to monitor the depletion of the NADH. Figure 5.5 shows the absorbance 
measurements for each of the urease concentrations used. The concentrations shown in 
figure 5.5 are a tenth of those mentioned in the text, as they were diluted by a factor of 
ten in the assay mix. As shown in Figure 5.5, lower urease concentrations lead to a 
shallower gradient. As the gradient is a measure of initial velocity, the lower the amount 
of urease, the lower the velocity.
The initial reaction velocity is calculated as a change in absorbance over time. It is 
measured by dividing the change in absorbance during the period when the absorbance is 
decreasing linearly by the time period over which it is linear. The simplest way to 
determine the gradient of each plot in the linear phase was to take a tangent of the curve 
and use the extremes of the tangent for the absorbance and time values (for example,
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Figure 5.6). The logarithmic x axis helps in the determination of the linear portion of the 
curve. The same curve can also be achieved through plotting the natural log of the 
absorbance against time.
0 U/ml Urease 
0 22 U/ml Urease 
0 45 U/ml Urease 
0 90 U/ml Urease 
1.80 U/ml Urease 
3 60 U/ml Urease 
7 19 U/ml Urease 
14 4 U/ml Urease 
28 7 U/ml Urease
Time (minutes)
Figure 5.5: Absorbance versus time for urease concentrations of 0,0.22,0.45,0.90,1.80,3.60, 
7.19,14.4 and 28.7 U/ml measured using the GLDH coupled assay with 0.25M urea.
Time (minutes)
Figure 5.6: An exemplar plot for absorbance versus time used to determine the initial reaction 
velocity by drawing a tangent to the curve.
From the plots shown in Figure 5.5 and plots such as 5.6, the initial reaction velocities for 
each of the known urease concentrations was calculated and plotted on the calibration 
curve for velocity versus urease concentration shown in Figure 5.7.
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Urease Concentration (U/ml)
Figure 5.7: Calibration curve for initial reaction velocity versus urease concentration. The data 
was fitted with a curve using equation 5.1 (R2 = 0.99).
From the fit of the calibration curve, one can use Equation 5.1 to calculate the 
concentration of urease in samples with an unknown amount from the initial reaction 
velocity.
V =  Ae~xl tx +  y 0 5.1
Where V is the initial reaction velocity, A is -2.303 ± 0.093, x is the urease concentration 
(U/ml), ti is 7.423 ± 0.840 (minutes) and y0 is 2.372 ± 0.092. Rearranging the equation 
with x (urease concentration) as the subject allows one to calculate the urease 
concentration in experimental samples as the initial velocity for the sample can be 
measured.
Figure 5.8 shows the plots obtained for all samples generated for urease non-specifically 
bound to SWNTs. The first thing to notice with this result is that the urease must still be 
active in order to have catalysed the hydrolysis of urea. This finding also applies to the 
PBSE conjugated samples.
For each of the conjugation methods used (non-specific binding and non-covalent 
binding), six different sample stages are created which were then analysed for urease 
activity. These stages (unfiltered sample, flow through, washes 1-3 and recovered 
sample) were applied to all of the samples created for this investigation, including the 
controls (plain SWNTs, plain urease, plain PBSE and SWNTs with PBSE). All of the samples 
that did not contain urease showed no change in absorbance at 340nm, signifying that 
any decrease on absorbance is due only to the presence of urease.
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Tim e (m inutes)
Figure 5.8: Absorbance measurements for all sample treatments of SWNTs functionalised non- 
specifically with urease.
The traces on Figure 5.8 with the shallowest gradients correspond to the absorbances for 
each of the three washes. Although urease is a large protein (545KDa in mass based on 
the amino acid sequence’3261) and is found with a homo-hexameric tertiary structure 
(each subunit is 91KDa), it would still be smaller than the 0.1pm pore size of the filters 
used to wash the functionalised nanotubes. Jack bean urease was the first enzyme ever 
crystallised but its exact structure and therefore dimensions still remains a mystery. Any 
urease that is not bound to the nanotubes passes freely through the filter, as 
demonstrated by the lack of activity after the initial urease containing solution is passed 
through the filter (the flow-through sample). This finding was backed up with the urease 
only sample, which showed no activity other than in the unfiltered and flow-through 
sample stages. No activity was found in the recovered sample for the plain urease 
control, meaning that the urease itself is not retained by the filter.
Using the equation determined from the fit of the data in the calibration curve (Figure 
5.6), the relative urease concentrations in each of the samples and each stage in the 
sample preparation can be calculated. Figure 5.9 shows the calculated urease 
concentrations for all the samples that initially contained urease. Those samples that did 
not contain urease to begin with did not cause NADH to be reduced in the assay and 
therefore the absorbance at 340nm did not change. No change in the assay absorbance 
indicates a velocity of zero and therefore no urease. The SWNTs and PBSE themselves 
therefore did not contribute to the assay. Despite all of the experimental samples having
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had the same amount of urease added from the same stock solution, the relative amount 
measured from its activity in the unfiltered samples is different. The native urease 
sample (green bars) shows the highest amount of activity and therefore relative urease 
concentration, followed by the urease non-specifically bound to the nanotubes and finally 
the urease bound with PBSE. This indicates that the presence of the nanotubes may alter 
the catalytic activity of the enzyme.
The sample containing native urease as a control shows that all of the urease passes 
through the filter in the first stage; none is retained by the filter, as evidenced by the 
washes and the lack of activity in the recovered sample. The amount of urease in the 
flow through stage of the same sample is roughly the same as the amount measured in 
the unfiltered sample. It is the only sample to show a slightly higher activity after 
filtration than the unfiltered sample.
Urease
SWNTs and Urease
Sample Treatment
Figure 5.9: Estimated urease concentrations for plain urease (green bars), urease bound non- 
specifically to SWNTs (SWNTs and urease, pink bars) and urease bound using PBSE (SWNTs,
PBSE and urease, brown bars). Concentrations were calculated using the calibration curve of 
known urease concentrations versus the initial velocity of a coupled activity assay shown in 
Figure5.6.
The samples that contain SWNTs both show a lower amount of urease removed during 
filtration than for the plain urease. They do however, both show evidence of catalytic 
activity in the sample recovered from the filter after washing. The fact that no urease is 
present in the washes indicates that any that had not bound to the SWNTs is washed off 
in the first filtration stage. The amount of urease in the recovered samples is less than 
that found in the original samples. It is sensible to assume that the amount of urease
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washed off the nanotubes initially corresponds to the difference between the unfiltered 
and the recovered samples. This initial loss of urease could be due to either a lack of 
binding sites for the urease, or the inability of the urease to bind.
The urease concentration present in each sample should have initially been 30U/ml. 26pl 
of the 1150U/ml stock urease solution was added to all of the samples and dilutions that 
were made. However, the concentration calculated for the unfiltered plain urease 
solution used as a positive control was found to be approximately 4.4U/ml, with the flow 
through containing approximately 4.9U/ml, around six times less than the amount 
originally intended. This discrepancy between the expected concentration measurements 
and the actual measurements was unexpected, as the urease solutions used for the 
calibration curve and the experimental samples were made simultaneously. The sample 
containing native urease without nanotubes showed the same decrease in activity as the 
samples containing nanotubes. However, all of the measured urease calculations showed 
similarly low results, indicating that the discrepancy must be as a result of the activity 
assay itself, not the sample preparation. Repeats of the assay showed a similar difference 
in the expected and measured values. The physical amount of urease had not been 
analysed, as the amount of protein in a sample does not always equate to the same 
amount of activity. This would be one potential way of confirming whether the activity 
assay was at fault or there was a genuine mistake in the preparation of the samples. A 
handling error is unlikely however, as all of the samples containing urease showed 
similarly lower velocities and therefore apparent urease concentrations.
As the lower measurements were noted across all of the samples that were made, it is 
still possible to compare the samples and draw conclusions from the measurements. The 
only thing that cannot be said with any certainty without considerable further 
investigation is whether the assay was correct in the concentrations of urease that had 
been calculated.
One can see from the graph that there is not much difference between the 
concentrations of urease remaining on the SWNTs for the two different methods of 
conjugation. They both have approximately the same amount of urease removed in the 
first filtration step relative to their starting concentration. The activity of the non- 
specifically bound urease is higher than that of the urease bound using PBSE in all of the 
sample stages. This could be due to either a difference in the amount of active urease
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that has been bound to the nanotubes, or a difference in the kinetic activity of the urease. 
To assess the kinetic properties of urease, one needs to repeat the experiments with the 
same sample using varying concentrations of urea. If this had been investigated, the 
Michaelis constant (Km) for the urease determined for each sample could be compared 
with the known Km for urease (1.3mM(327)) as well as the values for each conjugation 
method.
5.4 Conclusions
This chapter has aimed to conjugate the enzyme urease to SWNTs in two different ways, 
and understand how much urease was bound to the nanotubes.
Four main questions were asked of this chapter. Has the urease been conjugated to the 
nanotubes and was the urease active? Was it possible to work out the amount of urease 
attached to the SWNTs through monitoring its enzymatic activity, and did the method of 
attachment have any influence on the amount of urease bound to the nanotubes? 
Evidence shown with the atomic force microscope has suggested that urease remains in 
close contact with the nanotubes on a surface. The gradual increase in height over the 
four sample types made showed the various stages of functionalization. However, as the 
three dimensional structure for the urease used in this thesis is unknown, one cannot 
provide information as to the possible amount of urease that could exist on a unit length 
of nanotube. The preparation method was simple, with the gradual building of the layers 
upon a mica piece signifying that the urease and PBSE were free to bind to the whole 
mica sheet, and were therefore not confined to the surface of the SWNTs. In addition to 
the pictorial evidence, without the presence of urease, the nanotubes did not remain 
suspended in solution.
The question of whether the urease was still active in the presence of the nanotubes was 
answered with the coupled activity assay in which GLDH utilised the ammonia produced 
through the hydrolysis of urea. It found that there was certainly enough ammonia 
produced by the urease to be easily measurable with the assay. However, no information 
on whether the catalytic activity of urease has been affected by conjugation can be 
gathered from the data described here. In order to assess this, one must carry out the 
assay on each sample using different concentrations of the substrate, i.e. urea. With that 
data, the values of Km and Vma)( can be calculated and compared with native urease. The
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affect of nanotube binding on enzyme activity has been investigated by several groups, 
with varying results*116'128'138'3281. Many of the results suggest that binding decreases the 
activity, but none have suggested that it can be enhanced. The binding of enzymes to a 
substrate not only means the enzyme can be regenerated, but it is often protected from 
damage from the environment (e.g. pH and temperature). A high concentration of 
enzyme and environmental protection can often lead to an apparent increase in enzyme 
activity.
The next question to answer was whether the coupled assay could be used to determine 
the amount of urease on the nanotubes. The answer to this question is that it could 
potentially be used. Although the determined urease concentrations were approximately 
l/6th of those expected, especially for the positive control of native urease, it was easy to 
establish a calibration curve with a good relationship for urease concentration versus 
velocity (r2=0.991). Even with a repeat experiment showing similar results, the only 
feasible explanation for the lower velocities and therefore lower apparent urease 
concentrations is a decrease in the velocity of the GLDH assay. Ignoring the translations 
of the velocities to urease concentration, the relationship between all of the samples 
containing urease was very similar. They all appeared to have roughly the same amount 
of activity initially, indicating a similar amount of urease. All of the native urease passed 
through the 0.1pm filters, so there was no reason why any that had not been firmly 
bound to the nanotubes should not be washed off. The amounts of urease that were 
removed from the non-specific binding and PBSE samples were similar, with similar 
results again for the recovered samples.
The observations stated above can answer the last question in this chapter -  does the 
conjugation method affect the apparent amount of urease on the nanotubes? It does 
not.
The reasoning behind the wish to establish whether the conjugation method affected the 
amount of urease was to try to determine which would be best if a biosensor were to be 
constructed. Urea sensors based on potentiometric*329'3311, amperometric*332'3351 and 
conductometric*336,3371 methods have all been found in the literature. In a biosensor, the 
carbon nanotubes would detect and transduce any signal produced as a result of a 
chemical reaction or a binding event (in the case of antibodies) to be interpreted as a 
quantifiable signal. In the case of a urea sensor, the reaction could be monitored either
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as a result of a change in ion concentration (pH) from the ammonia, or a change in 
resistance due to the interaction of the local environment with the nanotubes. Several 
researchers have shown carbon nanotubes to be sensitive to ammonia’338'339*, but in the 
gaseous form. pH based sensors have also been created’192,340*. Functionalized 
nanotubes can be trapped between electrodes for placing into a sensor using 
dielectrophoresis’339*, grown as an array into a sensor platform’23* or immobilized on 
existing commercial electrodes’341*.
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The multidisciplinary subject of nanotechnology offers great hope and potential in 
understanding and potentially solving many biological problems. These range from the 
creation of novel smaller and more sensitive biosensors to targeting drug delivery agents 
in areas such as cancer therapeutics. No matter what the application is, in situations 
where a protein must be bound to a surface for any reason the amount of the 
immobilized protein and its retention of structure and function are of great importance. 
This thesis aimed to conjugate BSA and urease to single walled nanotubes in several 
different ways. Attempts were made to determine the amount of these proteins bound 
to the nanotubes in order to elucidate the most efficient method of binding these 
particular proteins.
In chapter three, initial experiments using BSA as an exemplar protein showed that 
conventional protein concentration assays suffer greatly from interference by the carbon 
nanotubes present. Fluorescence based techniques could be used to overcome the 
nanotube absorbance. However, there is potential for carbon nanotubes to also interfere 
with fluorescence, as they could absorb much of the light needed to excite the 
fluorophore in question. A comparison of the apparent amount of BSA removed from 
nanotubes after washing revealed that the best method of functionalization appeared to 
be simple non-specific binding, or physisorption, as compared to a non-covalent method 
using PBSE and covalent carbodiimide coupling. This result is mirrored by the findings of 
Cang-Rong et al.(116)
Chapter 4 demonstrated a novel method for protein binding using a short DNA 
oligonucleotide as a molecular linker between the nanotubes and the BSA. As with the 
previous methods, fluorescently tagged BSA was used to investigate the apparent amount 
of the protein bound to the nanotubes. This investigation found that the method used 
seemed to allow even more binding of the BSA to the SWNTs with approximately 88% of 
the original BSA adhered to the nanotubes as opposed to 79% for non-specifically bound 
BSA.
As well as BSA, the enzyme urease has also been conjugated to SWNTs in chapter five. 
Atomic force microscopy of the non-covalently functionalised nanotubes with PBSE and
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urease revealed a regular increase in height corresponding to the heights measured for 
native urease samples. As an alternative to tagging the urease with a fluorophore, its 
enzymatic activity was used to try to establish the amount bound to SWNTs. A calibration 
curve for urease concentration versus initial reaction velocity was established which was 
then used to estimate the amount of urease bound to SWNTs both non-specifically and 
non-covalently. Although the calculated urease concentrations were not as high as 
expected, a comparison between the samples has revealed that the conjugation 
techniques used does not seem to have been a factor in the amount of urease bound to 
the nanotubes. It would be interesting to investigate the use of DNA to bind urease to 
SWNTs. The effect that conjugation has on the kinetic properties of the urease also needs 
to be investigated. This would be done through assaying the relevant samples with 
several different urea concentrations. As well as the GLDH coupled assay that has been 
used in this thesis, Fourier transform infrared spectroscopy (FTIR) has also been used to 
monitor urease activity*342*. In this assay, the extinction coefficients of both urea and 
bicarbonate are monitored. There is every chance however, that the nanotubes could 
again mask any signal specifically related to the presence of either the urea or the 
bicarbonate.
In addition to a general activity investigation, it would be interesting to physically 
investigate the urease, i.e. determine if there had been any change in its structure upon 
binding to nanotubes. Several researchers have used circular dichroism (CD) to assess the 
structure of proteins bound to carbon nanotubes1116'139'343'344*. CD spectroscopy measures 
the differential absorption of left- and right-handed circularly polarized light.
Ultimately, the creation of a novel urea sensor incorporating the methods used in this 
thesis would be desirable. As already stated, many different types of sensors have been 
created in the literature, all of which could be suitable for use with carbon nanotubes as a 
transducing element. However, if the author were to create a sensor, a Wheatstone 
bridge type circuit would be constructed. This setup monitors the difference in resistance 
between the two different arms of a circuit, one of which would contain the 
functionalised nanotubes with which the biochemical test was to be performed.
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Figure 6.1: An illustration of the Wheatstone bridge, used to measure the resistance at point R*. 
The resistances at Rlf (fixed) R2 (changeable) and R3 (fixed) are known, and the resistance of 
point R2 is altered to reach a point where it cancels out the resistance of the unknown.
Shown in Figure 6.1, this circuit, tries to nullify the resistance at Rx by balancing it against 
Ri, R2 and R3. These points all contain resistors of known resistance, with the resistor at 
R2 being adjustable. The idea is that the resistances on both sides of the bridge should 
balance out so that Ri/R2 = R3/Rx. This method allows the detection of small amounts of 
resistance, and therefore would create a device with good sensitivity. Such a device 
would be similar to the potentiometric urea sensors already present in the 
literature'345,346*. Functionalised nanotubes could be trapped at point Rx using a technique 
such as dielectrophoresis, which can cause the movement of particles under a non­
uniform electric field.
One further type of protein not used in this work but of great medical importance are 
antibodies. Specifically targeted to their antigen, antibodies can not only be used to 
detect and identify foreign substances in the body (as part of the immune system), they 
can be used as targeting molecules. Today in oncology, a big challenge is getting the right 
treatment to where it is needed in the body. Many chemotherapeutic agents tend to 
attack all cells that are rapidly dividing, causing the many side effects that we all too often 
associate with cancer. Cell targeting and delivery of drugs only to the cancerous cells is 
therefore of huge interest. The functionalization of nanotubes with antibodies that could 
deliver the chemotherapy agent has already been shown to be possible by several 
groups'47,308,347*. Maintaining the structure of antibodies is more important than 
maintaining the structure of enzymes, as a loss in the ability of an antibody to recognise 
its binding site would result in the homing device being useless. This would potentially
158
Chapter 6. Conclusions
lead to the nanotubes accumulating in an undesired area, and problems with toxicity 
could arise(348 350).
In addition to being drug carriers in oncology, carbon nanotubes have potential as tumour 
killers as well. Nanotubes are highly absorbent of light in the near-infrared range, which 
our bodies are permeable to. Once in place, a laser could be used to induce local heating 
of ingested nanotubes which would then cause the lysis of the cells*351,3521.
This seemingly simple thesis has striven to answer a big question that faces 
manufacturers who want to create devices that incorporate proteins. That is to say, does 
the device that has been created have the best possible protein loading, is the 
conjugation method we have used suitable for the application and does the conjugation 
method have any influence on the activity of an enzyme? These questions can only be 
answered using investigations such as those used in this thesis.
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